data_2n68_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2n68 _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.578 0 N-CA-C 117.138 1.615 . . . . 0.0 117.138 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 94.9 mt -125.06 -30.24 3.23 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 120.258 3.429 . . . . 0.0 120.258 177.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 70.5 m -143.57 -178.64 5.99 Favored 'General case' 0 N--CA 1.449 -0.522 0 O-C-N 125.556 1.785 . . . . 0.0 110.263 -176.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . 0.325 82.6 mm-40 -62.36 136.26 57.83 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 113.593 -1.639 . . . . 0.0 113.545 -174.109 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -174.3 -164.91 30.03 Favored Glycine 0 C--N 1.336 0.578 0 CA-C-N 119.764 1.166 . . . . 0.0 114.574 -176.162 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 12.1 t -87.21 -38.18 11.86 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 CA-C-N 111.819 -2.19 . . . . 0.0 110.986 -171.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -115.49 87.13 16.33 Favored Pre-proline 0 N--CA 1.449 -0.502 0 C-N-CA 131.031 3.733 . . . . 0.0 115.994 -164.142 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -64.26 140.73 72.21 Favored 'Trans proline' 0 N--CA 1.449 -1.109 0 C-N-CA 123.148 2.565 . . . . 0.0 109.42 -179.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -121.66 -88.0 0.63 Allowed 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 128.673 2.789 . . . . 0.0 111.138 -158.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 6.6 pt -130.3 160.77 41.11 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.475 0 CA-C-O 122.5 1.143 . . . . 0.0 110.989 165.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 66.98 -100.51 0.57 Allowed Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 125.454 1.502 . . . . 0.0 113.626 -177.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -137.04 1.15 2.44 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 116.538 2.051 . . . . 0.0 116.538 179.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 31.8 p -119.59 177.79 4.8 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.739 1.216 . . . . 0.0 110.306 -172.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -124.6 -83.61 0.64 Allowed 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.136 1.374 . . . . 0.0 113.98 -156.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -126.89 165.49 19.26 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.75 1.62 . . . . 0.0 111.921 172.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -85.99 50.75 2.04 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 124.744 2.212 . . . . 0.0 109.187 176.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 . . . . . 0 N--CA 1.45 -0.448 0 O-C-N 117.426 -3.296 . . . . 0.0 111.841 -166.826 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.434 0 N-CA-C 117.426 1.73 . . . . 0.0 117.426 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 62.4 mt -134.73 -29.18 1.18 Allowed 'General case' 0 N--CA 1.449 -0.502 0 CA-C-O 117.141 -1.409 . . . . 0.0 114.141 171.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 67.3 m -145.77 -161.76 1.37 Allowed 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 120.723 1.601 . . . . 0.0 107.44 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -62.46 164.26 7.62 Favored 'General case' 0 N--CA 1.448 -0.552 0 O-C-N 124.762 1.289 . . . . 0.0 114.287 -167.178 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 164.47 -152.28 21.91 Favored Glycine 0 C--N 1.334 0.466 0 C-N-CA 119.067 -1.539 . . . . 0.0 116.658 165.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 27.6 m -105.26 -20.04 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 C-N-CA 125.778 1.631 . . . . 0.0 114.605 169.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.535 ' HB3' ' CD1' ' A' ' 15' ' ' PHE . 6.5 tp10 -102.87 77.47 0.23 Allowed Pre-proline 0 N--CA 1.449 -0.497 0 C-N-CA 126.888 2.075 . . . . 0.0 115.72 -176.07 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_endo -66.11 143.34 71.3 Favored 'Trans proline' 0 N--CA 1.449 -1.128 0 O-C-N 117.205 -2.05 . . . . 0.0 107.465 -169.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -130.93 -84.86 0.52 Allowed 'General case' 0 N--CA 1.45 -0.463 1 C-N-CA 132.734 4.414 . . . . 0.0 110.056 -161.658 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 5.3 mt -97.0 97.48 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 O-C-N 124.732 1.27 . . . . 0.0 111.824 170.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 51.4 -100.01 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 126.033 1.778 . . . . 0.0 115.75 179.005 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -88.42 7.28 33.46 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 117.972 2.582 . . . . 0.0 117.972 177.29 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 7.4 p -119.41 172.58 7.52 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 116.754 2.131 . . . . 0.0 116.754 169.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 15.2 m-85 -137.83 -89.0 0.25 Allowed 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 126.649 1.98 . . . . 0.0 113.382 -160.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.535 ' CD1' ' HB3' ' A' ' 7' ' ' GLU . 25.0 m-85 -140.58 169.72 17.12 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 129.225 3.01 . . . . 0.0 109.319 179.327 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . 0.271 5.7 tp10 -88.25 60.85 5.94 Favored 'General case' 0 N--CA 1.45 -0.456 0 O-C-N 120.436 -1.415 . . . . 0.0 110.594 -160.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 . . . . . 0 N--CA 1.45 -0.469 0 CA-C-N 114.759 -1.11 . . . . 0.0 113.449 178.518 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.514 0 N-CA-C 120.91 3.124 . . . . 0.0 120.91 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 12.9 mt -128.9 -26.76 2.61 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 115.379 1.622 . . . . 0.0 115.379 179.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 61.3 m -147.03 -173.26 4.19 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 128.083 2.553 . . . . 0.0 109.478 -174.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 7.4 pm0 -55.02 171.54 0.14 Allowed 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 124.547 2.118 . . . . 0.0 114.334 176.319 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 166.3 -163.9 37.21 Favored Glycine 0 C--N 1.335 0.52 0 CA-C-O 126.425 3.236 . . . . 0.0 113.744 -176.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 16.1 m -130.13 -10.3 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 CA-C-N 111.412 -2.394 . . . . 0.0 113.064 179.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -114.59 84.43 9.95 Favored Pre-proline 0 N--CA 1.449 -0.482 0 C-N-CA 124.592 1.157 . . . . 0.0 110.842 174.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -63.88 148.04 91.92 Favored 'Trans proline' 0 N--CA 1.45 -1.086 0 CA-C-N 122.34 1.871 . . . . 0.0 108.955 -173.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -125.81 -58.36 1.4 Allowed 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 129.987 3.315 . . . . 0.0 109.221 -167.334 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 30.6 mm -83.01 175.54 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 C-N-CA 130.267 3.427 . . . . 0.0 109.042 165.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -54.09 -56.27 22.01 Favored Glycine 0 C--N 1.335 0.493 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 170.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -84.26 -33.76 23.96 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 127.726 2.41 . . . . 0.0 111.913 -175.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 27.9 p -132.94 173.65 11.18 Favored 'General case' 0 N--CA 1.45 -0.464 0 O-C-N 117.402 -3.311 . . . . 0.0 112.386 -155.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -128.22 -85.65 0.58 Allowed 'General case' 0 N--CA 1.45 -0.463 0 O-C-N 126.9 2.625 . . . . 0.0 116.455 -154.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 30.1 m-85 -137.43 169.35 17.94 Favored 'General case' 0 N--CA 1.448 -0.529 0 O-C-N 120.207 -1.558 . . . . 0.0 110.114 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -89.04 69.59 8.43 Favored 'General case' 0 N--CA 1.449 -0.5 0 O-C-N 118.393 -2.692 . . . . 0.0 108.505 175.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 . . . . . 0 N--CA 1.448 -0.537 0 CA-C-O 124.592 2.139 . . . . 0.0 112.02 -166.521 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.479 0 N-CA-C 117.353 1.701 . . . . 0.0 117.353 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . 0.351 0.5 OUTLIER -154.88 -17.11 0.12 Allowed 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 118.688 2.847 . . . . 0.0 118.688 165.557 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.0 m -130.92 165.88 22.15 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 126.719 2.008 . . . . 0.0 111.215 -177.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 22.7 mp0 -68.0 142.4 55.94 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 126.959 2.104 . . . . 0.0 110.607 -175.041 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -176.86 -150.23 8.18 Favored Glycine 0 CA--C 1.522 0.482 0 O-C-N 119.091 -2.256 . . . . 0.0 108.873 -175.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 43.5 t -117.91 -21.7 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 1 C-N-CA 133.224 4.61 . . . . 0.0 116.628 -173.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 13.4 tp10 -113.15 83.23 6.14 Favored Pre-proline 0 N--CA 1.449 -0.5 0 C-N-CA 127.222 2.209 . . . . 0.0 111.939 -177.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -68.93 146.98 67.16 Favored 'Trans proline' 0 N--CA 1.45 -1.088 0 C-N-CA 124.737 3.625 . . . . 0.0 109.28 -167.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -139.62 -74.77 0.36 Allowed 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 128.254 2.622 . . . . 0.0 111.716 -159.016 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 18.9 mm -112.1 141.51 27.37 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 N-CA-C 105.318 -2.104 . . . . 0.0 105.318 171.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 62.54 -91.41 0.07 OUTLIER Glycine 0 C--N 1.336 0.547 0 C-N-CA 127.503 2.478 . . . . 0.0 111.525 158.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 7.2 mm-40 -132.77 19.89 4.2 Favored 'General case' 0 N--CA 1.45 -0.464 1 C-N-CA 133.409 4.684 . . . . 0.0 113.532 178.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 80.3 p -141.86 164.16 30.94 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-O 125.369 2.509 . . . . 0.0 112.665 -170.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 14.6 m-85 -128.4 -87.73 0.55 Allowed 'General case' 0 N--CA 1.449 -0.496 0 O-C-N 118.814 -2.429 . . . . 0.0 115.108 -151.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -140.88 153.34 45.68 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-O 122.818 1.294 . . . . 0.0 110.995 176.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -62.92 98.13 0.12 Allowed 'General case' 0 N--CA 1.449 -0.506 0 O-C-N 118.348 -2.72 . . . . 0.0 116.313 -176.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 30.7 mm-40 . . . . . 0 N--CA 1.449 -0.494 0 C-N-CA 127.612 2.365 . . . . 0.0 108.942 177.477 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.521 0 N-CA-C 120.499 2.96 . . . . 0.0 120.499 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 55.2 mt -120.33 -39.3 2.8 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 115.841 -2.028 . . . . 0.0 116.446 -169.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.7 m -139.7 178.58 7.13 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 127.705 2.402 . . . . 0.0 110.237 -168.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 21.9 pt20 -74.8 156.66 36.28 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 124.711 1.205 . . . . 0.0 113.612 -168.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 164.24 -153.01 23.1 Favored Glycine 0 CA--C 1.523 0.554 0 C-N-CA 119.893 -1.146 . . . . 0.0 114.731 -171.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 20.1 m -120.85 -8.79 10.28 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 1 C-N-CA 136.097 5.759 . . . . 0.0 115.824 -165.204 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 19.0 tt0 -128.33 88.93 51.27 Favored Pre-proline 0 N--CA 1.45 -0.461 0 C-N-CA 129.081 2.952 . . . . 0.0 113.785 171.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -73.31 99.14 1.08 Allowed 'Trans proline' 0 N--CA 1.449 -1.116 0 C-N-CA 122.526 2.151 . . . . 0.0 110.863 -177.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -61.02 -59.14 5.85 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 126.66 1.984 . . . . 0.0 112.951 167.21 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 7.6 mt -90.78 141.99 13.59 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 C-N-CA 128.923 2.889 . . . . 0.0 103.958 162.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -48.13 -32.57 9.53 Favored Glycine 0 CA--C 1.522 0.515 0 O-C-N 119.613 -1.93 . . . . 0.0 114.025 167.145 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . 0.269 25.5 tt0 -67.38 -43.08 82.26 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 117.25 2.315 . . . . 0.0 117.25 168.603 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 16.5 p -149.12 150.89 33.45 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 120.649 3.574 . . . . 0.0 120.649 -164.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . 0.27 0.7 OUTLIER -110.66 -102.95 0.39 Allowed 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 130.118 3.367 . . . . 0.0 115.981 -151.687 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 18.5 m-85 -136.16 167.55 21.06 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 169.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -73.6 60.53 0.68 Allowed 'General case' 0 N--CA 1.449 -0.488 0 O-C-N 126.738 2.524 . . . . 0.0 115.966 -158.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 . . . . . 0 N--CA 1.449 -0.508 0 C-N-CA 126.431 1.893 . . . . 0.0 110.106 -179.932 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.542 0 N-CA-C 122.434 3.733 . . . . 0.0 122.434 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 68.0 mt -126.53 -18.19 4.89 Favored 'General case' 0 N--CA 1.449 -0.514 0 O-C-N 129.241 3.553 . . . . 0.0 117.055 -172.133 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 70.2 m -144.91 176.65 9.31 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 131.3 3.84 . . . . 0.0 112.104 177.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 24.0 mp0 -70.67 156.77 39.04 Favored 'General case' 0 N--CA 1.448 -0.534 0 O-C-N 117.952 -2.968 . . . . 0.0 112.716 178.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 176.28 -139.55 4.61 Favored Glycine 0 CA--C 1.522 0.508 0 CA-C-O 121.763 0.646 . . . . 0.0 114.603 178.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 14.5 p -118.14 -17.0 7.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 O-C-N 119.652 -2.087 . . . . 0.0 113.141 -176.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -112.05 87.25 8.56 Favored Pre-proline 0 N--CA 1.45 -0.468 0 C-N-CA 128.683 2.793 . . . . 0.0 110.881 -172.11 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_endo -74.51 86.58 1.33 Allowed 'Trans proline' 0 N--CA 1.449 -1.14 0 CA-C-N 122.086 1.781 . . . . 0.0 112.829 -177.384 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -34.93 -82.73 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.519 1 C-N-CA 134.321 5.049 . . . . 0.0 111.958 154.055 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 22.7 mm -76.27 174.7 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 O-C-N 118.77 -2.456 . . . . 0.0 106.747 163.04 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -57.81 -51.45 58.03 Favored Glycine 0 C--N 1.336 0.536 0 O-C-N 118.129 -2.857 . . . . 0.0 114.602 154.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 21.3 tt0 -62.88 -47.33 83.78 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 120.122 3.379 . . . . 0.0 120.122 174.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 17.0 p -133.56 159.52 40.19 Favored 'General case' 0 N--CA 1.449 -0.483 0 O-C-N 117.163 -3.461 . . . . 0.0 116.872 -178.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 40.5 m-85 -111.11 -81.69 0.58 Allowed 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 124.911 1.284 . . . . 0.0 109.094 -158.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -149.86 156.29 41.52 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 178.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . 0.256 0.2 OUTLIER -79.34 77.04 5.89 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-O 116.975 -1.488 . . . . 0.0 109.092 -176.775 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 . . . . . 0 N--CA 1.45 -0.431 0 C-N-CA 128.049 2.539 . . . . 0.0 112.335 -165.807 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.464 0 CA-C-O 122.059 0.811 . . . . 0.0 112.732 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.8 pp -153.36 -2.53 0.21 Allowed 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 118.179 2.659 . . . . 0.0 118.179 168.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 49.6 m -147.48 173.61 12.5 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-O 123.386 1.565 . . . . 0.0 110.81 176.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 -52.87 146.3 11.0 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 128.479 2.711 . . . . 0.0 112.079 172.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 171.67 -178.31 44.02 Favored Glycine 0 C--N 1.335 0.526 1 O-C-N 115.789 -4.32 . . . . 0.0 114.254 -173.171 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 33.1 m -92.68 -18.08 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 C-N-CA 124.855 1.262 . . . . 0.0 113.05 -178.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 12.5 tt0 -121.71 82.9 41.83 Favored Pre-proline 0 N--CA 1.45 -0.438 0 C-N-CA 124.245 1.018 . . . . 0.0 113.332 -165.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.421 ' HA ' ' HA ' ' A' ' 14' ' ' TYR . 5.0 Cg_exo -64.79 142.72 77.5 Favored 'Trans proline' 0 N--CA 1.449 -1.105 0 C-N-CA 120.693 0.928 . . . . 0.0 110.22 -165.723 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -119.03 -72.39 0.69 Allowed 'General case' 0 N--CA 1.449 -0.512 1 C-N-CA 133.196 4.599 . . . . 0.0 109.388 -178.145 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 96.8 mt -72.37 -20.28 19.73 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 CA-C-N 119.686 1.13 . . . . 0.0 108.586 171.005 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 94.17 -47.51 2.19 Favored Glycine 0 C--N 1.335 0.503 0 CA-C-O 123.879 1.822 . . . . 0.0 110.15 -177.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 58.5 mm-40 -63.06 -42.85 99.77 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 112.736 -1.732 . . . . 0.0 109.399 164.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 75.9 p -130.41 176.13 8.4 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 127.848 2.459 . . . . 0.0 111.63 171.151 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.421 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 4.3 m-85 -131.96 -85.88 0.48 Allowed 'General case' 0 N--CA 1.449 -0.498 1 C-N-CA 133.045 4.538 . . . . 0.0 112.718 -153.327 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -145.04 153.87 41.92 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 121.19 1.814 . . . . 0.0 109.324 -175.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -39.3 133.09 1.36 Allowed 'General case' 0 N--CA 1.45 -0.464 0 O-C-N 119.479 -2.013 . . . . 0.0 115.312 153.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 . . . . . 0 N--CA 1.449 -0.502 0 C-N-CA 126.721 2.008 . . . . 0.0 109.365 -177.634 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.523 0 N-CA-C 119.378 2.511 . . . . 0.0 119.378 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 50.5 mt -128.22 -28.11 2.63 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 117.518 2.414 . . . . 0.0 117.518 -179.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.2 m -132.23 171.59 13.49 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 128.192 2.597 . . . . 0.0 111.961 -177.071 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 31.3 mt-30 -63.43 137.87 58.31 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 127.728 2.411 . . . . 0.0 106.43 168.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -170.03 -150.28 6.79 Favored Glycine 0 CA--C 1.523 0.551 0 C-N-CA 119.28 -1.438 . . . . 0.0 111.262 -174.199 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 9.8 p -117.42 -19.22 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 N-CA-C 117.237 2.31 . . . . 0.0 117.237 -177.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 55.0 tt0 -113.06 82.62 5.52 Favored Pre-proline 0 N--CA 1.449 -0.482 0 C-N-CA 126.831 2.052 . . . . 0.0 111.442 -178.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_endo -60.67 144.32 99.53 Favored 'Trans proline' 0 N--CA 1.449 -1.09 0 C-N-CA 124.018 3.146 . . . . 0.0 113.994 -172.186 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -135.87 -81.2 0.41 Allowed 'General case' 0 N--CA 1.449 -0.483 1 C-N-CA 132.337 4.255 . . . . 0.0 107.947 -162.235 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 11.7 mm -87.75 169.67 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 O-C-N 119.81 -1.806 . . . . 0.0 108.926 174.001 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -25.03 -58.08 0.06 OUTLIER Glycine 0 C--N 1.336 0.533 0 C-N-CA 130.589 3.947 . . . . 0.0 114.404 168.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 17.4 tt0 -100.8 -22.37 14.88 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 118.712 2.856 . . . . 0.0 118.712 178.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 33.0 p -118.1 174.09 6.41 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 115.711 1.745 . . . . 0.0 115.711 -167.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 67.6 m-85 -132.75 -82.16 0.48 Allowed 'General case' 0 N--CA 1.449 -0.48 0 O-C-N 126.018 2.074 . . . . 0.0 110.135 -160.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -144.53 162.43 36.61 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 128.363 2.665 . . . . 0.0 110.432 177.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -73.1 59.21 0.52 Allowed 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 128.2 2.6 . . . . 0.0 113.655 177.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 62.8 mt-10 . . . . . 0 N--CA 1.449 -0.503 0 CA-C-O 125.424 2.535 . . . . 0.0 112.96 -176.986 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.546 0 CA-C-O 118.246 -1.308 . . . . 0.0 115.544 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -142.41 5.49 1.64 Allowed 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 117.735 2.494 . . . . 0.0 117.735 -179.14 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 38.2 m -118.48 -172.28 2.24 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 130.7 3.6 . . . . 0.0 117.565 -169.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 29.0 mt-30 -95.29 122.75 38.31 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 125.381 1.472 . . . . 0.0 111.649 171.61 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 176.87 -162.97 31.58 Favored Glycine 0 C--N 1.336 0.532 0 N-CA-C 109.104 -1.599 . . . . 0.0 109.104 -164.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 45.3 t -116.05 -16.27 8.95 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 1 C-N-CA 132.854 4.462 . . . . 0.0 115.233 -155.45 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 50.7 tt0 -114.39 88.98 16.57 Favored Pre-proline 0 N--CA 1.448 -0.541 0 O-C-N 119.267 -2.146 . . . . 0.0 109.271 177.15 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -67.42 110.39 2.04 Favored 'Trans proline' 0 N--CA 1.45 -1.061 0 C-N-CA 124.956 3.771 . . . . 0.0 111.988 -178.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -90.29 -86.42 0.2 Allowed 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 126.205 1.802 . . . . 0.0 109.909 -159.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 9.2 mt -88.63 65.5 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 CA-C-O 126.716 3.15 . . . . 0.0 106.844 177.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 53.17 -87.64 0.01 OUTLIER Glycine 0 C--N 1.335 0.503 0 C-N-CA 127.681 2.562 . . . . 0.0 118.173 -166.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 44.6 tt0 -58.87 -30.39 67.71 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 119.737 3.236 . . . . 0.0 119.737 -169.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 24.3 p -127.36 172.16 10.89 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 126.873 2.069 . . . . 0.0 110.901 174.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 41.9 m-85 -125.58 174.15 8.45 Favored 'General case' 0 N--CA 1.45 -0.457 1 C-N-CA 133.289 4.636 . . . . 0.0 111.706 -153.528 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -54.92 134.85 48.7 Favored 'General case' 0 N--CA 1.449 -0.505 0 O-C-N 124.217 0.948 . . . . 0.0 109.878 175.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . 0.306 30.6 tt0 -59.12 65.67 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 130.926 3.69 . . . . 0.0 111.875 159.216 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . 0.276 29.5 tt0 . . . . . 0 N--CA 1.449 -0.511 0 C-N-CA 127.21 2.204 . . . . 0.0 111.391 178.062 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.495 0 N-CA-C 116.146 1.218 . . . . 0.0 116.146 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -158.85 -1.66 0.09 Allowed 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 117.59 2.441 . . . . 0.0 117.59 177.418 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 25.9 m -149.45 167.31 26.58 Favored 'General case' 0 N--CA 1.45 -0.468 0 O-C-N 118.418 -2.676 . . . . 0.0 114.082 -175.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 40.6 mt-30 -61.46 138.18 58.26 Favored 'General case' 0 N--CA 1.449 -0.499 0 O-C-N 120.358 -1.464 . . . . 0.0 112.413 -177.243 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 178.1 -153.03 12.27 Favored Glycine 0 CA--C 1.523 0.556 0 O-C-N 121.099 -1.001 . . . . 0.0 114.093 -167.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 63.6 t -124.66 -20.52 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 C-N-CA 125.816 1.647 . . . . 0.0 113.118 -168.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 28.8 tp10 -105.62 89.27 3.29 Favored Pre-proline 0 N--CA 1.45 -0.465 0 CA-C-O 116.224 -1.846 . . . . 0.0 111.091 173.161 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -60.19 140.32 91.63 Favored 'Trans proline' 0 N--CA 1.449 -1.143 0 C-N-CA 123.31 2.673 . . . . 0.0 113.457 178.285 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 38.1 t0 -128.57 -93.94 0.44 Allowed 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 126.089 1.755 . . . . 0.0 111.857 -164.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 28.3 mm -107.27 143.88 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 C-N-CA 126.419 1.888 . . . . 0.0 108.748 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 56.52 -89.72 0.01 OUTLIER Glycine 0 C--N 1.336 0.53 0 C-N-CA 126.971 2.224 . . . . 0.0 115.226 174.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -134.04 4.04 3.48 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 116.083 1.883 . . . . 0.0 116.083 176.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 42.8 p -114.31 -177.25 3.08 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -131.08 -170.71 2.41 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 131.159 3.784 . . . . 0.0 110.877 -160.717 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -68.53 150.89 47.52 Favored 'General case' 0 N--CA 1.449 -0.516 0 O-C-N 119.07 -2.269 . . . . 0.0 109.866 177.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -63.68 87.71 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 128.07 2.548 . . . . 0.0 113.566 174.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 . . . . . 0 N--CA 1.449 -0.502 0 CA-C-O 123.162 1.458 . . . . 0.0 112.53 159.928 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.483 0 N-CA-C 111.131 -0.788 . . . . 0.0 111.131 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 78.9 mt -144.69 -12.86 0.57 Allowed 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.682 1.593 . . . . 0.0 113.177 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 6.1 t -138.68 -152.12 0.41 Allowed 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 127.87 2.468 . . . . 0.0 113.176 -166.349 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -116.7 156.92 26.3 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 125.128 1.371 . . . . 0.0 110.072 173.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 164.86 -144.37 9.28 Favored Glycine 0 N--CA 1.448 -0.547 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.46 -171.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 18.6 m -120.97 -15.56 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 -175.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 33.2 mm-40 -107.83 96.78 18.2 Favored Pre-proline 0 N--CA 1.449 -0.479 0 O-C-N 119.689 -1.882 . . . . 0.0 112.74 174.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -74.24 101.89 1.47 Allowed 'Trans proline' 0 N--CA 1.45 -1.033 0 C-N-CA 123.463 2.776 . . . . 0.0 109.853 -179.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -68.22 -63.12 1.12 Allowed 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 129.252 3.021 . . . . 0.0 112.492 176.578 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 27.1 mt -75.89 157.21 5.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 N-CA-C 106.753 -1.573 . . . . 0.0 106.753 162.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -41.64 -48.27 4.92 Favored Glycine 0 CA--C 1.523 0.573 0 O-C-N 119.467 -2.021 . . . . 0.0 112.972 164.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 39.1 tt0 -76.13 -47.66 23.53 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 116.597 2.073 . . . . 0.0 116.597 179.052 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 35.9 p -129.24 164.09 24.21 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 127.288 2.235 . . . . 0.0 116.034 -160.251 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 13.9 m-85 -121.79 178.22 4.95 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 126.353 1.861 . . . . 0.0 110.905 -161.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -62.91 144.71 56.47 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 -179.197 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -61.89 106.58 0.71 Allowed 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 125.97 1.708 . . . . 0.0 109.175 178.599 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 . . . . . 0 N--CA 1.449 -0.5 0 CA-C-N 114.239 -1.346 . . . . 0.0 112.627 173.67 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.526 0 N-CA-C 117.45 1.74 . . . . 0.0 117.45 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 95.0 mt -137.7 -37.05 0.61 Allowed 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 116.566 2.062 . . . . 0.0 116.566 171.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.5 m -138.97 -162.14 1.28 Allowed 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 125.164 1.386 . . . . 0.0 112.325 -175.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 70.8 mt-30 -54.15 165.35 0.52 Allowed 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 114.351 1.241 . . . . 0.0 114.351 175.529 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 160.29 -173.79 36.94 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.95 -0.643 . . . . 0.0 114.196 160.135 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 13.7 p -91.3 -7.09 10.73 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 C-N-CA 125.812 1.645 . . . . 0.0 113.468 178.479 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -121.94 90.75 48.72 Favored Pre-proline 0 N--CA 1.449 -0.517 0 C-N-CA 125.644 1.578 . . . . 0.0 111.094 -171.412 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_exo -51.19 140.85 40.57 Favored 'Trans proline' 0 N--CA 1.45 -1.067 0 C-N-CA 121.912 1.742 . . . . 0.0 113.121 174.338 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -128.74 -53.38 1.24 Allowed 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 126.229 1.812 . . . . 0.0 109.242 -175.136 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.426 HG22 ' H ' ' A' ' 11' ' ' GLY . 3.0 mt -121.98 172.68 8.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 C-N-CA 125.823 1.649 . . . . 0.0 108.064 172.46 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.426 ' H ' HG22 ' A' ' 10' ' ' ILE . . . -46.58 -42.74 14.51 Favored Glycine 0 C--N 1.335 0.501 0 C-N-CA 126.202 1.858 . . . . 0.0 116.138 178.586 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 45.2 tt0 -92.85 -36.25 12.93 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 116.763 2.135 . . . . 0.0 116.763 176.058 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 82.2 p -124.38 167.7 14.03 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 119.587 -1.946 . . . . 0.0 115.972 -160.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 16.9 m-85 -131.64 -83.57 0.51 Allowed 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.982 1.313 . . . . 0.0 111.664 -161.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -141.02 171.15 14.47 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 125.556 1.543 . . . . 0.0 110.714 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -80.09 59.46 3.29 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 121.98 2.173 . . . . 0.0 111.87 177.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 . . . . . 0 N--CA 1.45 -0.463 0 C-N-CA 126.372 1.869 . . . . 0.0 111.623 -175.392 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.534 0 CA-C-O 123.002 1.335 . . . . 0.0 114.979 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -130.11 -5.79 4.41 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 129.317 3.047 . . . . 0.0 113.546 -174.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 26.6 m -120.56 -166.14 1.29 Allowed 'General case' 0 N--CA 1.448 -0.533 0 O-C-N 126.805 2.566 . . . . 0.0 114.772 -162.445 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 20.1 mp0 -102.68 155.76 18.09 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 119.42 1.009 . . . . 0.0 110.41 161.074 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 161.89 -165.16 35.68 Favored Glycine 0 CA--C 1.523 0.568 0 O-C-N 119.462 -2.024 . . . . 0.0 113.776 -177.614 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 14.0 p -69.68 -26.95 31.81 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 N-CA-C 119.203 3.038 . . . . 0.0 119.203 174.175 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 16.2 tp10 -118.12 90.12 36.75 Favored Pre-proline 0 N--CA 1.449 -0.515 0 O-C-N 118.324 -2.735 . . . . 0.0 114.691 -164.198 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . 0.326 17.8 Cg_endo -60.74 127.72 23.43 Favored 'Trans proline' 0 N--CA 1.449 -1.115 0 CA-C-O 125.371 2.154 . . . . 0.0 114.6 173.029 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 49.9 t0 -117.63 -88.76 0.6 Allowed 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 128.282 2.633 . . . . 0.0 115.17 -161.047 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.6 mm -99.86 144.34 12.41 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 C-N-CA 126.946 2.098 . . . . 0.0 106.471 163.562 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.457 ' C ' ' H ' ' A' ' 13' ' ' THR . . . -45.56 143.5 3.63 Favored Glycine 0 CA--C 1.522 0.531 0 N-CA-C 121.338 3.295 . . . . 0.0 121.338 -163.747 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 15.7 tt0 62.39 -15.38 0.05 Allowed 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 109.966 -3.117 . . . . 0.0 114.323 -163.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.457 ' H ' ' C ' ' A' ' 11' ' ' GLY 0.277 24.9 p -122.28 168.54 11.91 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 126.01 2.814 . . . . 0.0 112.82 -166.006 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -134.5 162.69 31.56 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 128.041 2.536 . . . . 0.0 111.317 -166.166 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -57.73 145.58 34.09 Favored 'General case' 0 N--CA 1.449 -0.518 0 O-C-N 119.5 -2.0 . . . . 0.0 109.677 172.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -70.49 84.91 0.6 Allowed 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 127.931 2.492 . . . . 0.0 112.004 -169.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 . . . . . 0 N--CA 1.449 -0.511 0 C-N-CA 126.682 1.993 . . . . 0.0 111.828 174.544 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.546 0 N-CA-C 111.764 -0.535 . . . . 0.0 111.764 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -160.68 10.49 0.1 Allowed 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 126.36 1.864 . . . . 0.0 114.926 -169.377 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 53.8 m -131.58 169.85 15.55 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-O 115.017 -2.42 . . . . 0.0 117.137 164.294 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 16.9 mm100 -57.91 145.93 33.92 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 122.898 2.59 . . . . 0.0 111.317 164.263 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 169.17 -152.01 18.95 Favored Glycine 0 C--N 1.335 0.519 0 N-CA-C 116.911 1.524 . . . . 0.0 116.911 174.382 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.9 t -97.44 -18.63 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 O-C-N 127.08 2.282 . . . . 0.0 117.027 -177.518 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.407 ' O ' ' HA ' ' A' ' 14' ' ' TYR . 4.2 tp10 -125.88 92.42 46.22 Favored Pre-proline 0 N--CA 1.449 -0.518 0 N-CA-C 106.649 -1.611 . . . . 0.0 106.649 -168.048 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -71.99 94.98 0.73 Allowed 'Trans proline' 0 N--CA 1.448 -1.153 0 C-N-CA 124.409 3.406 . . . . 0.0 110.048 173.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -64.26 -52.28 59.44 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 130.734 3.613 . . . . 0.0 109.88 -177.83 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.443 HG22 ' H ' ' A' ' 12' ' ' GLN . 47.3 mm -85.12 160.03 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 161.282 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -51.3 -41.22 47.13 Favored Glycine 0 CA--C 1.523 0.534 0 CA-C-O 124.774 2.319 . . . . 0.0 114.806 173.472 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.443 ' H ' HG22 ' A' ' 10' ' ' ILE . 8.9 tt0 -61.99 -81.21 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 128.258 2.623 . . . . 0.0 111.506 172.314 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . 0.273 0.7 OUTLIER -121.79 178.28 4.93 Favored 'General case' 0 N--CA 1.449 -0.517 0 O-C-N 117.794 -3.066 . . . . 0.0 117.196 -167.563 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.407 ' HA ' ' O ' ' A' ' 7' ' ' GLU . 0.7 OUTLIER -117.13 170.67 8.48 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 130.82 3.648 . . . . 0.0 112.259 -154.79 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -51.64 137.23 25.4 Favored 'General case' 0 N--CA 1.449 -0.491 0 O-C-N 118.923 -2.361 . . . . 0.0 109.478 -174.552 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -46.52 125.02 6.47 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 129.69 3.196 . . . . 0.0 113.539 -175.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 . . . . . 0 N--CA 1.449 -0.505 0 CA-C-N 122.307 2.322 . . . . 0.0 106.501 -168.167 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.493 0 CA-C-O 119.503 -0.609 . . . . 0.0 113.315 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -121.23 12.15 10.95 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 126.874 2.07 . . . . 0.0 114.33 -177.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -118.82 -148.65 0.42 Allowed 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 128.351 2.661 . . . . 0.0 110.94 178.772 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 15.4 mp0 -122.15 152.49 39.87 Favored 'General case' 0 N--CA 1.45 -0.45 0 O-C-N 116.959 -3.588 . . . . 0.0 115.042 167.002 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 170.57 -138.11 4.79 Favored Glycine 0 C--N 1.336 0.543 0 CA-C-N 113.055 -1.884 . . . . 0.0 112.291 -170.577 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 13.1 m -128.15 -8.64 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 CA-C-N 119.464 1.632 . . . . 0.0 110.647 -175.442 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -112.36 81.46 4.0 Favored Pre-proline 0 N--CA 1.449 -0.508 0 N-CA-C 116.442 2.015 . . . . 0.0 116.442 173.406 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -65.89 136.61 45.83 Favored 'Trans proline' 0 N--CA 1.449 -1.101 0 C-N-CA 123.439 2.759 . . . . 0.0 107.367 -179.418 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -130.8 -102.42 0.29 Allowed 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 109.61 -3.45 . . . . 0.0 110.074 -151.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 17.1 mt -70.8 88.83 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 CA-C-N 122.706 2.503 . . . . 0.0 110.447 168.224 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 46.82 -107.9 0.24 Allowed Glycine 0 CA--C 1.523 0.537 0 O-C-N 117.173 -3.455 . . . . 0.0 117.179 -175.102 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -64.58 -10.71 28.15 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 120.05 3.352 . . . . 0.0 120.05 179.227 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 46.2 p -124.06 159.92 28.86 Favored 'General case' 0 N--CA 1.449 -0.5 0 O-C-N 125.572 1.795 . . . . 0.0 113.541 -173.315 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -124.6 175.73 7.0 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 131.48 3.912 . . . . 0.0 112.729 -160.443 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -57.78 156.4 8.82 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 115.835 1.791 . . . . 0.0 115.835 -177.707 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -69.87 88.0 0.55 Allowed 'General case' 0 N--CA 1.449 -0.509 0 O-C-N 118.299 -2.751 . . . . 0.0 115.814 -166.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 . . . . . 0 N--CA 1.449 -0.488 0 C-N-CA 131.228 3.811 . . . . 0.0 112.274 164.077 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.503 0 N-CA-C 116.59 1.396 . . . . 0.0 116.59 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -158.61 -3.93 0.08 Allowed 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 121.232 3.79 . . . . 0.0 121.232 171.133 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' SER . . . . . 0.426 ' HB2' ' HA ' ' A' ' 16' ' ' GLU . 17.7 m -150.17 -177.05 5.71 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 129.744 3.218 . . . . 0.0 111.311 175.195 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -63.3 162.44 12.18 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 130.618 3.567 . . . . 0.0 111.771 -170.535 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 163.21 -173.27 39.35 Favored Glycine 0 C--N 1.335 0.495 0 N-CA-C 118.303 2.081 . . . . 0.0 118.303 -170.273 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 20.2 m -111.51 -14.85 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 C-N-CA 128.102 2.561 . . . . 0.0 113.65 171.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -105.91 77.78 0.44 Allowed Pre-proline 0 N--CA 1.449 -0.514 0 C-N-CA 128.144 2.577 . . . . 0.0 115.625 177.158 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -63.87 96.8 0.22 Allowed 'Trans proline' 0 N--CA 1.449 -1.089 0 CA-C-O 124.301 1.709 . . . . 0.0 113.643 -176.391 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -62.27 -66.62 0.51 Allowed 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 130.443 3.497 . . . . 0.0 112.37 -165.507 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . 0.254 42.8 pt -109.41 -166.39 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 CA-C-N 113.277 -1.783 . . . . 0.0 112.363 169.229 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -45.75 -47.21 13.54 Favored Glycine 0 C--N 1.335 0.514 0 N-CA-C 118.491 2.157 . . . . 0.0 118.491 -178.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 20.6 mp0 -121.84 150.39 41.99 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 129.605 3.162 . . . . 0.0 107.408 174.325 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.46 ' HA ' ' CD1' ' A' ' 14' ' ' TYR 0.28 4.7 p 56.38 179.45 0.04 OUTLIER 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 111.127 -2.76 . . . . 0.0 113.973 179.386 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.46 ' CD1' ' HA ' ' A' ' 13' ' ' THR . 2.2 m-85 -133.53 -99.06 0.27 Allowed 'General case' 0 N--CA 1.449 -0.518 0 O-C-N 117.823 -3.048 . . . . 0.0 111.203 -148.017 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -133.9 161.88 33.55 Favored 'General case' 0 N--CA 1.45 -0.475 0 CA-C-O 126.807 3.194 . . . . 0.0 107.363 -179.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.426 ' HA ' ' HB2' ' A' ' 3' ' ' SER . 21.0 tt0 -74.11 70.48 1.58 Allowed 'General case' 0 N--CA 1.449 -0.497 0 O-C-N 117.837 -3.039 . . . . 0.0 114.158 -175.334 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 . . . . . 0 N--CA 1.449 -0.518 0 C-N-CA 131.229 3.812 . . . . 0.0 116.008 175.146 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.501 0 N-CA-C 115.529 0.972 . . . . 0.0 115.529 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -159.41 -10.92 0.06 Allowed 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 115.98 1.844 . . . . 0.0 115.98 171.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 37.8 m -127.42 164.75 21.19 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 122.756 2.525 . . . . 0.0 116.003 -172.123 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -66.95 129.06 38.66 Favored 'General case' 0 N--CA 1.449 -0.519 0 O-C-N 120.532 -1.355 . . . . 0.0 110.581 -179.369 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -167.76 -151.88 7.24 Favored Glycine 0 C--N 1.334 0.449 0 N-CA-C 119.133 2.413 . . . . 0.0 119.133 -169.59 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 6.2 t -129.1 -19.15 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 C-N-CA 129.698 3.199 . . . . 0.0 113.911 -168.28 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -116.34 95.58 45.66 Favored Pre-proline 0 N--CA 1.45 -0.473 0 CA-C-O 117.49 -1.243 . . . . 0.0 111.637 171.58 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -74.76 90.5 1.05 Allowed 'Trans proline' 0 N--CA 1.449 -1.101 0 CA-C-N 124.092 2.497 . . . . 0.0 112.427 -175.286 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -52.34 -60.92 2.64 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 130.898 3.679 . . . . 0.0 111.458 170.652 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 20.9 pt -108.34 176.88 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 CA-C-O 124.424 2.059 . . . . 0.0 111.477 178.193 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -66.59 113.08 5.39 Favored Glycine 0 C--N 1.336 0.536 0 C-N-CA 128.438 2.923 . . . . 0.0 113.649 161.052 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 14.9 tt0 55.01 86.45 0.05 Allowed 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 128.526 2.73 . . . . 0.0 115.81 -159.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.404 ' HA ' ' CE1' ' A' ' 14' ' ' TYR 0.358 30.7 p 114.67 179.14 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.488 1 C-N-CA 133.63 4.772 . . . . 0.0 118.508 159.889 . . . . . . . . 4 3 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.404 ' CE1' ' HA ' ' A' ' 13' ' ' THR . 6.2 m-85 -129.59 -168.95 2.02 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 128.627 2.771 . . . . 0.0 108.373 -151.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -64.03 163.51 12.16 Favored 'General case' 0 N--CA 1.45 -0.466 0 O-C-N 119.401 -2.062 . . . . 0.0 113.102 -178.396 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -76.75 85.68 3.37 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-O 126.819 3.2 . . . . 0.0 113.459 178.577 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.448 -0.542 0 CA-C-N 110.558 -3.019 . . . . 0.0 116.609 173.349 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.57 0 N-CA-C 114.052 0.381 . . . . 0.0 114.052 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 79.1 mt -139.61 -13.11 1.13 Allowed 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 126.312 1.845 . . . . 0.0 114.664 179.45 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 73.6 m -144.56 177.76 8.44 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-O 123.798 1.761 . . . . 0.0 109.395 -178.372 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 32.1 mt-30 -56.72 154.79 8.49 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 118.91 -2.369 . . . . 0.0 112.384 160.044 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 157.2 -156.39 27.19 Favored Glycine 0 C--N 1.335 0.516 0 O-C-N 118.773 -2.454 . . . . 0.0 114.453 178.556 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 16.8 m -110.26 -6.89 11.38 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 118.991 2.96 . . . . 0.0 118.991 -173.126 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 30.2 mm-40 -112.03 83.22 4.74 Favored Pre-proline 0 N--CA 1.45 -0.473 0 CA-C-O 116.012 -1.947 . . . . 0.0 114.476 176.102 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -64.59 142.53 77.97 Favored 'Trans proline' 0 N--CA 1.45 -1.074 0 C-N-CA 123.525 2.817 . . . . 0.0 111.44 -168.378 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -140.48 -79.88 0.28 Allowed 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 118.12 2.637 . . . . 0.0 118.12 -157.012 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 8.0 mm -91.46 161.06 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 N-CA-C 102.965 -2.976 . . . . 0.0 102.965 165.371 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -47.23 -18.64 0.52 Allowed Glycine 0 C--N 1.335 0.506 0 CA-C-N 113.633 -1.621 . . . . 0.0 117.135 -170.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 71.5 mt-30 -123.96 -8.56 7.76 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 129.822 3.249 . . . . 0.0 114.595 -171.568 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 64.0 p -137.98 178.79 6.86 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 117.39 2.367 . . . . 0.0 117.39 -166.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 -134.01 -97.99 0.27 Allowed 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 127.277 2.231 . . . . 0.0 112.421 -165.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 14.7 m-85 -142.81 150.28 39.74 Favored 'General case' 0 N--CA 1.449 -0.478 0 O-C-N 121.047 -1.033 . . . . 0.0 112.211 166.67 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -60.11 82.85 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.481 0 CA-C-O 127.231 3.396 . . . . 0.0 111.486 -174.373 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 . . . . . 0 N--CA 1.449 -0.478 1 O-C-N 116.181 -4.074 . . . . 0.0 112.08 164.454 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.538 0 N-CA-C 116.509 1.364 . . . . 0.0 116.509 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -152.58 -8.47 0.19 Allowed 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 120.7 3.592 . . . . 0.0 120.7 157.412 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 21.4 m -134.01 -179.23 5.42 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 123.318 2.781 . . . . 0.0 115.816 174.289 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 22.6 mp0 -64.39 129.81 41.33 Favored 'General case' 0 N--CA 1.448 -0.527 0 O-C-N 118.197 -2.815 . . . . 0.0 113.956 -176.622 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -170.76 -149.16 6.3 Favored Glycine 0 C--N 1.336 0.539 0 CA-C-O 124.156 1.975 . . . . 0.0 113.048 171.541 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 26.7 m -117.01 -13.65 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 O-C-N 116.47 -3.959 . . . . 0.0 114.083 -171.349 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 23.6 tp10 -103.64 82.35 0.53 Allowed Pre-proline 0 N--CA 1.449 -0.479 0 O-C-N 126.943 2.652 . . . . 0.0 117.315 171.703 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.402 ' HB3' ' CE2' ' A' ' 14' ' ' TYR . 15.0 Cg_endo -64.47 149.75 89.44 Favored 'Trans proline' 0 N--CA 1.449 -1.136 0 C-N-CA 122.384 2.056 . . . . 0.0 108.683 -169.581 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -138.51 -92.25 0.2 Allowed 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 112.512 -2.131 . . . . 0.0 107.775 -159.34 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 6.4 mt -97.35 152.4 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 CA-C-O 117.138 -1.411 . . . . 0.0 107.217 169.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -36.35 141.81 0.19 Allowed Glycine 0 C--N 1.336 0.57 0 C-N-CA 129.534 3.445 . . . . 0.0 110.367 176.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 6.2 tm0? 58.13 -11.59 0.03 OUTLIER 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 116.962 2.208 . . . . 0.0 116.962 -168.186 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 22.6 p -133.73 168.07 19.37 Favored 'General case' 0 N--CA 1.45 -0.467 1 O-C-N 114.283 -5.261 . . . . 0.0 117.644 -170.221 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.408 ' O ' ' CD1' ' A' ' 15' ' ' PHE . 9.1 m-85 -127.79 -82.92 0.6 Allowed 'General case' 0 N--CA 1.449 -0.48 0 CA-C-O 126.762 3.172 . . . . 0.0 112.316 -172.027 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.408 ' CD1' ' O ' ' A' ' 14' ' ' TYR . 19.7 m-85 -140.58 141.85 35.16 Favored 'General case' 0 N--CA 1.45 -0.469 1 O-C-N 116.11 -4.118 . . . . 0.0 113.463 175.887 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -59.03 84.83 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.484 0 CA-C-O 117.567 -1.206 . . . . 0.0 113.874 166.483 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 . . . . . 0 N--CA 1.45 -0.46 0 N-CA-C 116.237 1.939 . . . . 0.0 116.237 -166.57 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.504 0 N-CA-C 118.233 2.053 . . . . 0.0 118.233 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -143.46 -11.64 0.71 Allowed 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 128.328 2.651 . . . . 0.0 117.916 -176.812 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 69.5 m -114.84 -174.01 2.41 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 127.85 2.46 . . . . 0.0 110.245 -164.59 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -102.76 135.27 44.72 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 128.83 2.852 . . . . 0.0 109.68 161.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 176.47 -158.5 24.81 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 108.126 -1.99 . . . . 0.0 108.126 -157.307 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.2 p -130.06 -0.27 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 O-C-N 121.29 -1.124 . . . . 0.0 111.743 -167.637 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 27.1 tp10 -116.56 107.58 46.56 Favored Pre-proline 0 N--CA 1.449 -0.522 1 O-C-N 115.477 -4.514 . . . . 0.0 102.673 163.687 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -66.02 142.91 70.24 Favored 'Trans proline' 0 N--CA 1.449 -1.146 0 CA-C-O 127.324 2.969 . . . . 0.0 110.867 169.194 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -119.58 -94.1 0.51 Allowed 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 110.545 -3.025 . . . . 0.0 109.477 -165.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 24.5 pt -118.36 154.73 20.48 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 C-N-CA 130.047 3.339 . . . . 0.0 109.7 177.026 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 45.15 -111.13 0.51 Allowed Glycine 0 C--N 1.335 0.498 0 C-N-CA 127.178 2.323 . . . . 0.0 112.388 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 71.8 mm-40 -97.36 -1.43 44.53 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-O 124.979 2.323 . . . . 0.0 115.624 -177.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 18.3 p -128.41 176.8 7.44 Favored 'General case' 0 N--CA 1.45 -0.429 0 O-C-N 117.075 -3.516 . . . . 0.0 110.636 -155.111 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 16.8 m-85 -127.92 173.09 10.3 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 125.415 1.486 . . . . 0.0 113.051 -165.544 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -53.31 141.34 24.38 Favored 'General case' 0 N--CA 1.448 -0.526 0 O-C-N 117.991 -2.943 . . . . 0.0 112.046 169.548 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . 0.445 30.4 tt0 -55.34 90.67 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 118.856 2.91 . . . . 0.0 118.856 174.672 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 29.7 tp10 . . . . . 0 N--CA 1.449 -0.516 0 N-CA-C 114.448 1.277 . . . . 0.0 114.448 166.022 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.578 0 N-CA-C 117.138 1.615 . . . . 0.0 117.138 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 94.9 mt -125.06 -30.24 3.23 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 120.258 3.429 . . . . 0.0 120.258 177.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 70.5 m -143.57 -178.64 5.99 Favored 'General case' 0 N--CA 1.449 -0.522 0 O-C-N 125.556 1.785 . . . . 0.0 110.263 -176.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . 0.325 82.6 mm-40 -62.36 136.26 57.83 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 113.593 -1.639 . . . . 0.0 113.545 -174.109 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -174.3 -164.91 30.03 Favored Glycine 0 C--N 1.336 0.578 0 CA-C-N 119.764 1.166 . . . . 0.0 114.574 -176.162 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 12.1 t -87.21 -38.18 11.86 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 CA-C-N 111.819 -2.19 . . . . 0.0 110.986 -171.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -115.49 87.13 16.33 Favored Pre-proline 0 N--CA 1.449 -0.502 0 C-N-CA 131.031 3.733 . . . . 0.0 115.994 -164.142 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -64.26 140.73 72.21 Favored 'Trans proline' 0 N--CA 1.449 -1.109 0 C-N-CA 123.148 2.565 . . . . 0.0 109.42 -179.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -121.66 -88.0 0.63 Allowed 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 128.673 2.789 . . . . 0.0 111.138 -158.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 6.6 pt -130.3 160.77 41.11 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.475 0 CA-C-O 122.5 1.143 . . . . 0.0 110.989 165.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 66.98 -100.51 0.57 Allowed Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 125.454 1.502 . . . . 0.0 113.626 -177.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -137.04 1.15 2.44 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 116.538 2.051 . . . . 0.0 116.538 179.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 31.8 p -119.59 177.79 4.8 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.739 1.216 . . . . 0.0 110.306 -172.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -124.6 -83.61 0.64 Allowed 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.136 1.374 . . . . 0.0 113.98 -156.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -126.89 165.49 19.26 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.75 1.62 . . . . 0.0 111.921 172.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -85.99 50.75 2.04 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 124.744 2.212 . . . . 0.0 109.187 176.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -60.93 140.71 57.67 Favored 'General case' 0 N--CA 1.45 -0.448 0 O-C-N 117.426 -3.296 . . . . 0.0 111.841 -166.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 43.4 m -70.35 46.19 0.08 Allowed 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 117.098 2.258 . . . . 0.0 117.098 -162.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 38.1 ptt85 -56.46 37.72 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.508 1 C-N-CA 133.186 4.595 . . . . 0.0 120.139 -167.323 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 59.8 mt -57.09 129.88 19.32 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 CA-C-O 115.225 -2.321 . . . . 0.0 112.09 -176.099 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 57.8 t30 -147.41 160.14 42.9 Favored 'General case' 0 N--CA 1.449 -0.493 0 O-C-N 125.849 1.968 . . . . 0.0 114.12 -178.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 21.3 tt0 -133.07 -76.81 0.49 Allowed 'General case' 0 N--CA 1.449 -0.494 0 O-C-N 127.268 2.855 . . . . 0.0 106.637 177.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.7 t70 . . . . . 0 C--O 1.25 1.083 0 CA-C-O 114.858 -2.496 . . . . 0.0 116.392 163.495 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.434 0 N-CA-C 117.426 1.73 . . . . 0.0 117.426 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 62.4 mt -134.73 -29.18 1.18 Allowed 'General case' 0 N--CA 1.449 -0.502 0 CA-C-O 117.141 -1.409 . . . . 0.0 114.141 171.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 67.3 m -145.77 -161.76 1.37 Allowed 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 120.723 1.601 . . . . 0.0 107.44 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -62.46 164.26 7.62 Favored 'General case' 0 N--CA 1.448 -0.552 0 O-C-N 124.762 1.289 . . . . 0.0 114.287 -167.178 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 164.47 -152.28 21.91 Favored Glycine 0 C--N 1.334 0.466 0 C-N-CA 119.067 -1.539 . . . . 0.0 116.658 165.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 27.6 m -105.26 -20.04 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 C-N-CA 125.778 1.631 . . . . 0.0 114.605 169.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.535 ' HB3' ' CD1' ' A' ' 15' ' ' PHE . 6.5 tp10 -102.87 77.47 0.23 Allowed Pre-proline 0 N--CA 1.449 -0.497 0 C-N-CA 126.888 2.075 . . . . 0.0 115.72 -176.07 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_endo -66.11 143.34 71.3 Favored 'Trans proline' 0 N--CA 1.449 -1.128 0 O-C-N 117.205 -2.05 . . . . 0.0 107.465 -169.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -130.93 -84.86 0.52 Allowed 'General case' 0 N--CA 1.45 -0.463 1 C-N-CA 132.734 4.414 . . . . 0.0 110.056 -161.658 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 5.3 mt -97.0 97.48 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 O-C-N 124.732 1.27 . . . . 0.0 111.824 170.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 51.4 -100.01 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 126.033 1.778 . . . . 0.0 115.75 179.005 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -88.42 7.28 33.46 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 117.972 2.582 . . . . 0.0 117.972 177.29 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 7.4 p -119.41 172.58 7.52 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 116.754 2.131 . . . . 0.0 116.754 169.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 15.2 m-85 -137.83 -89.0 0.25 Allowed 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 126.649 1.98 . . . . 0.0 113.382 -160.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.535 ' CD1' ' HB3' ' A' ' 7' ' ' GLU . 25.0 m-85 -140.58 169.72 17.12 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 129.225 3.01 . . . . 0.0 109.319 179.327 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . 0.271 5.7 tp10 -88.25 60.85 5.94 Favored 'General case' 0 N--CA 1.45 -0.456 0 O-C-N 120.436 -1.415 . . . . 0.0 110.594 -160.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -89.93 159.56 16.86 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 114.759 -1.11 . . . . 0.0 113.449 178.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 46.1 t -47.01 154.41 0.35 Allowed 'General case' 0 N--CA 1.45 -0.473 1 O-C-N 129.351 4.157 . . . . 0.0 113.286 173.555 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 57.2 ttt-85 -80.38 56.58 2.57 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 124.706 2.193 . . . . 0.0 113.189 167.43 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 3.1 mt -64.04 125.43 20.74 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 O-C-N 118.147 -2.846 . . . . 0.0 106.599 175.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 17.2 p30 -144.07 166.03 26.14 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 128.356 2.662 . . . . 0.0 111.448 -158.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -137.59 5.59 2.68 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 116.442 2.016 . . . . 0.0 116.442 172.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 21.2 t70 . . . . . 0 C--O 1.25 1.099 0 CA-C-O 124.921 2.296 . . . . 0.0 107.138 -179.687 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.514 0 N-CA-C 120.91 3.124 . . . . 0.0 120.91 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 12.9 mt -128.9 -26.76 2.61 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 115.379 1.622 . . . . 0.0 115.379 179.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 61.3 m -147.03 -173.26 4.19 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 128.083 2.553 . . . . 0.0 109.478 -174.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 7.4 pm0 -55.02 171.54 0.14 Allowed 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 124.547 2.118 . . . . 0.0 114.334 176.319 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 166.3 -163.9 37.21 Favored Glycine 0 C--N 1.335 0.52 0 CA-C-O 126.425 3.236 . . . . 0.0 113.744 -176.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 16.1 m -130.13 -10.3 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 CA-C-N 111.412 -2.394 . . . . 0.0 113.064 179.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -114.59 84.43 9.95 Favored Pre-proline 0 N--CA 1.449 -0.482 0 C-N-CA 124.592 1.157 . . . . 0.0 110.842 174.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -63.88 148.04 91.92 Favored 'Trans proline' 0 N--CA 1.45 -1.086 0 CA-C-N 122.34 1.871 . . . . 0.0 108.955 -173.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -125.81 -58.36 1.4 Allowed 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 129.987 3.315 . . . . 0.0 109.221 -167.334 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 30.6 mm -83.01 175.54 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 C-N-CA 130.267 3.427 . . . . 0.0 109.042 165.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -54.09 -56.27 22.01 Favored Glycine 0 C--N 1.335 0.493 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 170.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -84.26 -33.76 23.96 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 127.726 2.41 . . . . 0.0 111.913 -175.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 27.9 p -132.94 173.65 11.18 Favored 'General case' 0 N--CA 1.45 -0.464 0 O-C-N 117.402 -3.311 . . . . 0.0 112.386 -155.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -128.22 -85.65 0.58 Allowed 'General case' 0 N--CA 1.45 -0.463 0 O-C-N 126.9 2.625 . . . . 0.0 116.455 -154.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 30.1 m-85 -137.43 169.35 17.94 Favored 'General case' 0 N--CA 1.448 -0.529 0 O-C-N 120.207 -1.558 . . . . 0.0 110.114 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -89.04 69.59 8.43 Favored 'General case' 0 N--CA 1.449 -0.5 0 O-C-N 118.393 -2.692 . . . . 0.0 108.505 175.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -58.16 -41.76 84.49 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-O 124.592 2.139 . . . . 0.0 112.02 -166.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 39.66 53.41 2.48 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 129.652 3.181 . . . . 0.0 111.477 -177.016 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 71.0 ttt-85 -123.29 67.09 0.99 Allowed 'General case' 0 N--CA 1.449 -0.494 0 O-C-N 118.852 -2.405 . . . . 0.0 108.007 -162.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 35.3 mm -113.68 122.59 68.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 C-N-CA 126.861 2.064 . . . . 0.0 107.302 -178.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -106.77 157.31 17.83 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 126.362 1.865 . . . . 0.0 111.576 -177.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 21.9 mm100 -71.82 116.33 12.07 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 126.64 1.976 . . . . 0.0 114.468 168.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 . . . . . 0 C--O 1.251 1.169 0 CA-C-N 121.331 1.878 . . . . 0.0 113.865 170.508 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.479 0 N-CA-C 117.353 1.701 . . . . 0.0 117.353 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . 0.351 0.5 OUTLIER -154.88 -17.11 0.12 Allowed 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 118.688 2.847 . . . . 0.0 118.688 165.557 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.0 m -130.92 165.88 22.15 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 126.719 2.008 . . . . 0.0 111.215 -177.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 22.7 mp0 -68.0 142.4 55.94 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 126.959 2.104 . . . . 0.0 110.607 -175.041 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -176.86 -150.23 8.18 Favored Glycine 0 CA--C 1.522 0.482 0 O-C-N 119.091 -2.256 . . . . 0.0 108.873 -175.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 43.5 t -117.91 -21.7 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 1 C-N-CA 133.224 4.61 . . . . 0.0 116.628 -173.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 13.4 tp10 -113.15 83.23 6.14 Favored Pre-proline 0 N--CA 1.449 -0.5 0 C-N-CA 127.222 2.209 . . . . 0.0 111.939 -177.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -68.93 146.98 67.16 Favored 'Trans proline' 0 N--CA 1.45 -1.088 0 C-N-CA 124.737 3.625 . . . . 0.0 109.28 -167.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -139.62 -74.77 0.36 Allowed 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 128.254 2.622 . . . . 0.0 111.716 -159.016 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 18.9 mm -112.1 141.51 27.37 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 N-CA-C 105.318 -2.104 . . . . 0.0 105.318 171.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 62.54 -91.41 0.07 OUTLIER Glycine 0 C--N 1.336 0.547 0 C-N-CA 127.503 2.478 . . . . 0.0 111.525 158.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 7.2 mm-40 -132.77 19.89 4.2 Favored 'General case' 0 N--CA 1.45 -0.464 1 C-N-CA 133.409 4.684 . . . . 0.0 113.532 178.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 80.3 p -141.86 164.16 30.94 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-O 125.369 2.509 . . . . 0.0 112.665 -170.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 14.6 m-85 -128.4 -87.73 0.55 Allowed 'General case' 0 N--CA 1.449 -0.496 0 O-C-N 118.814 -2.429 . . . . 0.0 115.108 -151.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -140.88 153.34 45.68 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-O 122.818 1.294 . . . . 0.0 110.995 176.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -62.92 98.13 0.12 Allowed 'General case' 0 N--CA 1.449 -0.506 0 O-C-N 118.348 -2.72 . . . . 0.0 116.313 -176.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 30.7 mm-40 -112.03 112.43 24.06 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 127.612 2.365 . . . . 0.0 108.942 177.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 67.5 m -138.82 45.6 2.01 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 128.481 2.713 . . . . 0.0 108.98 -174.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 36.5 ttm-85 -74.93 55.56 0.71 Allowed 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 129.063 2.945 . . . . 0.0 113.715 -178.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 19.0 mt -73.68 143.88 13.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 O-C-N 124.796 1.31 . . . . 0.0 112.676 -178.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 58.7 t30 -101.05 75.55 1.67 Allowed 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 127.379 2.272 . . . . 0.0 115.452 166.203 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 -74.36 -12.59 60.56 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 124.711 1.204 . . . . 0.0 112.9 -161.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 . . . . . 0 C--O 1.249 1.058 0 O-C-N 121.067 -1.021 . . . . 0.0 109.555 -177.297 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.521 0 N-CA-C 120.499 2.96 . . . . 0.0 120.499 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 55.2 mt -120.33 -39.3 2.8 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 115.841 -2.028 . . . . 0.0 116.446 -169.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.7 m -139.7 178.58 7.13 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 127.705 2.402 . . . . 0.0 110.237 -168.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 21.9 pt20 -74.8 156.66 36.28 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 124.711 1.205 . . . . 0.0 113.612 -168.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 164.24 -153.01 23.1 Favored Glycine 0 CA--C 1.523 0.554 0 C-N-CA 119.893 -1.146 . . . . 0.0 114.731 -171.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 20.1 m -120.85 -8.79 10.28 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 1 C-N-CA 136.097 5.759 . . . . 0.0 115.824 -165.204 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 19.0 tt0 -128.33 88.93 51.27 Favored Pre-proline 0 N--CA 1.45 -0.461 0 C-N-CA 129.081 2.952 . . . . 0.0 113.785 171.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -73.31 99.14 1.08 Allowed 'Trans proline' 0 N--CA 1.449 -1.116 0 C-N-CA 122.526 2.151 . . . . 0.0 110.863 -177.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -61.02 -59.14 5.85 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 126.66 1.984 . . . . 0.0 112.951 167.21 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 7.6 mt -90.78 141.99 13.59 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 C-N-CA 128.923 2.889 . . . . 0.0 103.958 162.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -48.13 -32.57 9.53 Favored Glycine 0 CA--C 1.522 0.515 0 O-C-N 119.613 -1.93 . . . . 0.0 114.025 167.145 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . 0.269 25.5 tt0 -67.38 -43.08 82.26 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 117.25 2.315 . . . . 0.0 117.25 168.603 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 16.5 p -149.12 150.89 33.45 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 120.649 3.574 . . . . 0.0 120.649 -164.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . 0.27 0.7 OUTLIER -110.66 -102.95 0.39 Allowed 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 130.118 3.367 . . . . 0.0 115.981 -151.687 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 18.5 m-85 -136.16 167.55 21.06 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 169.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -73.6 60.53 0.68 Allowed 'General case' 0 N--CA 1.449 -0.488 0 O-C-N 126.738 2.524 . . . . 0.0 115.966 -158.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -75.86 96.71 3.76 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 126.431 1.893 . . . . 0.0 110.106 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 54.8 m -155.62 134.79 12.23 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 124.279 1.032 . . . . 0.0 110.262 177.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 22.3 mmt85 -138.8 27.6 2.43 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 126.398 1.879 . . . . 0.0 113.873 -171.033 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 12.2 mt -42.08 110.05 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 C-N-CA 127.721 2.408 . . . . 0.0 110.451 179.115 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 58.1 t30 -150.3 150.15 31.1 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 113.283 -1.781 . . . . 0.0 111.444 174.299 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 28.5 tt0 -77.9 159.19 29.05 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 131.238 3.815 . . . . 0.0 111.695 167.266 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . 0.287 48.4 m-20 . . . . . 0 C--O 1.25 1.111 0 CA-C-O 126.971 3.272 . . . . 0.0 115.896 178.096 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.542 0 N-CA-C 122.434 3.733 . . . . 0.0 122.434 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 68.0 mt -126.53 -18.19 4.89 Favored 'General case' 0 N--CA 1.449 -0.514 0 O-C-N 129.241 3.553 . . . . 0.0 117.055 -172.133 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 70.2 m -144.91 176.65 9.31 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 131.3 3.84 . . . . 0.0 112.104 177.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 24.0 mp0 -70.67 156.77 39.04 Favored 'General case' 0 N--CA 1.448 -0.534 0 O-C-N 117.952 -2.968 . . . . 0.0 112.716 178.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 176.28 -139.55 4.61 Favored Glycine 0 CA--C 1.522 0.508 0 CA-C-O 121.763 0.646 . . . . 0.0 114.603 178.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 14.5 p -118.14 -17.0 7.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 O-C-N 119.652 -2.087 . . . . 0.0 113.141 -176.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -112.05 87.25 8.56 Favored Pre-proline 0 N--CA 1.45 -0.468 0 C-N-CA 128.683 2.793 . . . . 0.0 110.881 -172.11 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_endo -74.51 86.58 1.33 Allowed 'Trans proline' 0 N--CA 1.449 -1.14 0 CA-C-N 122.086 1.781 . . . . 0.0 112.829 -177.384 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -34.93 -82.73 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.519 1 C-N-CA 134.321 5.049 . . . . 0.0 111.958 154.055 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 22.7 mm -76.27 174.7 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 O-C-N 118.77 -2.456 . . . . 0.0 106.747 163.04 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -57.81 -51.45 58.03 Favored Glycine 0 C--N 1.336 0.536 0 O-C-N 118.129 -2.857 . . . . 0.0 114.602 154.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 21.3 tt0 -62.88 -47.33 83.78 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 120.122 3.379 . . . . 0.0 120.122 174.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 17.0 p -133.56 159.52 40.19 Favored 'General case' 0 N--CA 1.449 -0.483 0 O-C-N 117.163 -3.461 . . . . 0.0 116.872 -178.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 40.5 m-85 -111.11 -81.69 0.58 Allowed 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 124.911 1.284 . . . . 0.0 109.094 -158.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -149.86 156.29 41.52 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 178.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . 0.256 0.2 OUTLIER -79.34 77.04 5.89 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-O 116.975 -1.488 . . . . 0.0 109.092 -176.775 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -84.31 -33.72 23.88 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 128.049 2.539 . . . . 0.0 112.335 -165.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 3.3 t 45.09 47.36 9.74 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 123.27 2.759 . . . . 0.0 113.905 -177.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.57 2.39 5.55 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 114.732 1.382 . . . . 0.0 114.732 -159.783 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 3.8 mt -63.63 116.56 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 CA-C-O 117.696 -1.145 . . . . 0.0 111.187 154.071 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 34.1 m120 -75.24 71.54 2.25 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-O 123.785 1.755 . . . . 0.0 109.843 -176.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 47.0 tt0 -60.53 130.69 47.83 Favored 'General case' 0 N--CA 1.449 -0.494 1 C-N-CA 132.802 4.441 . . . . 0.0 110.816 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 24.7 t70 . . . . . 0 C--O 1.25 1.115 1 N-CA-C 122.03 4.085 . . . . 0.0 122.03 176.175 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.464 0 CA-C-O 122.059 0.811 . . . . 0.0 112.732 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.8 pp -153.36 -2.53 0.21 Allowed 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 118.179 2.659 . . . . 0.0 118.179 168.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 49.6 m -147.48 173.61 12.5 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-O 123.386 1.565 . . . . 0.0 110.81 176.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 -52.87 146.3 11.0 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 128.479 2.711 . . . . 0.0 112.079 172.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 171.67 -178.31 44.02 Favored Glycine 0 C--N 1.335 0.526 1 O-C-N 115.789 -4.32 . . . . 0.0 114.254 -173.171 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 33.1 m -92.68 -18.08 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 C-N-CA 124.855 1.262 . . . . 0.0 113.05 -178.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 12.5 tt0 -121.71 82.9 41.83 Favored Pre-proline 0 N--CA 1.45 -0.438 0 C-N-CA 124.245 1.018 . . . . 0.0 113.332 -165.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.421 ' HA ' ' HA ' ' A' ' 14' ' ' TYR . 5.0 Cg_exo -64.79 142.72 77.5 Favored 'Trans proline' 0 N--CA 1.449 -1.105 0 C-N-CA 120.693 0.928 . . . . 0.0 110.22 -165.723 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -119.03 -72.39 0.69 Allowed 'General case' 0 N--CA 1.449 -0.512 1 C-N-CA 133.196 4.599 . . . . 0.0 109.388 -178.145 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 96.8 mt -72.37 -20.28 19.73 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 CA-C-N 119.686 1.13 . . . . 0.0 108.586 171.005 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 94.17 -47.51 2.19 Favored Glycine 0 C--N 1.335 0.503 0 CA-C-O 123.879 1.822 . . . . 0.0 110.15 -177.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 58.5 mm-40 -63.06 -42.85 99.77 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 112.736 -1.732 . . . . 0.0 109.399 164.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 75.9 p -130.41 176.13 8.4 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 127.848 2.459 . . . . 0.0 111.63 171.151 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.421 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 4.3 m-85 -131.96 -85.88 0.48 Allowed 'General case' 0 N--CA 1.449 -0.498 1 C-N-CA 133.045 4.538 . . . . 0.0 112.718 -153.327 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -145.04 153.87 41.92 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 121.19 1.814 . . . . 0.0 109.324 -175.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -39.3 133.09 1.36 Allowed 'General case' 0 N--CA 1.45 -0.464 0 O-C-N 119.479 -2.013 . . . . 0.0 115.312 153.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -134.92 -67.06 0.56 Allowed 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 126.721 2.008 . . . . 0.0 109.365 -177.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.453 ' C ' ' H ' ' A' ' 20' ' ' ILE 0.265 16.2 m -61.1 76.49 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 120.568 3.544 . . . . 0.0 120.568 -166.195 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 27.5 ttm-85 -70.53 11.21 0.37 Allowed 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 126.604 1.961 . . . . 0.0 112.895 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.453 ' H ' ' C ' ' A' ' 18' ' ' SER . 55.2 mt -50.16 131.91 9.77 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 C-N-CA 128.973 2.909 . . . . 0.0 113.32 -177.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -72.98 116.43 13.48 Favored 'General case' 0 N--CA 1.447 -0.583 0 O-C-N 126.499 2.374 . . . . 0.0 111.204 179.323 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 18.9 tt0 -74.47 125.33 28.34 Favored 'General case' 0 N--CA 1.449 -0.506 0 O-C-N 118.82 -2.425 . . . . 0.0 108.931 -172.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 . . . . . 0 C--O 1.25 1.126 0 C-N-CA 126.559 1.944 . . . . 0.0 110.232 174.36 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.523 0 N-CA-C 119.378 2.511 . . . . 0.0 119.378 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 50.5 mt -128.22 -28.11 2.63 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 117.518 2.414 . . . . 0.0 117.518 -179.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.2 m -132.23 171.59 13.49 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 128.192 2.597 . . . . 0.0 111.961 -177.071 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 31.3 mt-30 -63.43 137.87 58.31 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 127.728 2.411 . . . . 0.0 106.43 168.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -170.03 -150.28 6.79 Favored Glycine 0 CA--C 1.523 0.551 0 C-N-CA 119.28 -1.438 . . . . 0.0 111.262 -174.199 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 9.8 p -117.42 -19.22 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 N-CA-C 117.237 2.31 . . . . 0.0 117.237 -177.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 55.0 tt0 -113.06 82.62 5.52 Favored Pre-proline 0 N--CA 1.449 -0.482 0 C-N-CA 126.831 2.052 . . . . 0.0 111.442 -178.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_endo -60.67 144.32 99.53 Favored 'Trans proline' 0 N--CA 1.449 -1.09 0 C-N-CA 124.018 3.146 . . . . 0.0 113.994 -172.186 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -135.87 -81.2 0.41 Allowed 'General case' 0 N--CA 1.449 -0.483 1 C-N-CA 132.337 4.255 . . . . 0.0 107.947 -162.235 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 11.7 mm -87.75 169.67 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 O-C-N 119.81 -1.806 . . . . 0.0 108.926 174.001 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -25.03 -58.08 0.06 OUTLIER Glycine 0 C--N 1.336 0.533 0 C-N-CA 130.589 3.947 . . . . 0.0 114.404 168.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 17.4 tt0 -100.8 -22.37 14.88 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 118.712 2.856 . . . . 0.0 118.712 178.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 33.0 p -118.1 174.09 6.41 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 115.711 1.745 . . . . 0.0 115.711 -167.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 67.6 m-85 -132.75 -82.16 0.48 Allowed 'General case' 0 N--CA 1.449 -0.48 0 O-C-N 126.018 2.074 . . . . 0.0 110.135 -160.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -144.53 162.43 36.61 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 128.363 2.665 . . . . 0.0 110.432 177.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -73.1 59.21 0.52 Allowed 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 128.2 2.6 . . . . 0.0 113.655 177.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 62.8 mt-10 -68.59 -59.47 3.11 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-O 125.424 2.535 . . . . 0.0 112.96 -176.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 6.7 t -166.77 173.08 9.86 Favored 'General case' 0 N--CA 1.449 -0.479 1 C-N-CA 132.433 4.293 . . . . 0.0 110.753 179.352 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . 0.275 10.9 ttt180 -134.9 10.78 3.62 Favored 'General case' 0 N--CA 1.449 -0.5 1 C-N-CA 133.615 4.766 . . . . 0.0 113.598 167.785 . . . . . . . . 3 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 76.2 mt -54.81 138.51 14.82 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 C-N-CA 127.03 2.132 . . . . 0.0 114.116 177.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 27.2 m-80 -137.05 162.95 31.93 Favored 'General case' 0 N--CA 1.448 -0.53 0 O-C-N 117.471 -3.268 . . . . 0.0 109.504 171.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . 0.26 33.4 tt0 -132.14 57.71 1.77 Allowed 'General case' 0 N--CA 1.449 -0.501 0 O-C-N 117.832 -3.042 . . . . 0.0 110.534 -177.298 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 . . . . . 0 C--O 1.25 1.127 1 O-C-N 115.538 -4.476 . . . . 0.0 110.443 -176.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.546 0 CA-C-O 118.246 -1.308 . . . . 0.0 115.544 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -142.41 5.49 1.64 Allowed 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 117.735 2.494 . . . . 0.0 117.735 -179.14 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 38.2 m -118.48 -172.28 2.24 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 130.7 3.6 . . . . 0.0 117.565 -169.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 29.0 mt-30 -95.29 122.75 38.31 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 125.381 1.472 . . . . 0.0 111.649 171.61 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 176.87 -162.97 31.58 Favored Glycine 0 C--N 1.336 0.532 0 N-CA-C 109.104 -1.599 . . . . 0.0 109.104 -164.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 45.3 t -116.05 -16.27 8.95 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 1 C-N-CA 132.854 4.462 . . . . 0.0 115.233 -155.45 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 50.7 tt0 -114.39 88.98 16.57 Favored Pre-proline 0 N--CA 1.448 -0.541 0 O-C-N 119.267 -2.146 . . . . 0.0 109.271 177.15 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -67.42 110.39 2.04 Favored 'Trans proline' 0 N--CA 1.45 -1.061 0 C-N-CA 124.956 3.771 . . . . 0.0 111.988 -178.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -90.29 -86.42 0.2 Allowed 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 126.205 1.802 . . . . 0.0 109.909 -159.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 9.2 mt -88.63 65.5 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 CA-C-O 126.716 3.15 . . . . 0.0 106.844 177.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 53.17 -87.64 0.01 OUTLIER Glycine 0 C--N 1.335 0.503 0 C-N-CA 127.681 2.562 . . . . 0.0 118.173 -166.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 44.6 tt0 -58.87 -30.39 67.71 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 119.737 3.236 . . . . 0.0 119.737 -169.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 24.3 p -127.36 172.16 10.89 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 126.873 2.069 . . . . 0.0 110.901 174.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 41.9 m-85 -125.58 174.15 8.45 Favored 'General case' 0 N--CA 1.45 -0.457 1 C-N-CA 133.289 4.636 . . . . 0.0 111.706 -153.528 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -54.92 134.85 48.7 Favored 'General case' 0 N--CA 1.449 -0.505 0 O-C-N 124.217 0.948 . . . . 0.0 109.878 175.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . 0.306 30.6 tt0 -59.12 65.67 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 130.926 3.69 . . . . 0.0 111.875 159.216 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . 0.276 29.5 tt0 -78.44 -39.6 38.19 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 127.21 2.204 . . . . 0.0 111.391 178.062 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 17.3 t -169.86 125.48 0.82 Allowed 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.372 1.469 . . . . 0.0 112.862 167.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 35.2 ttt-85 -126.01 16.57 7.91 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 126.771 2.029 . . . . 0.0 112.693 176.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 73.7 mt -52.27 123.02 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 CA-C-O 124.829 2.252 . . . . 0.0 110.282 176.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 47.0 t30 -80.46 140.87 35.72 Favored 'General case' 0 N--CA 1.449 -0.504 0 O-C-N 120.194 -1.566 . . . . 0.0 114.073 178.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 11.5 tm0? -104.6 132.18 51.15 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 126.335 1.854 . . . . 0.0 109.678 173.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 15.5 t70 . . . . . 0 C--O 1.25 1.089 0 C-N-CA 125.376 1.471 . . . . 0.0 112.863 166.054 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.495 0 N-CA-C 116.146 1.218 . . . . 0.0 116.146 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -158.85 -1.66 0.09 Allowed 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 117.59 2.441 . . . . 0.0 117.59 177.418 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 25.9 m -149.45 167.31 26.58 Favored 'General case' 0 N--CA 1.45 -0.468 0 O-C-N 118.418 -2.676 . . . . 0.0 114.082 -175.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 40.6 mt-30 -61.46 138.18 58.26 Favored 'General case' 0 N--CA 1.449 -0.499 0 O-C-N 120.358 -1.464 . . . . 0.0 112.413 -177.243 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 178.1 -153.03 12.27 Favored Glycine 0 CA--C 1.523 0.556 0 O-C-N 121.099 -1.001 . . . . 0.0 114.093 -167.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 63.6 t -124.66 -20.52 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 C-N-CA 125.816 1.647 . . . . 0.0 113.118 -168.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 28.8 tp10 -105.62 89.27 3.29 Favored Pre-proline 0 N--CA 1.45 -0.465 0 CA-C-O 116.224 -1.846 . . . . 0.0 111.091 173.161 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -60.19 140.32 91.63 Favored 'Trans proline' 0 N--CA 1.449 -1.143 0 C-N-CA 123.31 2.673 . . . . 0.0 113.457 178.285 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 38.1 t0 -128.57 -93.94 0.44 Allowed 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 126.089 1.755 . . . . 0.0 111.857 -164.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 28.3 mm -107.27 143.88 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 C-N-CA 126.419 1.888 . . . . 0.0 108.748 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 56.52 -89.72 0.01 OUTLIER Glycine 0 C--N 1.336 0.53 0 C-N-CA 126.971 2.224 . . . . 0.0 115.226 174.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -134.04 4.04 3.48 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 116.083 1.883 . . . . 0.0 116.083 176.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 42.8 p -114.31 -177.25 3.08 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -131.08 -170.71 2.41 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 131.159 3.784 . . . . 0.0 110.877 -160.717 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -68.53 150.89 47.52 Favored 'General case' 0 N--CA 1.449 -0.516 0 O-C-N 119.07 -2.269 . . . . 0.0 109.866 177.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -63.68 87.71 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 128.07 2.548 . . . . 0.0 113.566 174.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -76.19 -34.64 59.32 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-O 123.162 1.458 . . . . 0.0 112.53 159.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 2.2 t 59.06 50.59 7.99 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 128.701 2.8 . . . . 0.0 111.341 -168.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 33.9 ttt85 -82.36 39.29 0.59 Allowed 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 126.273 1.829 . . . . 0.0 113.376 -175.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 54.9 mt -75.04 133.72 30.89 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 O-C-N 120.823 -1.173 . . . . 0.0 108.551 -172.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 31.4 t30 -128.15 94.34 3.89 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 126.765 2.026 . . . . 0.0 110.924 -158.058 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 37.6 tt0 -138.91 169.18 18.26 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 126.34 1.856 . . . . 0.0 111.761 -175.013 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 31.6 t70 . . . . . 0 C--O 1.25 1.086 0 C-N-CA 127.519 2.328 . . . . 0.0 113.747 169.906 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.483 0 N-CA-C 111.131 -0.788 . . . . 0.0 111.131 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 78.9 mt -144.69 -12.86 0.57 Allowed 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.682 1.593 . . . . 0.0 113.177 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 6.1 t -138.68 -152.12 0.41 Allowed 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 127.87 2.468 . . . . 0.0 113.176 -166.349 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -116.7 156.92 26.3 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 125.128 1.371 . . . . 0.0 110.072 173.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 164.86 -144.37 9.28 Favored Glycine 0 N--CA 1.448 -0.547 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.46 -171.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 18.6 m -120.97 -15.56 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 -175.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 33.2 mm-40 -107.83 96.78 18.2 Favored Pre-proline 0 N--CA 1.449 -0.479 0 O-C-N 119.689 -1.882 . . . . 0.0 112.74 174.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -74.24 101.89 1.47 Allowed 'Trans proline' 0 N--CA 1.45 -1.033 0 C-N-CA 123.463 2.776 . . . . 0.0 109.853 -179.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -68.22 -63.12 1.12 Allowed 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 129.252 3.021 . . . . 0.0 112.492 176.578 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 27.1 mt -75.89 157.21 5.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 N-CA-C 106.753 -1.573 . . . . 0.0 106.753 162.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -41.64 -48.27 4.92 Favored Glycine 0 CA--C 1.523 0.573 0 O-C-N 119.467 -2.021 . . . . 0.0 112.972 164.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 39.1 tt0 -76.13 -47.66 23.53 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 116.597 2.073 . . . . 0.0 116.597 179.052 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 35.9 p -129.24 164.09 24.21 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 127.288 2.235 . . . . 0.0 116.034 -160.251 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 13.9 m-85 -121.79 178.22 4.95 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 126.353 1.861 . . . . 0.0 110.905 -161.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -62.91 144.71 56.47 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 -179.197 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -61.89 106.58 0.71 Allowed 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 125.97 1.708 . . . . 0.0 109.175 178.599 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -67.87 -45.63 73.99 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 114.239 -1.346 . . . . 0.0 112.627 173.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 42.5 t 176.62 137.31 0.06 Allowed 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 129.38 3.072 . . . . 0.0 107.782 177.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 42.3 mtt180 -151.46 89.57 1.5 Allowed 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 125.236 1.414 . . . . 0.0 108.166 167.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 46.9 mm -57.97 132.79 22.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 CA-C-N 115.135 -0.939 . . . . 0.0 111.058 159.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -51.43 146.65 6.93 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 126.449 1.899 . . . . 0.0 112.115 -178.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 30.6 tt0 49.08 90.98 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 128.256 2.623 . . . . 0.0 115.25 -177.311 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 . . . . . 0 C--O 1.25 1.108 0 C-N-CA 128.429 2.691 . . . . 0.0 115.466 -177.006 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.526 0 N-CA-C 117.45 1.74 . . . . 0.0 117.45 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 95.0 mt -137.7 -37.05 0.61 Allowed 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 116.566 2.062 . . . . 0.0 116.566 171.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.5 m -138.97 -162.14 1.28 Allowed 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 125.164 1.386 . . . . 0.0 112.325 -175.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 70.8 mt-30 -54.15 165.35 0.52 Allowed 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 114.351 1.241 . . . . 0.0 114.351 175.529 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 160.29 -173.79 36.94 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.95 -0.643 . . . . 0.0 114.196 160.135 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 13.7 p -91.3 -7.09 10.73 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 C-N-CA 125.812 1.645 . . . . 0.0 113.468 178.479 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -121.94 90.75 48.72 Favored Pre-proline 0 N--CA 1.449 -0.517 0 C-N-CA 125.644 1.578 . . . . 0.0 111.094 -171.412 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_exo -51.19 140.85 40.57 Favored 'Trans proline' 0 N--CA 1.45 -1.067 0 C-N-CA 121.912 1.742 . . . . 0.0 113.121 174.338 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -128.74 -53.38 1.24 Allowed 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 126.229 1.812 . . . . 0.0 109.242 -175.136 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.426 HG22 ' H ' ' A' ' 11' ' ' GLY . 3.0 mt -121.98 172.68 8.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 C-N-CA 125.823 1.649 . . . . 0.0 108.064 172.46 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.426 ' H ' HG22 ' A' ' 10' ' ' ILE . . . -46.58 -42.74 14.51 Favored Glycine 0 C--N 1.335 0.501 0 C-N-CA 126.202 1.858 . . . . 0.0 116.138 178.586 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 45.2 tt0 -92.85 -36.25 12.93 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 116.763 2.135 . . . . 0.0 116.763 176.058 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 82.2 p -124.38 167.7 14.03 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 119.587 -1.946 . . . . 0.0 115.972 -160.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 16.9 m-85 -131.64 -83.57 0.51 Allowed 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.982 1.313 . . . . 0.0 111.664 -161.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -141.02 171.15 14.47 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 125.556 1.543 . . . . 0.0 110.714 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -80.09 59.46 3.29 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 121.98 2.173 . . . . 0.0 111.87 177.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -67.94 146.45 53.58 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 126.372 1.869 . . . . 0.0 111.623 -175.392 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 22.6 t 117.62 123.51 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 131.438 3.895 . . . . 0.0 110.605 -173.513 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 34.1 ttp180 -146.58 28.57 1.06 Allowed 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 125.978 1.711 . . . . 0.0 112.545 -172.374 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 37.6 mt -52.96 115.35 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 O-C-N 118.927 -2.358 . . . . 0.0 111.749 174.386 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 31.4 t30 -129.78 82.41 2.07 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 127.029 2.132 . . . . 0.0 108.192 179.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 40.4 tt0 -143.48 -19.93 0.61 Allowed 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.815 1.646 . . . . 0.0 113.871 -169.166 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 . . . . . 0 C--O 1.251 1.139 0 N-CA-C 117.49 2.404 . . . . 0.0 117.49 177.266 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.534 0 CA-C-O 123.002 1.335 . . . . 0.0 114.979 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -130.11 -5.79 4.41 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 129.317 3.047 . . . . 0.0 113.546 -174.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 26.6 m -120.56 -166.14 1.29 Allowed 'General case' 0 N--CA 1.448 -0.533 0 O-C-N 126.805 2.566 . . . . 0.0 114.772 -162.445 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 20.1 mp0 -102.68 155.76 18.09 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 119.42 1.009 . . . . 0.0 110.41 161.074 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 161.89 -165.16 35.68 Favored Glycine 0 CA--C 1.523 0.568 0 O-C-N 119.462 -2.024 . . . . 0.0 113.776 -177.614 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 14.0 p -69.68 -26.95 31.81 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 N-CA-C 119.203 3.038 . . . . 0.0 119.203 174.175 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 16.2 tp10 -118.12 90.12 36.75 Favored Pre-proline 0 N--CA 1.449 -0.515 0 O-C-N 118.324 -2.735 . . . . 0.0 114.691 -164.198 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . 0.326 17.8 Cg_endo -60.74 127.72 23.43 Favored 'Trans proline' 0 N--CA 1.449 -1.115 0 CA-C-O 125.371 2.154 . . . . 0.0 114.6 173.029 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 49.9 t0 -117.63 -88.76 0.6 Allowed 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 128.282 2.633 . . . . 0.0 115.17 -161.047 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.6 mm -99.86 144.34 12.41 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 C-N-CA 126.946 2.098 . . . . 0.0 106.471 163.562 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.457 ' C ' ' H ' ' A' ' 13' ' ' THR . . . -45.56 143.5 3.63 Favored Glycine 0 CA--C 1.522 0.531 0 N-CA-C 121.338 3.295 . . . . 0.0 121.338 -163.747 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 15.7 tt0 62.39 -15.38 0.05 Allowed 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 109.966 -3.117 . . . . 0.0 114.323 -163.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.457 ' H ' ' C ' ' A' ' 11' ' ' GLY 0.277 24.9 p -122.28 168.54 11.91 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 126.01 2.814 . . . . 0.0 112.82 -166.006 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -134.5 162.69 31.56 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 128.041 2.536 . . . . 0.0 111.317 -166.166 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -57.73 145.58 34.09 Favored 'General case' 0 N--CA 1.449 -0.518 0 O-C-N 119.5 -2.0 . . . . 0.0 109.677 172.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -70.49 84.91 0.6 Allowed 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 127.931 2.492 . . . . 0.0 112.004 -169.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -75.3 -39.9 59.1 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 126.682 1.993 . . . . 0.0 111.828 174.544 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 47.0 m 52.51 53.72 11.82 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 126.87 2.068 . . . . 0.0 111.913 176.542 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 6.1 mmp_? -131.09 66.32 1.54 Allowed 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 126.456 1.902 . . . . 0.0 106.501 173.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.2 mp -56.49 114.21 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 C-N-CA 127.876 2.47 . . . . 0.0 110.316 -172.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 5.4 t30 61.16 38.09 17.09 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 129.59 3.156 . . . . 0.0 114.068 164.415 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -37.3 155.5 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 117.927 2.566 . . . . 0.0 117.927 179.403 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.6 t70 . . . . . 0 C--O 1.249 1.053 0 N-CA-C 116.382 1.993 . . . . 0.0 116.382 169.097 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.546 0 N-CA-C 111.764 -0.535 . . . . 0.0 111.764 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -160.68 10.49 0.1 Allowed 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 126.36 1.864 . . . . 0.0 114.926 -169.377 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 53.8 m -131.58 169.85 15.55 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-O 115.017 -2.42 . . . . 0.0 117.137 164.294 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 16.9 mm100 -57.91 145.93 33.92 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 122.898 2.59 . . . . 0.0 111.317 164.263 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 169.17 -152.01 18.95 Favored Glycine 0 C--N 1.335 0.519 0 N-CA-C 116.911 1.524 . . . . 0.0 116.911 174.382 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.9 t -97.44 -18.63 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 O-C-N 127.08 2.282 . . . . 0.0 117.027 -177.518 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.407 ' O ' ' HA ' ' A' ' 14' ' ' TYR . 4.2 tp10 -125.88 92.42 46.22 Favored Pre-proline 0 N--CA 1.449 -0.518 0 N-CA-C 106.649 -1.611 . . . . 0.0 106.649 -168.048 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -71.99 94.98 0.73 Allowed 'Trans proline' 0 N--CA 1.448 -1.153 0 C-N-CA 124.409 3.406 . . . . 0.0 110.048 173.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -64.26 -52.28 59.44 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 130.734 3.613 . . . . 0.0 109.88 -177.83 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.443 HG22 ' H ' ' A' ' 12' ' ' GLN . 47.3 mm -85.12 160.03 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 161.282 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -51.3 -41.22 47.13 Favored Glycine 0 CA--C 1.523 0.534 0 CA-C-O 124.774 2.319 . . . . 0.0 114.806 173.472 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.443 ' H ' HG22 ' A' ' 10' ' ' ILE . 8.9 tt0 -61.99 -81.21 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 128.258 2.623 . . . . 0.0 111.506 172.314 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . 0.273 0.7 OUTLIER -121.79 178.28 4.93 Favored 'General case' 0 N--CA 1.449 -0.517 0 O-C-N 117.794 -3.066 . . . . 0.0 117.196 -167.563 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.407 ' HA ' ' O ' ' A' ' 7' ' ' GLU . 0.7 OUTLIER -117.13 170.67 8.48 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 130.82 3.648 . . . . 0.0 112.259 -154.79 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -51.64 137.23 25.4 Favored 'General case' 0 N--CA 1.449 -0.491 0 O-C-N 118.923 -2.361 . . . . 0.0 109.478 -174.552 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -46.52 125.02 6.47 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 129.69 3.196 . . . . 0.0 113.539 -175.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -120.77 -66.24 1.07 Allowed 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 122.307 2.322 . . . . 0.0 106.501 -168.167 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 35.6 t -145.45 156.1 43.53 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-O 116.236 -1.84 . . . . 0.0 113.589 -179.375 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 21.7 ttt-85 -134.89 9.48 3.57 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 125.265 1.426 . . . . 0.0 113.96 170.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 92.1 mt -61.11 122.69 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 O-C-N 118.727 -2.483 . . . . 0.0 111.876 -154.51 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 32.3 t30 -139.73 117.53 11.64 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 125.99 1.716 . . . . 0.0 111.614 -172.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 8.6 mp0 -79.63 -20.7 46.12 Favored 'General case' 0 N--CA 1.448 -0.538 0 O-C-N 121.022 -1.048 . . . . 0.0 113.681 174.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 51.1 t0 . . . . . 0 C--O 1.25 1.086 0 C-N-CA 128.163 2.585 . . . . 0.0 115.762 -167.654 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.493 0 CA-C-O 119.503 -0.609 . . . . 0.0 113.315 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -121.23 12.15 10.95 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 126.874 2.07 . . . . 0.0 114.33 -177.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -118.82 -148.65 0.42 Allowed 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 128.351 2.661 . . . . 0.0 110.94 178.772 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 15.4 mp0 -122.15 152.49 39.87 Favored 'General case' 0 N--CA 1.45 -0.45 0 O-C-N 116.959 -3.588 . . . . 0.0 115.042 167.002 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 170.57 -138.11 4.79 Favored Glycine 0 C--N 1.336 0.543 0 CA-C-N 113.055 -1.884 . . . . 0.0 112.291 -170.577 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 13.1 m -128.15 -8.64 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 CA-C-N 119.464 1.632 . . . . 0.0 110.647 -175.442 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -112.36 81.46 4.0 Favored Pre-proline 0 N--CA 1.449 -0.508 0 N-CA-C 116.442 2.015 . . . . 0.0 116.442 173.406 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -65.89 136.61 45.83 Favored 'Trans proline' 0 N--CA 1.449 -1.101 0 C-N-CA 123.439 2.759 . . . . 0.0 107.367 -179.418 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -130.8 -102.42 0.29 Allowed 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 109.61 -3.45 . . . . 0.0 110.074 -151.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 17.1 mt -70.8 88.83 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 CA-C-N 122.706 2.503 . . . . 0.0 110.447 168.224 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 46.82 -107.9 0.24 Allowed Glycine 0 CA--C 1.523 0.537 0 O-C-N 117.173 -3.455 . . . . 0.0 117.179 -175.102 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -64.58 -10.71 28.15 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 120.05 3.352 . . . . 0.0 120.05 179.227 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 46.2 p -124.06 159.92 28.86 Favored 'General case' 0 N--CA 1.449 -0.5 0 O-C-N 125.572 1.795 . . . . 0.0 113.541 -173.315 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -124.6 175.73 7.0 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 131.48 3.912 . . . . 0.0 112.729 -160.443 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -57.78 156.4 8.82 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 115.835 1.791 . . . . 0.0 115.835 -177.707 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -69.87 88.0 0.55 Allowed 'General case' 0 N--CA 1.449 -0.509 0 O-C-N 118.299 -2.751 . . . . 0.0 115.814 -166.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -81.52 151.49 27.74 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 131.228 3.811 . . . . 0.0 112.274 164.077 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . 0.268 28.0 p 59.87 -179.09 0.09 Allowed 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 118.953 2.946 . . . . 0.0 118.953 173.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 48.4 ttt180 43.16 56.0 4.36 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 129.866 3.266 . . . . 0.0 112.366 175.282 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 15.1 mm -65.35 140.38 19.77 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 CA-C-O 124.569 2.128 . . . . 0.0 107.459 175.366 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 67.0 m-20 -117.18 167.02 11.57 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 129.869 3.268 . . . . 0.0 112.447 170.436 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 20.8 tt0 34.28 61.56 0.52 Allowed 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 128.59 2.756 . . . . 0.0 116.013 -174.374 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . 0.346 41.3 m-20 . . . . . 0 C--O 1.25 1.089 0 C-N-CA 129.152 2.981 . . . . 0.0 118.167 -176.569 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.503 0 N-CA-C 116.59 1.396 . . . . 0.0 116.59 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -158.61 -3.93 0.08 Allowed 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 121.232 3.79 . . . . 0.0 121.232 171.133 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.426 ' HB2' ' HA ' ' A' ' 16' ' ' GLU . 17.7 m -150.17 -177.05 5.71 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 129.744 3.218 . . . . 0.0 111.311 175.195 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -63.3 162.44 12.18 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 130.618 3.567 . . . . 0.0 111.771 -170.535 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 163.21 -173.27 39.35 Favored Glycine 0 C--N 1.335 0.495 0 N-CA-C 118.303 2.081 . . . . 0.0 118.303 -170.273 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 20.2 m -111.51 -14.85 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 C-N-CA 128.102 2.561 . . . . 0.0 113.65 171.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -105.91 77.78 0.44 Allowed Pre-proline 0 N--CA 1.449 -0.514 0 C-N-CA 128.144 2.577 . . . . 0.0 115.625 177.158 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -63.87 96.8 0.22 Allowed 'Trans proline' 0 N--CA 1.449 -1.089 0 CA-C-O 124.301 1.709 . . . . 0.0 113.643 -176.391 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -62.27 -66.62 0.51 Allowed 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 130.443 3.497 . . . . 0.0 112.37 -165.507 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . 0.254 42.8 pt -109.41 -166.39 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 CA-C-N 113.277 -1.783 . . . . 0.0 112.363 169.229 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -45.75 -47.21 13.54 Favored Glycine 0 C--N 1.335 0.514 0 N-CA-C 118.491 2.157 . . . . 0.0 118.491 -178.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 20.6 mp0 -121.84 150.39 41.99 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 129.605 3.162 . . . . 0.0 107.408 174.325 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.46 ' HA ' ' CD1' ' A' ' 14' ' ' TYR 0.28 4.7 p 56.38 179.45 0.04 OUTLIER 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 111.127 -2.76 . . . . 0.0 113.973 179.386 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.46 ' CD1' ' HA ' ' A' ' 13' ' ' THR . 2.2 m-85 -133.53 -99.06 0.27 Allowed 'General case' 0 N--CA 1.449 -0.518 0 O-C-N 117.823 -3.048 . . . . 0.0 111.203 -148.017 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -133.9 161.88 33.55 Favored 'General case' 0 N--CA 1.45 -0.475 0 CA-C-O 126.807 3.194 . . . . 0.0 107.363 -179.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.426 ' HA ' ' HB2' ' A' ' 3' ' ' SER . 21.0 tt0 -74.11 70.48 1.58 Allowed 'General case' 0 N--CA 1.449 -0.497 0 O-C-N 117.837 -3.039 . . . . 0.0 114.158 -175.334 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 -79.13 -8.23 58.82 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 131.229 3.812 . . . . 0.0 116.008 175.146 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 41.8 m -142.19 132.76 25.3 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 130.078 3.351 . . . . 0.0 116.844 -175.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 43.3 mtt180 -134.27 84.83 2.14 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 126.978 2.111 . . . . 0.0 108.251 168.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 30.2 mt -60.8 133.95 26.31 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 C-N-CA 126.938 2.095 . . . . 0.0 108.631 170.245 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 56.5 t30 -154.47 -177.71 6.65 Favored 'General case' 0 N--CA 1.45 -0.455 0 O-C-N 119.159 -2.213 . . . . 0.0 111.118 -165.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 19.3 tt0 -149.01 126.56 11.64 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-O 124.606 2.146 . . . . 0.0 109.789 -165.359 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 . . . . . 0 C--O 1.251 1.165 0 CA-C-N 113.625 -1.625 . . . . 0.0 114.489 179.395 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.501 0 N-CA-C 115.529 0.972 . . . . 0.0 115.529 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -159.41 -10.92 0.06 Allowed 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 115.98 1.844 . . . . 0.0 115.98 171.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 37.8 m -127.42 164.75 21.19 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 122.756 2.525 . . . . 0.0 116.003 -172.123 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -66.95 129.06 38.66 Favored 'General case' 0 N--CA 1.449 -0.519 0 O-C-N 120.532 -1.355 . . . . 0.0 110.581 -179.369 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -167.76 -151.88 7.24 Favored Glycine 0 C--N 1.334 0.449 0 N-CA-C 119.133 2.413 . . . . 0.0 119.133 -169.59 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 6.2 t -129.1 -19.15 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 C-N-CA 129.698 3.199 . . . . 0.0 113.911 -168.28 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -116.34 95.58 45.66 Favored Pre-proline 0 N--CA 1.45 -0.473 0 CA-C-O 117.49 -1.243 . . . . 0.0 111.637 171.58 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -74.76 90.5 1.05 Allowed 'Trans proline' 0 N--CA 1.449 -1.101 0 CA-C-N 124.092 2.497 . . . . 0.0 112.427 -175.286 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -52.34 -60.92 2.64 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 130.898 3.679 . . . . 0.0 111.458 170.652 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 20.9 pt -108.34 176.88 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 CA-C-O 124.424 2.059 . . . . 0.0 111.477 178.193 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -66.59 113.08 5.39 Favored Glycine 0 C--N 1.336 0.536 0 C-N-CA 128.438 2.923 . . . . 0.0 113.649 161.052 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 14.9 tt0 55.01 86.45 0.05 Allowed 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 128.526 2.73 . . . . 0.0 115.81 -159.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.404 ' HA ' ' CE1' ' A' ' 14' ' ' TYR 0.358 30.7 p 114.67 179.14 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.488 1 C-N-CA 133.63 4.772 . . . . 0.0 118.508 159.889 . . . . . . . . 4 3 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.404 ' CE1' ' HA ' ' A' ' 13' ' ' THR . 6.2 m-85 -129.59 -168.95 2.02 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 128.627 2.771 . . . . 0.0 108.373 -151.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -64.03 163.51 12.16 Favored 'General case' 0 N--CA 1.45 -0.466 0 O-C-N 119.401 -2.062 . . . . 0.0 113.102 -178.396 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -76.75 85.68 3.37 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-O 126.819 3.2 . . . . 0.0 113.459 178.577 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -66.63 173.99 3.11 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 110.558 -3.019 . . . . 0.0 116.609 173.349 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 36.6 t -46.35 132.9 10.06 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 130.905 3.682 . . . . 0.0 114.395 161.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 2.2 ttt180 -123.25 16.03 9.81 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 130.563 3.545 . . . . 0.0 114.593 164.402 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.8 mp -61.16 132.62 26.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 O-C-N 118.524 -2.61 . . . . 0.0 108.95 168.657 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 50.2 t30 -151.56 160.2 43.78 Favored 'General case' 0 N--CA 1.449 -0.523 0 O-C-N 118.745 -2.472 . . . . 0.0 113.42 -165.356 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 18.9 mp0 -126.16 167.33 15.56 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 127.73 2.412 . . . . 0.0 112.848 174.528 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 . . . . . 0 C--O 1.251 1.142 0 C-N-CA 127.361 2.264 . . . . 0.0 112.276 170.971 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.57 0 N-CA-C 114.052 0.381 . . . . 0.0 114.052 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 79.1 mt -139.61 -13.11 1.13 Allowed 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 126.312 1.845 . . . . 0.0 114.664 179.45 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 73.6 m -144.56 177.76 8.44 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-O 123.798 1.761 . . . . 0.0 109.395 -178.372 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 32.1 mt-30 -56.72 154.79 8.49 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 118.91 -2.369 . . . . 0.0 112.384 160.044 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 157.2 -156.39 27.19 Favored Glycine 0 C--N 1.335 0.516 0 O-C-N 118.773 -2.454 . . . . 0.0 114.453 178.556 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 16.8 m -110.26 -6.89 11.38 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 118.991 2.96 . . . . 0.0 118.991 -173.126 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 30.2 mm-40 -112.03 83.22 4.74 Favored Pre-proline 0 N--CA 1.45 -0.473 0 CA-C-O 116.012 -1.947 . . . . 0.0 114.476 176.102 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -64.59 142.53 77.97 Favored 'Trans proline' 0 N--CA 1.45 -1.074 0 C-N-CA 123.525 2.817 . . . . 0.0 111.44 -168.378 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -140.48 -79.88 0.28 Allowed 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 118.12 2.637 . . . . 0.0 118.12 -157.012 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 8.0 mm -91.46 161.06 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 N-CA-C 102.965 -2.976 . . . . 0.0 102.965 165.371 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -47.23 -18.64 0.52 Allowed Glycine 0 C--N 1.335 0.506 0 CA-C-N 113.633 -1.621 . . . . 0.0 117.135 -170.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 71.5 mt-30 -123.96 -8.56 7.76 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 129.822 3.249 . . . . 0.0 114.595 -171.568 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 64.0 p -137.98 178.79 6.86 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 117.39 2.367 . . . . 0.0 117.39 -166.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 -134.01 -97.99 0.27 Allowed 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 127.277 2.231 . . . . 0.0 112.421 -165.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 14.7 m-85 -142.81 150.28 39.74 Favored 'General case' 0 N--CA 1.449 -0.478 0 O-C-N 121.047 -1.033 . . . . 0.0 112.211 166.67 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -60.11 82.85 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.481 0 CA-C-O 127.231 3.396 . . . . 0.0 111.486 -174.373 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -65.87 -24.47 66.87 Favored 'General case' 0 N--CA 1.449 -0.478 1 O-C-N 116.181 -4.074 . . . . 0.0 112.08 164.454 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 58.7 m -64.98 47.73 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.482 1 C-N-CA 134.782 5.233 . . . . 0.0 117.541 -170.276 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 62.8 ttt-85 -71.23 56.67 0.22 Allowed 'General case' 0 N--CA 1.449 -0.506 1 O-C-N 129.309 4.131 . . . . 0.0 110.956 176.751 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 24.2 mt -135.14 111.61 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 C-N-CA 128.474 2.71 . . . . 0.0 107.703 -171.463 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 -130.68 157.65 42.21 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 112.98 -1.918 . . . . 0.0 113.601 168.192 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 56.6 mt-30 -128.79 4.13 5.44 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.817 -179.553 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 . . . . . 0 C--O 1.25 1.106 0 C-N-CA 129.378 3.071 . . . . 0.0 112.9 173.926 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.538 0 N-CA-C 116.509 1.364 . . . . 0.0 116.509 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -152.58 -8.47 0.19 Allowed 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 120.7 3.592 . . . . 0.0 120.7 157.412 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 21.4 m -134.01 -179.23 5.42 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 123.318 2.781 . . . . 0.0 115.816 174.289 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 22.6 mp0 -64.39 129.81 41.33 Favored 'General case' 0 N--CA 1.448 -0.527 0 O-C-N 118.197 -2.815 . . . . 0.0 113.956 -176.622 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -170.76 -149.16 6.3 Favored Glycine 0 C--N 1.336 0.539 0 CA-C-O 124.156 1.975 . . . . 0.0 113.048 171.541 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 26.7 m -117.01 -13.65 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 O-C-N 116.47 -3.959 . . . . 0.0 114.083 -171.349 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 23.6 tp10 -103.64 82.35 0.53 Allowed Pre-proline 0 N--CA 1.449 -0.479 0 O-C-N 126.943 2.652 . . . . 0.0 117.315 171.703 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.402 ' HB3' ' CE2' ' A' ' 14' ' ' TYR . 15.0 Cg_endo -64.47 149.75 89.44 Favored 'Trans proline' 0 N--CA 1.449 -1.136 0 C-N-CA 122.384 2.056 . . . . 0.0 108.683 -169.581 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -138.51 -92.25 0.2 Allowed 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 112.512 -2.131 . . . . 0.0 107.775 -159.34 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 6.4 mt -97.35 152.4 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 CA-C-O 117.138 -1.411 . . . . 0.0 107.217 169.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -36.35 141.81 0.19 Allowed Glycine 0 C--N 1.336 0.57 0 C-N-CA 129.534 3.445 . . . . 0.0 110.367 176.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 6.2 tm0? 58.13 -11.59 0.03 OUTLIER 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 116.962 2.208 . . . . 0.0 116.962 -168.186 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 22.6 p -133.73 168.07 19.37 Favored 'General case' 0 N--CA 1.45 -0.467 1 O-C-N 114.283 -5.261 . . . . 0.0 117.644 -170.221 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.408 ' O ' ' CD1' ' A' ' 15' ' ' PHE . 9.1 m-85 -127.79 -82.92 0.6 Allowed 'General case' 0 N--CA 1.449 -0.48 0 CA-C-O 126.762 3.172 . . . . 0.0 112.316 -172.027 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.408 ' CD1' ' O ' ' A' ' 14' ' ' TYR . 19.7 m-85 -140.58 141.85 35.16 Favored 'General case' 0 N--CA 1.45 -0.469 1 O-C-N 116.11 -4.118 . . . . 0.0 113.463 175.887 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -59.03 84.83 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.484 0 CA-C-O 117.567 -1.206 . . . . 0.0 113.874 166.483 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -105.42 -59.14 1.8 Allowed 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 116.237 1.939 . . . . 0.0 116.237 -166.57 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 15.5 m -157.64 66.98 0.49 Allowed 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 129.354 3.062 . . . . 0.0 111.187 172.176 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 4.4 ppt_? -62.98 -11.17 17.03 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 127.97 2.508 . . . . 0.0 114.056 -172.189 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 19.3 mm -61.78 -17.18 16.76 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 CA-C-N 122.976 2.626 . . . . 0.0 110.015 178.135 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 11.4 p30 -54.72 166.95 0.41 Allowed 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 130.986 3.714 . . . . 0.0 120.004 -172.221 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -135.76 173.73 11.39 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 129.894 3.278 . . . . 0.0 108.527 176.185 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 37.2 m-20 . . . . . 0 C--O 1.25 1.107 0 CA-C-O 117.973 -1.013 . . . . 0.0 112.4 174.278 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.504 0 N-CA-C 118.233 2.053 . . . . 0.0 118.233 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -143.46 -11.64 0.71 Allowed 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 128.328 2.651 . . . . 0.0 117.916 -176.812 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 69.5 m -114.84 -174.01 2.41 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 127.85 2.46 . . . . 0.0 110.245 -164.59 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -102.76 135.27 44.72 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 128.83 2.852 . . . . 0.0 109.68 161.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 176.47 -158.5 24.81 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 108.126 -1.99 . . . . 0.0 108.126 -157.307 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.2 p -130.06 -0.27 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 O-C-N 121.29 -1.124 . . . . 0.0 111.743 -167.637 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 27.1 tp10 -116.56 107.58 46.56 Favored Pre-proline 0 N--CA 1.449 -0.522 1 O-C-N 115.477 -4.514 . . . . 0.0 102.673 163.687 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -66.02 142.91 70.24 Favored 'Trans proline' 0 N--CA 1.449 -1.146 0 CA-C-O 127.324 2.969 . . . . 0.0 110.867 169.194 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -119.58 -94.1 0.51 Allowed 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 110.545 -3.025 . . . . 0.0 109.477 -165.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 24.5 pt -118.36 154.73 20.48 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 C-N-CA 130.047 3.339 . . . . 0.0 109.7 177.026 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 45.15 -111.13 0.51 Allowed Glycine 0 C--N 1.335 0.498 0 C-N-CA 127.178 2.323 . . . . 0.0 112.388 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 71.8 mm-40 -97.36 -1.43 44.53 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-O 124.979 2.323 . . . . 0.0 115.624 -177.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 18.3 p -128.41 176.8 7.44 Favored 'General case' 0 N--CA 1.45 -0.429 0 O-C-N 117.075 -3.516 . . . . 0.0 110.636 -155.111 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 16.8 m-85 -127.92 173.09 10.3 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 125.415 1.486 . . . . 0.0 113.051 -165.544 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -53.31 141.34 24.38 Favored 'General case' 0 N--CA 1.448 -0.526 0 O-C-N 117.991 -2.943 . . . . 0.0 112.046 169.548 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . 0.445 30.4 tt0 -55.34 90.67 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 118.856 2.91 . . . . 0.0 118.856 174.672 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 29.7 tp10 -63.65 -22.37 66.86 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 114.448 1.277 . . . . 0.0 114.448 166.022 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 17.9 m -68.04 78.64 0.23 Allowed 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.973 1.709 . . . . 0.0 111.688 170.374 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 48.7 ttt180 -92.63 61.54 3.69 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-O 116.627 -1.654 . . . . 0.0 108.342 179.412 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 3.4 mt -58.09 105.72 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 C-N-CA 127.207 2.203 . . . . 0.0 108.009 179.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 14.7 t30 -128.07 105.68 8.55 Favored 'General case' 0 N--CA 1.449 -0.476 0 O-C-N 125.79 1.932 . . . . 0.0 108.889 -161.411 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -133.89 147.55 51.14 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 121.543 1.974 . . . . 0.0 114.976 154.144 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 13.7 t70 . . . . . 0 C--O 1.249 1.048 0 CA-C-O 115.59 -2.148 . . . . 0.0 113.51 -171.251 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 1' ' ' GLY . . . . . 0.449 ' HA3' ' O ' ' A' ' 14' ' ' TYR . . . . . . . . 0 CA--C 1.523 0.578 0 N-CA-C 117.138 1.615 . . . . 0.0 117.138 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 94.9 mt -125.06 -30.24 3.23 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 120.258 3.429 . . . . 0.0 120.258 177.896 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 70.5 m -143.57 -178.64 5.99 Favored 'General case' 0 N--CA 1.449 -0.522 0 O-C-N 125.556 1.785 . . . . 0.0 110.263 -176.873 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . 0.325 82.6 mm-40 -62.36 136.26 57.83 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 113.593 -1.639 . . . . 0.0 113.545 -174.109 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -174.3 -164.91 30.03 Favored Glycine 0 C--N 1.336 0.578 0 CA-C-N 119.764 1.166 . . . . 0.0 114.574 -176.162 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 12.1 t -87.21 -38.18 11.86 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 CA-C-N 111.819 -2.19 . . . . 0.0 110.986 -171.498 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -115.49 87.13 16.33 Favored Pre-proline 0 N--CA 1.449 -0.502 0 C-N-CA 131.031 3.733 . . . . 0.0 115.994 -164.142 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -64.26 140.73 72.21 Favored 'Trans proline' 0 N--CA 1.449 -1.109 0 C-N-CA 123.148 2.565 . . . . 0.0 109.42 -179.418 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -121.66 -88.0 0.63 Allowed 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 128.673 2.789 . . . . 0.0 111.138 -158.352 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 6.6 pt -130.3 160.77 41.11 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.475 0 CA-C-O 122.5 1.143 . . . . 0.0 110.989 165.654 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 66.98 -100.51 0.57 Allowed Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 125.454 1.502 . . . . 0.0 113.626 -177.394 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -137.04 1.15 2.44 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 116.538 2.051 . . . . 0.0 116.538 179.543 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 31.8 p -119.59 177.79 4.8 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.739 1.216 . . . . 0.0 110.306 -172.858 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.449 ' O ' ' HA3' ' A' ' 1' ' ' GLY . 6.2 m-85 -124.6 -83.61 0.64 Allowed 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.136 1.374 . . . . 0.0 113.98 -156.736 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -126.89 165.49 19.26 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.75 1.62 . . . . 0.0 111.921 172.338 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -85.99 50.75 2.04 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 124.744 2.212 . . . . 0.0 109.187 176.525 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 . . . . . 0 N--CA 1.45 -0.448 0 O-C-N 117.426 -3.296 . . . . 0.0 111.841 -166.826 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.434 0 N-CA-C 117.426 1.73 . . . . 0.0 117.426 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 62.4 mt -134.73 -29.18 1.18 Allowed 'General case' 0 N--CA 1.449 -0.502 0 CA-C-O 117.141 -1.409 . . . . 0.0 114.141 171.822 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 67.3 m -145.77 -161.76 1.37 Allowed 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 120.723 1.601 . . . . 0.0 107.44 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -62.46 164.26 7.62 Favored 'General case' 0 N--CA 1.448 -0.552 0 O-C-N 124.762 1.289 . . . . 0.0 114.287 -167.178 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 164.47 -152.28 21.91 Favored Glycine 0 C--N 1.334 0.466 0 C-N-CA 119.067 -1.539 . . . . 0.0 116.658 165.645 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 27.6 m -105.26 -20.04 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 C-N-CA 125.778 1.631 . . . . 0.0 114.605 169.849 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.52 ' HB3' ' CD1' ' A' ' 15' ' ' PHE . 6.5 tp10 -102.87 77.47 0.23 Allowed Pre-proline 0 N--CA 1.449 -0.497 0 C-N-CA 126.888 2.075 . . . . 0.0 115.72 -176.07 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_endo -66.11 143.34 71.3 Favored 'Trans proline' 0 N--CA 1.449 -1.128 0 O-C-N 117.205 -2.05 . . . . 0.0 107.465 -169.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -130.93 -84.86 0.52 Allowed 'General case' 0 N--CA 1.45 -0.463 1 C-N-CA 132.734 4.414 . . . . 0.0 110.056 -161.658 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 5.3 mt -97.0 97.48 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 O-C-N 124.732 1.27 . . . . 0.0 111.824 170.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 51.4 -100.01 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 126.033 1.778 . . . . 0.0 115.75 179.005 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -88.42 7.28 33.46 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 117.972 2.582 . . . . 0.0 117.972 177.29 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 7.4 p -119.41 172.58 7.52 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 116.754 2.131 . . . . 0.0 116.754 169.58 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 15.2 m-85 -137.83 -89.0 0.25 Allowed 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 126.649 1.98 . . . . 0.0 113.382 -160.382 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.52 ' CD1' ' HB3' ' A' ' 7' ' ' GLU . 25.0 m-85 -140.58 169.72 17.12 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 129.225 3.01 . . . . 0.0 109.319 179.327 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . 0.271 5.7 tp10 -88.25 60.85 5.94 Favored 'General case' 0 N--CA 1.45 -0.456 0 O-C-N 120.436 -1.415 . . . . 0.0 110.594 -160.895 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 . . . . . 0 N--CA 1.45 -0.469 0 CA-C-N 114.759 -1.11 . . . . 0.0 113.449 178.518 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.514 0 N-CA-C 120.91 3.124 . . . . 0.0 120.91 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 12.9 mt -128.9 -26.76 2.61 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 115.379 1.622 . . . . 0.0 115.379 179.551 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' SER . . . . . 0.409 ' HB2' ' O ' ' A' ' 15' ' ' PHE . 61.3 m -147.03 -173.26 4.19 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 128.083 2.553 . . . . 0.0 109.478 -174.695 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 7.4 pm0 -55.02 171.54 0.14 Allowed 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 124.547 2.118 . . . . 0.0 114.334 176.319 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 166.3 -163.9 37.21 Favored Glycine 0 C--N 1.335 0.52 0 CA-C-O 126.425 3.236 . . . . 0.0 113.744 -176.642 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 16.1 m -130.13 -10.3 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 CA-C-N 111.412 -2.394 . . . . 0.0 113.064 179.474 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -114.59 84.43 9.95 Favored Pre-proline 0 N--CA 1.449 -0.482 0 C-N-CA 124.592 1.157 . . . . 0.0 110.842 174.55 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -63.88 148.04 91.92 Favored 'Trans proline' 0 N--CA 1.45 -1.086 0 CA-C-N 122.34 1.871 . . . . 0.0 108.955 -173.52 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -125.81 -58.36 1.4 Allowed 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 129.987 3.315 . . . . 0.0 109.221 -167.334 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 30.6 mm -83.01 175.54 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 C-N-CA 130.267 3.427 . . . . 0.0 109.042 165.501 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -54.09 -56.27 22.01 Favored Glycine 0 C--N 1.335 0.493 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 170.894 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -84.26 -33.76 23.96 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 127.726 2.41 . . . . 0.0 111.913 -175.642 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 27.9 p -132.94 173.65 11.18 Favored 'General case' 0 N--CA 1.45 -0.464 0 O-C-N 117.402 -3.311 . . . . 0.0 112.386 -155.536 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -128.22 -85.65 0.58 Allowed 'General case' 0 N--CA 1.45 -0.463 0 O-C-N 126.9 2.625 . . . . 0.0 116.455 -154.909 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.409 ' O ' ' HB2' ' A' ' 3' ' ' SER . 30.1 m-85 -137.43 169.35 17.94 Favored 'General case' 0 N--CA 1.448 -0.529 0 O-C-N 120.207 -1.558 . . . . 0.0 110.114 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -89.04 69.59 8.43 Favored 'General case' 0 N--CA 1.449 -0.5 0 O-C-N 118.393 -2.692 . . . . 0.0 108.505 175.196 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 . . . . . 0 N--CA 1.448 -0.537 0 CA-C-O 124.592 2.139 . . . . 0.0 112.02 -166.521 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.479 0 N-CA-C 117.353 1.701 . . . . 0.0 117.353 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . 0.351 0.5 OUTLIER -154.88 -17.11 0.12 Allowed 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 118.688 2.847 . . . . 0.0 118.688 165.557 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.0 m -130.92 165.88 22.15 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 126.719 2.008 . . . . 0.0 111.215 -177.119 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 22.7 mp0 -68.0 142.4 55.94 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 126.959 2.104 . . . . 0.0 110.607 -175.041 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -176.86 -150.23 8.18 Favored Glycine 0 CA--C 1.522 0.482 0 O-C-N 119.091 -2.256 . . . . 0.0 108.873 -175.548 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 43.5 t -117.91 -21.7 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 1 C-N-CA 133.224 4.61 . . . . 0.0 116.628 -173.873 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 13.4 tp10 -113.15 83.23 6.14 Favored Pre-proline 0 N--CA 1.449 -0.5 0 C-N-CA 127.222 2.209 . . . . 0.0 111.939 -177.414 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -68.93 146.98 67.16 Favored 'Trans proline' 0 N--CA 1.45 -1.088 0 C-N-CA 124.737 3.625 . . . . 0.0 109.28 -167.35 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -139.62 -74.77 0.36 Allowed 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 128.254 2.622 . . . . 0.0 111.716 -159.016 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 18.9 mm -112.1 141.51 27.37 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 N-CA-C 105.318 -2.104 . . . . 0.0 105.318 171.392 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 62.54 -91.41 0.07 OUTLIER Glycine 0 C--N 1.336 0.547 0 C-N-CA 127.503 2.478 . . . . 0.0 111.525 158.494 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 7.2 mm-40 -132.77 19.89 4.2 Favored 'General case' 0 N--CA 1.45 -0.464 1 C-N-CA 133.409 4.684 . . . . 0.0 113.532 178.772 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 80.3 p -141.86 164.16 30.94 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-O 125.369 2.509 . . . . 0.0 112.665 -170.632 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 14.6 m-85 -128.4 -87.73 0.55 Allowed 'General case' 0 N--CA 1.449 -0.496 0 O-C-N 118.814 -2.429 . . . . 0.0 115.108 -151.652 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -140.88 153.34 45.68 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-O 122.818 1.294 . . . . 0.0 110.995 176.022 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -62.92 98.13 0.12 Allowed 'General case' 0 N--CA 1.449 -0.506 0 O-C-N 118.348 -2.72 . . . . 0.0 116.313 -176.381 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 30.7 mm-40 . . . . . 0 N--CA 1.449 -0.494 0 C-N-CA 127.612 2.365 . . . . 0.0 108.942 177.477 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 1' ' ' GLY . . . . . 0.434 ' HA3' ' O ' ' A' ' 14' ' ' TYR . . . . . . . . 0 CA--C 1.522 0.521 0 N-CA-C 120.499 2.96 . . . . 0.0 120.499 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 55.2 mt -120.33 -39.3 2.8 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 115.841 -2.028 . . . . 0.0 116.446 -169.768 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.7 m -139.7 178.58 7.13 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 127.705 2.402 . . . . 0.0 110.237 -168.916 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 21.9 pt20 -74.8 156.66 36.28 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 124.711 1.205 . . . . 0.0 113.612 -168.029 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 164.24 -153.01 23.1 Favored Glycine 0 CA--C 1.523 0.554 0 C-N-CA 119.893 -1.146 . . . . 0.0 114.731 -171.679 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 20.1 m -120.85 -8.79 10.28 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 1 C-N-CA 136.097 5.759 . . . . 0.0 115.824 -165.204 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 19.0 tt0 -128.33 88.93 51.27 Favored Pre-proline 0 N--CA 1.45 -0.461 0 C-N-CA 129.081 2.952 . . . . 0.0 113.785 171.791 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -73.31 99.14 1.08 Allowed 'Trans proline' 0 N--CA 1.449 -1.116 0 C-N-CA 122.526 2.151 . . . . 0.0 110.863 -177.566 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -61.02 -59.14 5.85 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 126.66 1.984 . . . . 0.0 112.951 167.21 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.509 HG22 ' H ' ' A' ' 12' ' ' GLN . 7.6 mt -90.78 141.99 13.59 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 C-N-CA 128.923 2.889 . . . . 0.0 103.958 162.571 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -48.13 -32.57 9.53 Favored Glycine 0 CA--C 1.522 0.515 0 O-C-N 119.613 -1.93 . . . . 0.0 114.025 167.145 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.509 ' H ' HG22 ' A' ' 10' ' ' ILE 0.269 25.5 tt0 -67.38 -43.08 82.26 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 117.25 2.315 . . . . 0.0 117.25 168.603 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 16.5 p -149.12 150.89 33.45 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 120.649 3.574 . . . . 0.0 120.649 -164.907 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.434 ' O ' ' HA3' ' A' ' 1' ' ' GLY 0.27 0.7 OUTLIER -110.66 -102.95 0.39 Allowed 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 130.118 3.367 . . . . 0.0 115.981 -151.687 . . . . . . . . 4 4 . 1 . 005 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 18.5 m-85 -136.16 167.55 21.06 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 169.637 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -73.6 60.53 0.68 Allowed 'General case' 0 N--CA 1.449 -0.488 0 O-C-N 126.738 2.524 . . . . 0.0 115.966 -158.303 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 . . . . . 0 N--CA 1.449 -0.508 0 C-N-CA 126.431 1.893 . . . . 0.0 110.106 -179.932 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.542 0 N-CA-C 122.434 3.733 . . . . 0.0 122.434 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 68.0 mt -126.53 -18.19 4.89 Favored 'General case' 0 N--CA 1.449 -0.514 0 O-C-N 129.241 3.553 . . . . 0.0 117.055 -172.133 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 70.2 m -144.91 176.65 9.31 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 131.3 3.84 . . . . 0.0 112.104 177.511 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 24.0 mp0 -70.67 156.77 39.04 Favored 'General case' 0 N--CA 1.448 -0.534 0 O-C-N 117.952 -2.968 . . . . 0.0 112.716 178.527 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 176.28 -139.55 4.61 Favored Glycine 0 CA--C 1.522 0.508 0 CA-C-O 121.763 0.646 . . . . 0.0 114.603 178.693 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 14.5 p -118.14 -17.0 7.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 O-C-N 119.652 -2.087 . . . . 0.0 113.141 -176.823 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -112.05 87.25 8.56 Favored Pre-proline 0 N--CA 1.45 -0.468 0 C-N-CA 128.683 2.793 . . . . 0.0 110.881 -172.11 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_endo -74.51 86.58 1.33 Allowed 'Trans proline' 0 N--CA 1.449 -1.14 0 CA-C-N 122.086 1.781 . . . . 0.0 112.829 -177.384 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -34.93 -82.73 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.519 1 C-N-CA 134.321 5.049 . . . . 0.0 111.958 154.055 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.444 HG22 ' N ' ' A' ' 11' ' ' GLY . 22.7 mm -76.27 174.7 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 O-C-N 118.77 -2.456 . . . . 0.0 106.747 163.04 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.444 ' N ' HG22 ' A' ' 10' ' ' ILE . . . -57.81 -51.45 58.03 Favored Glycine 0 C--N 1.336 0.536 0 O-C-N 118.129 -2.857 . . . . 0.0 114.602 154.612 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 21.3 tt0 -62.88 -47.33 83.78 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 120.122 3.379 . . . . 0.0 120.122 174.475 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 17.0 p -133.56 159.52 40.19 Favored 'General case' 0 N--CA 1.449 -0.483 0 O-C-N 117.163 -3.461 . . . . 0.0 116.872 -178.343 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 40.5 m-85 -111.11 -81.69 0.58 Allowed 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 124.911 1.284 . . . . 0.0 109.094 -158.922 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -149.86 156.29 41.52 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 178.524 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . 0.256 0.2 OUTLIER -79.34 77.04 5.89 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-O 116.975 -1.488 . . . . 0.0 109.092 -176.775 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 . . . . . 0 N--CA 1.45 -0.431 0 C-N-CA 128.049 2.539 . . . . 0.0 112.335 -165.807 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.464 0 CA-C-O 122.059 0.811 . . . . 0.0 112.732 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.8 pp -153.36 -2.53 0.21 Allowed 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 118.179 2.659 . . . . 0.0 118.179 168.401 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 49.6 m -147.48 173.61 12.5 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-O 123.386 1.565 . . . . 0.0 110.81 176.688 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 -52.87 146.3 11.0 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 128.479 2.711 . . . . 0.0 112.079 172.507 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 171.67 -178.31 44.02 Favored Glycine 0 C--N 1.335 0.526 1 O-C-N 115.789 -4.32 . . . . 0.0 114.254 -173.171 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 33.1 m -92.68 -18.08 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 C-N-CA 124.855 1.262 . . . . 0.0 113.05 -178.448 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 12.5 tt0 -121.71 82.9 41.83 Favored Pre-proline 0 N--CA 1.45 -0.438 0 C-N-CA 124.245 1.018 . . . . 0.0 113.332 -165.535 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.471 ' HA ' ' HA ' ' A' ' 14' ' ' TYR . 5.0 Cg_exo -64.79 142.72 77.5 Favored 'Trans proline' 0 N--CA 1.449 -1.105 0 C-N-CA 120.693 0.928 . . . . 0.0 110.22 -165.723 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -119.03 -72.39 0.69 Allowed 'General case' 0 N--CA 1.449 -0.512 1 C-N-CA 133.196 4.599 . . . . 0.0 109.388 -178.145 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 96.8 mt -72.37 -20.28 19.73 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 CA-C-N 119.686 1.13 . . . . 0.0 108.586 171.005 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 94.17 -47.51 2.19 Favored Glycine 0 C--N 1.335 0.503 0 CA-C-O 123.879 1.822 . . . . 0.0 110.15 -177.596 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 58.5 mm-40 -63.06 -42.85 99.77 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 112.736 -1.732 . . . . 0.0 109.399 164.315 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 75.9 p -130.41 176.13 8.4 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 127.848 2.459 . . . . 0.0 111.63 171.151 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.471 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 4.3 m-85 -131.96 -85.88 0.48 Allowed 'General case' 0 N--CA 1.449 -0.498 1 C-N-CA 133.045 4.538 . . . . 0.0 112.718 -153.327 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -145.04 153.87 41.92 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 121.19 1.814 . . . . 0.0 109.324 -175.653 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -39.3 133.09 1.36 Allowed 'General case' 0 N--CA 1.45 -0.464 0 O-C-N 119.479 -2.013 . . . . 0.0 115.312 153.519 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 . . . . . 0 N--CA 1.449 -0.502 0 C-N-CA 126.721 2.008 . . . . 0.0 109.365 -177.634 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.523 0 N-CA-C 119.378 2.511 . . . . 0.0 119.378 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 50.5 mt -128.22 -28.11 2.63 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 117.518 2.414 . . . . 0.0 117.518 -179.732 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.2 m -132.23 171.59 13.49 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 128.192 2.597 . . . . 0.0 111.961 -177.071 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 31.3 mt-30 -63.43 137.87 58.31 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 127.728 2.411 . . . . 0.0 106.43 168.931 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -170.03 -150.28 6.79 Favored Glycine 0 CA--C 1.523 0.551 0 C-N-CA 119.28 -1.438 . . . . 0.0 111.262 -174.199 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 9.8 p -117.42 -19.22 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 N-CA-C 117.237 2.31 . . . . 0.0 117.237 -177.922 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 55.0 tt0 -113.06 82.62 5.52 Favored Pre-proline 0 N--CA 1.449 -0.482 0 C-N-CA 126.831 2.052 . . . . 0.0 111.442 -178.92 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_endo -60.67 144.32 99.53 Favored 'Trans proline' 0 N--CA 1.449 -1.09 0 C-N-CA 124.018 3.146 . . . . 0.0 113.994 -172.186 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -135.87 -81.2 0.41 Allowed 'General case' 0 N--CA 1.449 -0.483 1 C-N-CA 132.337 4.255 . . . . 0.0 107.947 -162.235 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 11.7 mm -87.75 169.67 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 O-C-N 119.81 -1.806 . . . . 0.0 108.926 174.001 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -25.03 -58.08 0.06 OUTLIER Glycine 0 C--N 1.336 0.533 0 C-N-CA 130.589 3.947 . . . . 0.0 114.404 168.311 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 17.4 tt0 -100.8 -22.37 14.88 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 118.712 2.856 . . . . 0.0 118.712 178.261 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 33.0 p -118.1 174.09 6.41 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 115.711 1.745 . . . . 0.0 115.711 -167.623 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 67.6 m-85 -132.75 -82.16 0.48 Allowed 'General case' 0 N--CA 1.449 -0.48 0 O-C-N 126.018 2.074 . . . . 0.0 110.135 -160.884 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -144.53 162.43 36.61 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 128.363 2.665 . . . . 0.0 110.432 177.31 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -73.1 59.21 0.52 Allowed 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 128.2 2.6 . . . . 0.0 113.655 177.688 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 62.8 mt-10 . . . . . 0 N--CA 1.449 -0.503 0 CA-C-O 125.424 2.535 . . . . 0.0 112.96 -176.986 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.546 0 CA-C-O 118.246 -1.308 . . . . 0.0 115.544 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -142.41 5.49 1.64 Allowed 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 117.735 2.494 . . . . 0.0 117.735 -179.14 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 38.2 m -118.48 -172.28 2.24 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 130.7 3.6 . . . . 0.0 117.565 -169.757 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 29.0 mt-30 -95.29 122.75 38.31 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 125.381 1.472 . . . . 0.0 111.649 171.61 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 176.87 -162.97 31.58 Favored Glycine 0 C--N 1.336 0.532 0 N-CA-C 109.104 -1.599 . . . . 0.0 109.104 -164.783 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 45.3 t -116.05 -16.27 8.95 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 1 C-N-CA 132.854 4.462 . . . . 0.0 115.233 -155.45 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 50.7 tt0 -114.39 88.98 16.57 Favored Pre-proline 0 N--CA 1.448 -0.541 0 O-C-N 119.267 -2.146 . . . . 0.0 109.271 177.15 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -67.42 110.39 2.04 Favored 'Trans proline' 0 N--CA 1.45 -1.061 0 C-N-CA 124.956 3.771 . . . . 0.0 111.988 -178.651 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -90.29 -86.42 0.2 Allowed 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 126.205 1.802 . . . . 0.0 109.909 -159.506 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 9.2 mt -88.63 65.5 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 CA-C-O 126.716 3.15 . . . . 0.0 106.844 177.907 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 53.17 -87.64 0.01 OUTLIER Glycine 0 C--N 1.335 0.503 0 C-N-CA 127.681 2.562 . . . . 0.0 118.173 -166.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 44.6 tt0 -58.87 -30.39 67.71 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 119.737 3.236 . . . . 0.0 119.737 -169.64 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 24.3 p -127.36 172.16 10.89 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 126.873 2.069 . . . . 0.0 110.901 174.406 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 41.9 m-85 -125.58 174.15 8.45 Favored 'General case' 0 N--CA 1.45 -0.457 1 C-N-CA 133.289 4.636 . . . . 0.0 111.706 -153.528 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -54.92 134.85 48.7 Favored 'General case' 0 N--CA 1.449 -0.505 0 O-C-N 124.217 0.948 . . . . 0.0 109.878 175.761 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . 0.306 30.6 tt0 -59.12 65.67 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 130.926 3.69 . . . . 0.0 111.875 159.216 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . 0.276 29.5 tt0 . . . . . 0 N--CA 1.449 -0.511 0 C-N-CA 127.21 2.204 . . . . 0.0 111.391 178.062 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.495 0 N-CA-C 116.146 1.218 . . . . 0.0 116.146 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -158.85 -1.66 0.09 Allowed 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 117.59 2.441 . . . . 0.0 117.59 177.418 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 25.9 m -149.45 167.31 26.58 Favored 'General case' 0 N--CA 1.45 -0.468 0 O-C-N 118.418 -2.676 . . . . 0.0 114.082 -175.418 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 40.6 mt-30 -61.46 138.18 58.26 Favored 'General case' 0 N--CA 1.449 -0.499 0 O-C-N 120.358 -1.464 . . . . 0.0 112.413 -177.243 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 178.1 -153.03 12.27 Favored Glycine 0 CA--C 1.523 0.556 0 O-C-N 121.099 -1.001 . . . . 0.0 114.093 -167.576 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 63.6 t -124.66 -20.52 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 C-N-CA 125.816 1.647 . . . . 0.0 113.118 -168.497 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 28.8 tp10 -105.62 89.27 3.29 Favored Pre-proline 0 N--CA 1.45 -0.465 0 CA-C-O 116.224 -1.846 . . . . 0.0 111.091 173.161 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -60.19 140.32 91.63 Favored 'Trans proline' 0 N--CA 1.449 -1.143 0 C-N-CA 123.31 2.673 . . . . 0.0 113.457 178.285 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 38.1 t0 -128.57 -93.94 0.44 Allowed 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 126.089 1.755 . . . . 0.0 111.857 -164.767 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 28.3 mm -107.27 143.88 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 C-N-CA 126.419 1.888 . . . . 0.0 108.748 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 56.52 -89.72 0.01 OUTLIER Glycine 0 C--N 1.336 0.53 0 C-N-CA 126.971 2.224 . . . . 0.0 115.226 174.955 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -134.04 4.04 3.48 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 116.083 1.883 . . . . 0.0 116.083 176.68 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.421 ' HB ' ' H ' ' A' ' 14' ' ' TYR . 42.8 p -114.31 -177.25 3.08 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 -179.783 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.421 ' H ' ' HB ' ' A' ' 13' ' ' THR . 0.5 OUTLIER -131.08 -170.71 2.41 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 131.159 3.784 . . . . 0.0 110.877 -160.717 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -68.53 150.89 47.52 Favored 'General case' 0 N--CA 1.449 -0.516 0 O-C-N 119.07 -2.269 . . . . 0.0 109.866 177.304 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -63.68 87.71 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 128.07 2.548 . . . . 0.0 113.566 174.648 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 . . . . . 0 N--CA 1.449 -0.502 0 CA-C-O 123.162 1.458 . . . . 0.0 112.53 159.928 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.483 0 N-CA-C 111.131 -0.788 . . . . 0.0 111.131 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 78.9 mt -144.69 -12.86 0.57 Allowed 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.682 1.593 . . . . 0.0 113.177 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 6.1 t -138.68 -152.12 0.41 Allowed 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 127.87 2.468 . . . . 0.0 113.176 -166.349 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -116.7 156.92 26.3 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 125.128 1.371 . . . . 0.0 110.072 173.862 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 164.86 -144.37 9.28 Favored Glycine 0 N--CA 1.448 -0.547 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.46 -171.827 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 18.6 m -120.97 -15.56 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 -175.65 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 33.2 mm-40 -107.83 96.78 18.2 Favored Pre-proline 0 N--CA 1.449 -0.479 0 O-C-N 119.689 -1.882 . . . . 0.0 112.74 174.651 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -74.24 101.89 1.47 Allowed 'Trans proline' 0 N--CA 1.45 -1.033 0 C-N-CA 123.463 2.776 . . . . 0.0 109.853 -179.768 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -68.22 -63.12 1.12 Allowed 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 129.252 3.021 . . . . 0.0 112.492 176.578 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.404 HG22 ' H ' ' A' ' 12' ' ' GLN . 27.1 mt -75.89 157.21 5.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 N-CA-C 106.753 -1.573 . . . . 0.0 106.753 162.795 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -41.64 -48.27 4.92 Favored Glycine 0 CA--C 1.523 0.573 0 O-C-N 119.467 -2.021 . . . . 0.0 112.972 164.768 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.404 ' H ' HG22 ' A' ' 10' ' ' ILE . 39.1 tt0 -76.13 -47.66 23.53 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 116.597 2.073 . . . . 0.0 116.597 179.052 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 35.9 p -129.24 164.09 24.21 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 127.288 2.235 . . . . 0.0 116.034 -160.251 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 13.9 m-85 -121.79 178.22 4.95 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 126.353 1.861 . . . . 0.0 110.905 -161.717 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -62.91 144.71 56.47 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 -179.197 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -61.89 106.58 0.71 Allowed 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 125.97 1.708 . . . . 0.0 109.175 178.599 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 . . . . . 0 N--CA 1.449 -0.5 0 CA-C-N 114.239 -1.346 . . . . 0.0 112.627 173.67 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.526 0 N-CA-C 117.45 1.74 . . . . 0.0 117.45 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 95.0 mt -137.7 -37.05 0.61 Allowed 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 116.566 2.062 . . . . 0.0 116.566 171.541 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.5 m -138.97 -162.14 1.28 Allowed 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 125.164 1.386 . . . . 0.0 112.325 -175.921 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 70.8 mt-30 -54.15 165.35 0.52 Allowed 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 114.351 1.241 . . . . 0.0 114.351 175.529 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 160.29 -173.79 36.94 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.95 -0.643 . . . . 0.0 114.196 160.135 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 13.7 p -91.3 -7.09 10.73 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 C-N-CA 125.812 1.645 . . . . 0.0 113.468 178.479 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -121.94 90.75 48.72 Favored Pre-proline 0 N--CA 1.449 -0.517 0 C-N-CA 125.644 1.578 . . . . 0.0 111.094 -171.412 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_exo -51.19 140.85 40.57 Favored 'Trans proline' 0 N--CA 1.45 -1.067 0 C-N-CA 121.912 1.742 . . . . 0.0 113.121 174.338 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -128.74 -53.38 1.24 Allowed 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 126.229 1.812 . . . . 0.0 109.242 -175.136 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.474 HG22 ' H ' ' A' ' 11' ' ' GLY . 3.0 mt -121.98 172.68 8.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 C-N-CA 125.823 1.649 . . . . 0.0 108.064 172.46 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.474 ' H ' HG22 ' A' ' 10' ' ' ILE . . . -46.58 -42.74 14.51 Favored Glycine 0 C--N 1.335 0.501 0 C-N-CA 126.202 1.858 . . . . 0.0 116.138 178.586 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 45.2 tt0 -92.85 -36.25 12.93 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 116.763 2.135 . . . . 0.0 116.763 176.058 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 82.2 p -124.38 167.7 14.03 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 119.587 -1.946 . . . . 0.0 115.972 -160.81 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 16.9 m-85 -131.64 -83.57 0.51 Allowed 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.982 1.313 . . . . 0.0 111.664 -161.996 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -141.02 171.15 14.47 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 125.556 1.543 . . . . 0.0 110.714 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -80.09 59.46 3.29 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 121.98 2.173 . . . . 0.0 111.87 177.786 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 . . . . . 0 N--CA 1.45 -0.463 0 C-N-CA 126.372 1.869 . . . . 0.0 111.623 -175.392 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.534 0 CA-C-O 123.002 1.335 . . . . 0.0 114.979 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' LEU . . . . . 0.542 ' H ' HD23 ' A' ' 2' ' ' LEU . 2.1 pt? -130.11 -5.79 4.41 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 129.317 3.047 . . . . 0.0 113.546 -174.949 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 26.6 m -120.56 -166.14 1.29 Allowed 'General case' 0 N--CA 1.448 -0.533 0 O-C-N 126.805 2.566 . . . . 0.0 114.772 -162.445 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 20.1 mp0 -102.68 155.76 18.09 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 119.42 1.009 . . . . 0.0 110.41 161.074 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 161.89 -165.16 35.68 Favored Glycine 0 CA--C 1.523 0.568 0 O-C-N 119.462 -2.024 . . . . 0.0 113.776 -177.614 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 14.0 p -69.68 -26.95 31.81 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 N-CA-C 119.203 3.038 . . . . 0.0 119.203 174.175 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 16.2 tp10 -118.12 90.12 36.75 Favored Pre-proline 0 N--CA 1.449 -0.515 0 O-C-N 118.324 -2.735 . . . . 0.0 114.691 -164.198 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . 0.326 17.8 Cg_endo -60.74 127.72 23.43 Favored 'Trans proline' 0 N--CA 1.449 -1.115 0 CA-C-O 125.371 2.154 . . . . 0.0 114.6 173.029 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 49.9 t0 -117.63 -88.76 0.6 Allowed 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 128.282 2.633 . . . . 0.0 115.17 -161.047 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.6 mm -99.86 144.34 12.41 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 C-N-CA 126.946 2.098 . . . . 0.0 106.471 163.562 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -45.56 143.5 3.63 Favored Glycine 0 CA--C 1.522 0.531 0 N-CA-C 121.338 3.295 . . . . 0.0 121.338 -163.747 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 15.7 tt0 62.39 -15.38 0.05 Allowed 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 109.966 -3.117 . . . . 0.0 114.323 -163.912 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . 0.277 24.9 p -122.28 168.54 11.91 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 126.01 2.814 . . . . 0.0 112.82 -166.006 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -134.5 162.69 31.56 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 128.041 2.536 . . . . 0.0 111.317 -166.166 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -57.73 145.58 34.09 Favored 'General case' 0 N--CA 1.449 -0.518 0 O-C-N 119.5 -2.0 . . . . 0.0 109.677 172.95 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -70.49 84.91 0.6 Allowed 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 127.931 2.492 . . . . 0.0 112.004 -169.977 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 . . . . . 0 N--CA 1.449 -0.511 0 C-N-CA 126.682 1.993 . . . . 0.0 111.828 174.544 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.546 0 N-CA-C 111.764 -0.535 . . . . 0.0 111.764 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -160.68 10.49 0.1 Allowed 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 126.36 1.864 . . . . 0.0 114.926 -169.377 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 53.8 m -131.58 169.85 15.55 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-O 115.017 -2.42 . . . . 0.0 117.137 164.294 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 16.9 mm100 -57.91 145.93 33.92 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 122.898 2.59 . . . . 0.0 111.317 164.263 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 169.17 -152.01 18.95 Favored Glycine 0 C--N 1.335 0.519 0 N-CA-C 116.911 1.524 . . . . 0.0 116.911 174.382 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.9 t -97.44 -18.63 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 O-C-N 127.08 2.282 . . . . 0.0 117.027 -177.518 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.503 ' O ' ' HA ' ' A' ' 14' ' ' TYR . 4.2 tp10 -125.88 92.42 46.22 Favored Pre-proline 0 N--CA 1.449 -0.518 0 N-CA-C 106.649 -1.611 . . . . 0.0 106.649 -168.048 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -71.99 94.98 0.73 Allowed 'Trans proline' 0 N--CA 1.448 -1.153 0 C-N-CA 124.409 3.406 . . . . 0.0 110.048 173.732 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -64.26 -52.28 59.44 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 130.734 3.613 . . . . 0.0 109.88 -177.83 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.441 HG22 ' H ' ' A' ' 12' ' ' GLN . 47.3 mm -85.12 160.03 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 161.282 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -51.3 -41.22 47.13 Favored Glycine 0 CA--C 1.523 0.534 0 CA-C-O 124.774 2.319 . . . . 0.0 114.806 173.472 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.441 ' H ' HG22 ' A' ' 10' ' ' ILE . 8.9 tt0 -61.99 -81.21 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 128.258 2.623 . . . . 0.0 111.506 172.314 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . 0.273 0.7 OUTLIER -121.79 178.28 4.93 Favored 'General case' 0 N--CA 1.449 -0.517 0 O-C-N 117.794 -3.066 . . . . 0.0 117.196 -167.563 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.503 ' HA ' ' O ' ' A' ' 7' ' ' GLU . 0.7 OUTLIER -117.13 170.67 8.48 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 130.82 3.648 . . . . 0.0 112.259 -154.79 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -51.64 137.23 25.4 Favored 'General case' 0 N--CA 1.449 -0.491 0 O-C-N 118.923 -2.361 . . . . 0.0 109.478 -174.552 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -46.52 125.02 6.47 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 129.69 3.196 . . . . 0.0 113.539 -175.675 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 . . . . . 0 N--CA 1.449 -0.505 0 CA-C-N 122.307 2.322 . . . . 0.0 106.501 -168.167 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.493 0 CA-C-O 119.503 -0.609 . . . . 0.0 113.315 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -121.23 12.15 10.95 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 126.874 2.07 . . . . 0.0 114.33 -177.908 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -118.82 -148.65 0.42 Allowed 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 128.351 2.661 . . . . 0.0 110.94 178.772 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 15.4 mp0 -122.15 152.49 39.87 Favored 'General case' 0 N--CA 1.45 -0.45 0 O-C-N 116.959 -3.588 . . . . 0.0 115.042 167.002 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 170.57 -138.11 4.79 Favored Glycine 0 C--N 1.336 0.543 0 CA-C-N 113.055 -1.884 . . . . 0.0 112.291 -170.577 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 13.1 m -128.15 -8.64 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 CA-C-N 119.464 1.632 . . . . 0.0 110.647 -175.442 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -112.36 81.46 4.0 Favored Pre-proline 0 N--CA 1.449 -0.508 0 N-CA-C 116.442 2.015 . . . . 0.0 116.442 173.406 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -65.89 136.61 45.83 Favored 'Trans proline' 0 N--CA 1.449 -1.101 0 C-N-CA 123.439 2.759 . . . . 0.0 107.367 -179.418 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -130.8 -102.42 0.29 Allowed 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 109.61 -3.45 . . . . 0.0 110.074 -151.758 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 17.1 mt -70.8 88.83 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 CA-C-N 122.706 2.503 . . . . 0.0 110.447 168.224 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 46.82 -107.9 0.24 Allowed Glycine 0 CA--C 1.523 0.537 0 O-C-N 117.173 -3.455 . . . . 0.0 117.179 -175.102 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -64.58 -10.71 28.15 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 120.05 3.352 . . . . 0.0 120.05 179.227 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 46.2 p -124.06 159.92 28.86 Favored 'General case' 0 N--CA 1.449 -0.5 0 O-C-N 125.572 1.795 . . . . 0.0 113.541 -173.315 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -124.6 175.73 7.0 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 131.48 3.912 . . . . 0.0 112.729 -160.443 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -57.78 156.4 8.82 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 115.835 1.791 . . . . 0.0 115.835 -177.707 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -69.87 88.0 0.55 Allowed 'General case' 0 N--CA 1.449 -0.509 0 O-C-N 118.299 -2.751 . . . . 0.0 115.814 -166.918 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 . . . . . 0 N--CA 1.449 -0.488 0 C-N-CA 131.228 3.811 . . . . 0.0 112.274 164.077 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 1' ' ' GLY . . . . . 0.437 ' HA3' ' HB3' ' A' ' 9' ' ' ASP . . . . . . . . 0 CA--C 1.522 0.503 0 N-CA-C 116.59 1.396 . . . . 0.0 116.59 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -158.61 -3.93 0.08 Allowed 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 121.232 3.79 . . . . 0.0 121.232 171.133 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' SER . . . . . 0.421 ' HB2' ' HA ' ' A' ' 16' ' ' GLU . 17.7 m -150.17 -177.05 5.71 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 129.744 3.218 . . . . 0.0 111.311 175.195 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -63.3 162.44 12.18 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 130.618 3.567 . . . . 0.0 111.771 -170.535 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 163.21 -173.27 39.35 Favored Glycine 0 C--N 1.335 0.495 0 N-CA-C 118.303 2.081 . . . . 0.0 118.303 -170.273 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 20.2 m -111.51 -14.85 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 C-N-CA 128.102 2.561 . . . . 0.0 113.65 171.902 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -105.91 77.78 0.44 Allowed Pre-proline 0 N--CA 1.449 -0.514 0 C-N-CA 128.144 2.577 . . . . 0.0 115.625 177.158 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -63.87 96.8 0.22 Allowed 'Trans proline' 0 N--CA 1.449 -1.089 0 CA-C-O 124.301 1.709 . . . . 0.0 113.643 -176.391 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.437 ' HB3' ' HA3' ' A' ' 1' ' ' GLY . 0.2 OUTLIER -62.27 -66.62 0.51 Allowed 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 130.443 3.497 . . . . 0.0 112.37 -165.507 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . 0.254 42.8 pt -109.41 -166.39 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 CA-C-N 113.277 -1.783 . . . . 0.0 112.363 169.229 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -45.75 -47.21 13.54 Favored Glycine 0 C--N 1.335 0.514 0 N-CA-C 118.491 2.157 . . . . 0.0 118.491 -178.922 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 20.6 mp0 -121.84 150.39 41.99 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 129.605 3.162 . . . . 0.0 107.408 174.325 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.46 ' HA ' ' CD1' ' A' ' 14' ' ' TYR 0.28 4.7 p 56.38 179.45 0.04 OUTLIER 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 111.127 -2.76 . . . . 0.0 113.973 179.386 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.46 ' CD1' ' HA ' ' A' ' 13' ' ' THR . 2.2 m-85 -133.53 -99.06 0.27 Allowed 'General case' 0 N--CA 1.449 -0.518 0 O-C-N 117.823 -3.048 . . . . 0.0 111.203 -148.017 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -133.9 161.88 33.55 Favored 'General case' 0 N--CA 1.45 -0.475 0 CA-C-O 126.807 3.194 . . . . 0.0 107.363 -179.702 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.421 ' HA ' ' HB2' ' A' ' 3' ' ' SER . 21.0 tt0 -74.11 70.48 1.58 Allowed 'General case' 0 N--CA 1.449 -0.497 0 O-C-N 117.837 -3.039 . . . . 0.0 114.158 -175.334 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 . . . . . 0 N--CA 1.449 -0.518 0 C-N-CA 131.229 3.812 . . . . 0.0 116.008 175.146 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.501 0 N-CA-C 115.529 0.972 . . . . 0.0 115.529 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -159.41 -10.92 0.06 Allowed 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 115.98 1.844 . . . . 0.0 115.98 171.979 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 37.8 m -127.42 164.75 21.19 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 122.756 2.525 . . . . 0.0 116.003 -172.123 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -66.95 129.06 38.66 Favored 'General case' 0 N--CA 1.449 -0.519 0 O-C-N 120.532 -1.355 . . . . 0.0 110.581 -179.369 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -167.76 -151.88 7.24 Favored Glycine 0 C--N 1.334 0.449 0 N-CA-C 119.133 2.413 . . . . 0.0 119.133 -169.59 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 6.2 t -129.1 -19.15 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 C-N-CA 129.698 3.199 . . . . 0.0 113.911 -168.28 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -116.34 95.58 45.66 Favored Pre-proline 0 N--CA 1.45 -0.473 0 CA-C-O 117.49 -1.243 . . . . 0.0 111.637 171.58 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -74.76 90.5 1.05 Allowed 'Trans proline' 0 N--CA 1.449 -1.101 0 CA-C-N 124.092 2.497 . . . . 0.0 112.427 -175.286 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -52.34 -60.92 2.64 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 130.898 3.679 . . . . 0.0 111.458 170.652 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 20.9 pt -108.34 176.88 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 CA-C-O 124.424 2.059 . . . . 0.0 111.477 178.193 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -66.59 113.08 5.39 Favored Glycine 0 C--N 1.336 0.536 0 C-N-CA 128.438 2.923 . . . . 0.0 113.649 161.052 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 14.9 tt0 55.01 86.45 0.05 Allowed 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 128.526 2.73 . . . . 0.0 115.81 -159.792 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . 0.358 30.7 p 114.67 179.14 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.488 1 C-N-CA 133.63 4.772 . . . . 0.0 118.508 159.889 . . . . . . . . 3 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -129.59 -168.95 2.02 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 128.627 2.771 . . . . 0.0 108.373 -151.942 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -64.03 163.51 12.16 Favored 'General case' 0 N--CA 1.45 -0.466 0 O-C-N 119.401 -2.062 . . . . 0.0 113.102 -178.396 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -76.75 85.68 3.37 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-O 126.819 3.2 . . . . 0.0 113.459 178.577 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.448 -0.542 0 CA-C-N 110.558 -3.019 . . . . 0.0 116.609 173.349 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.57 0 N-CA-C 114.052 0.381 . . . . 0.0 114.052 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 79.1 mt -139.61 -13.11 1.13 Allowed 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 126.312 1.845 . . . . 0.0 114.664 179.45 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 73.6 m -144.56 177.76 8.44 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-O 123.798 1.761 . . . . 0.0 109.395 -178.372 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 32.1 mt-30 -56.72 154.79 8.49 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 118.91 -2.369 . . . . 0.0 112.384 160.044 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 157.2 -156.39 27.19 Favored Glycine 0 C--N 1.335 0.516 0 O-C-N 118.773 -2.454 . . . . 0.0 114.453 178.556 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 16.8 m -110.26 -6.89 11.38 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 118.991 2.96 . . . . 0.0 118.991 -173.126 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 30.2 mm-40 -112.03 83.22 4.74 Favored Pre-proline 0 N--CA 1.45 -0.473 0 CA-C-O 116.012 -1.947 . . . . 0.0 114.476 176.102 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -64.59 142.53 77.97 Favored 'Trans proline' 0 N--CA 1.45 -1.074 0 C-N-CA 123.525 2.817 . . . . 0.0 111.44 -168.378 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -140.48 -79.88 0.28 Allowed 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 118.12 2.637 . . . . 0.0 118.12 -157.012 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.401 HG22 ' H ' ' A' ' 11' ' ' GLY . 8.0 mm -91.46 161.06 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 N-CA-C 102.965 -2.976 . . . . 0.0 102.965 165.371 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.401 ' H ' HG22 ' A' ' 10' ' ' ILE . . . -47.23 -18.64 0.52 Allowed Glycine 0 C--N 1.335 0.506 0 CA-C-N 113.633 -1.621 . . . . 0.0 117.135 -170.879 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 71.5 mt-30 -123.96 -8.56 7.76 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 129.822 3.249 . . . . 0.0 114.595 -171.568 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 64.0 p -137.98 178.79 6.86 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 117.39 2.367 . . . . 0.0 117.39 -166.896 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 -134.01 -97.99 0.27 Allowed 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 127.277 2.231 . . . . 0.0 112.421 -165.947 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 14.7 m-85 -142.81 150.28 39.74 Favored 'General case' 0 N--CA 1.449 -0.478 0 O-C-N 121.047 -1.033 . . . . 0.0 112.211 166.67 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -60.11 82.85 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.481 0 CA-C-O 127.231 3.396 . . . . 0.0 111.486 -174.373 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 . . . . . 0 N--CA 1.449 -0.478 1 O-C-N 116.181 -4.074 . . . . 0.0 112.08 164.454 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.538 0 N-CA-C 116.509 1.364 . . . . 0.0 116.509 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -152.58 -8.47 0.19 Allowed 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 120.7 3.592 . . . . 0.0 120.7 157.412 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 21.4 m -134.01 -179.23 5.42 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 123.318 2.781 . . . . 0.0 115.816 174.289 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 22.6 mp0 -64.39 129.81 41.33 Favored 'General case' 0 N--CA 1.448 -0.527 0 O-C-N 118.197 -2.815 . . . . 0.0 113.956 -176.622 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -170.76 -149.16 6.3 Favored Glycine 0 C--N 1.336 0.539 0 CA-C-O 124.156 1.975 . . . . 0.0 113.048 171.541 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 26.7 m -117.01 -13.65 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 O-C-N 116.47 -3.959 . . . . 0.0 114.083 -171.349 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 23.6 tp10 -103.64 82.35 0.53 Allowed Pre-proline 0 N--CA 1.449 -0.479 0 O-C-N 126.943 2.652 . . . . 0.0 117.315 171.703 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.458 ' HB3' ' CE2' ' A' ' 14' ' ' TYR . 15.0 Cg_endo -64.47 149.75 89.44 Favored 'Trans proline' 0 N--CA 1.449 -1.136 0 C-N-CA 122.384 2.056 . . . . 0.0 108.683 -169.581 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -138.51 -92.25 0.2 Allowed 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 112.512 -2.131 . . . . 0.0 107.775 -159.34 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 6.4 mt -97.35 152.4 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 CA-C-O 117.138 -1.411 . . . . 0.0 107.217 169.979 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -36.35 141.81 0.19 Allowed Glycine 0 C--N 1.336 0.57 0 C-N-CA 129.534 3.445 . . . . 0.0 110.367 176.894 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 6.2 tm0? 58.13 -11.59 0.03 OUTLIER 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 116.962 2.208 . . . . 0.0 116.962 -168.186 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 22.6 p -133.73 168.07 19.37 Favored 'General case' 0 N--CA 1.45 -0.467 1 O-C-N 114.283 -5.261 . . . . 0.0 117.644 -170.221 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.458 ' CE2' ' HB3' ' A' ' 8' ' ' PRO . 9.1 m-85 -127.79 -82.92 0.6 Allowed 'General case' 0 N--CA 1.449 -0.48 0 CA-C-O 126.762 3.172 . . . . 0.0 112.316 -172.027 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.408 ' CD1' ' O ' ' A' ' 14' ' ' TYR . 19.7 m-85 -140.58 141.85 35.16 Favored 'General case' 0 N--CA 1.45 -0.469 1 O-C-N 116.11 -4.118 . . . . 0.0 113.463 175.887 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -59.03 84.83 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.484 0 CA-C-O 117.567 -1.206 . . . . 0.0 113.874 166.483 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 . . . . . 0 N--CA 1.45 -0.46 0 N-CA-C 116.237 1.939 . . . . 0.0 116.237 -166.57 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.504 0 N-CA-C 118.233 2.053 . . . . 0.0 118.233 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -143.46 -11.64 0.71 Allowed 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 128.328 2.651 . . . . 0.0 117.916 -176.812 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 69.5 m -114.84 -174.01 2.41 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 127.85 2.46 . . . . 0.0 110.245 -164.59 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -102.76 135.27 44.72 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 128.83 2.852 . . . . 0.0 109.68 161.782 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 176.47 -158.5 24.81 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 108.126 -1.99 . . . . 0.0 108.126 -157.307 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.2 p -130.06 -0.27 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 O-C-N 121.29 -1.124 . . . . 0.0 111.743 -167.637 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 27.1 tp10 -116.56 107.58 46.56 Favored Pre-proline 0 N--CA 1.449 -0.522 1 O-C-N 115.477 -4.514 . . . . 0.0 102.673 163.687 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -66.02 142.91 70.24 Favored 'Trans proline' 0 N--CA 1.449 -1.146 0 CA-C-O 127.324 2.969 . . . . 0.0 110.867 169.194 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -119.58 -94.1 0.51 Allowed 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 110.545 -3.025 . . . . 0.0 109.477 -165.942 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 24.5 pt -118.36 154.73 20.48 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 C-N-CA 130.047 3.339 . . . . 0.0 109.7 177.026 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 45.15 -111.13 0.51 Allowed Glycine 0 C--N 1.335 0.498 0 C-N-CA 127.178 2.323 . . . . 0.0 112.388 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 71.8 mm-40 -97.36 -1.43 44.53 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-O 124.979 2.323 . . . . 0.0 115.624 -177.857 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 18.3 p -128.41 176.8 7.44 Favored 'General case' 0 N--CA 1.45 -0.429 0 O-C-N 117.075 -3.516 . . . . 0.0 110.636 -155.111 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 16.8 m-85 -127.92 173.09 10.3 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 125.415 1.486 . . . . 0.0 113.051 -165.544 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -53.31 141.34 24.38 Favored 'General case' 0 N--CA 1.448 -0.526 0 O-C-N 117.991 -2.943 . . . . 0.0 112.046 169.548 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . 0.445 30.4 tt0 -55.34 90.67 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 118.856 2.91 . . . . 0.0 118.856 174.672 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 29.7 tp10 . . . . . 0 N--CA 1.449 -0.516 0 N-CA-C 114.448 1.277 . . . . 0.0 114.448 166.022 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.449 ' HA3' ' O ' ' A' ' 14' ' ' TYR . . . . . . . . 0 CA--C 1.523 0.578 0 N-CA-C 117.138 1.615 . . . . 0.0 117.138 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 94.9 mt -125.06 -30.24 3.23 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 120.258 3.429 . . . . 0.0 120.258 177.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 70.5 m -143.57 -178.64 5.99 Favored 'General case' 0 N--CA 1.449 -0.522 0 O-C-N 125.556 1.785 . . . . 0.0 110.263 -176.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . 0.325 82.6 mm-40 -62.36 136.26 57.83 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 113.593 -1.639 . . . . 0.0 113.545 -174.109 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -174.3 -164.91 30.03 Favored Glycine 0 C--N 1.336 0.578 0 CA-C-N 119.764 1.166 . . . . 0.0 114.574 -176.162 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 12.1 t -87.21 -38.18 11.86 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 CA-C-N 111.819 -2.19 . . . . 0.0 110.986 -171.498 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -115.49 87.13 16.33 Favored Pre-proline 0 N--CA 1.449 -0.502 0 C-N-CA 131.031 3.733 . . . . 0.0 115.994 -164.142 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -64.26 140.73 72.21 Favored 'Trans proline' 0 N--CA 1.449 -1.109 0 C-N-CA 123.148 2.565 . . . . 0.0 109.42 -179.418 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -121.66 -88.0 0.63 Allowed 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 128.673 2.789 . . . . 0.0 111.138 -158.352 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 6.6 pt -130.3 160.77 41.11 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.475 0 CA-C-O 122.5 1.143 . . . . 0.0 110.989 165.654 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 66.98 -100.51 0.57 Allowed Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 125.454 1.502 . . . . 0.0 113.626 -177.394 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -137.04 1.15 2.44 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 116.538 2.051 . . . . 0.0 116.538 179.543 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 31.8 p -119.59 177.79 4.8 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.739 1.216 . . . . 0.0 110.306 -172.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.449 ' O ' ' HA3' ' A' ' 1' ' ' GLY . 6.2 m-85 -124.6 -83.61 0.64 Allowed 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.136 1.374 . . . . 0.0 113.98 -156.736 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -126.89 165.49 19.26 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.75 1.62 . . . . 0.0 111.921 172.338 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -85.99 50.75 2.04 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 124.744 2.212 . . . . 0.0 109.187 176.525 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -60.93 140.71 57.67 Favored 'General case' 0 N--CA 1.45 -0.448 0 O-C-N 117.426 -3.296 . . . . 0.0 111.841 -166.826 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 43.4 m -70.35 46.19 0.08 Allowed 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 117.098 2.258 . . . . 0.0 117.098 -162.188 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 38.1 ptt85 -56.46 37.72 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.508 1 C-N-CA 133.186 4.595 . . . . 0.0 120.139 -167.323 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 59.8 mt -57.09 129.88 19.32 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 CA-C-O 115.225 -2.321 . . . . 0.0 112.09 -176.099 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 57.8 t30 -147.41 160.14 42.9 Favored 'General case' 0 N--CA 1.449 -0.493 0 O-C-N 125.849 1.968 . . . . 0.0 114.12 -178.351 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 21.3 tt0 -133.07 -76.81 0.49 Allowed 'General case' 0 N--CA 1.449 -0.494 0 O-C-N 127.268 2.855 . . . . 0.0 106.637 177.706 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.7 t70 . . . . . 0 C--O 1.25 1.083 0 CA-C-O 114.858 -2.496 . . . . 0.0 116.392 163.495 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.434 0 N-CA-C 117.426 1.73 . . . . 0.0 117.426 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 62.4 mt -134.73 -29.18 1.18 Allowed 'General case' 0 N--CA 1.449 -0.502 0 CA-C-O 117.141 -1.409 . . . . 0.0 114.141 171.822 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 67.3 m -145.77 -161.76 1.37 Allowed 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 120.723 1.601 . . . . 0.0 107.44 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -62.46 164.26 7.62 Favored 'General case' 0 N--CA 1.448 -0.552 0 O-C-N 124.762 1.289 . . . . 0.0 114.287 -167.178 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 164.47 -152.28 21.91 Favored Glycine 0 C--N 1.334 0.466 0 C-N-CA 119.067 -1.539 . . . . 0.0 116.658 165.645 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 27.6 m -105.26 -20.04 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 C-N-CA 125.778 1.631 . . . . 0.0 114.605 169.849 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.52 ' HB3' ' CD1' ' A' ' 15' ' ' PHE . 6.5 tp10 -102.87 77.47 0.23 Allowed Pre-proline 0 N--CA 1.449 -0.497 0 C-N-CA 126.888 2.075 . . . . 0.0 115.72 -176.07 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_endo -66.11 143.34 71.3 Favored 'Trans proline' 0 N--CA 1.449 -1.128 0 O-C-N 117.205 -2.05 . . . . 0.0 107.465 -169.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -130.93 -84.86 0.52 Allowed 'General case' 0 N--CA 1.45 -0.463 1 C-N-CA 132.734 4.414 . . . . 0.0 110.056 -161.658 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 5.3 mt -97.0 97.48 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 O-C-N 124.732 1.27 . . . . 0.0 111.824 170.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 51.4 -100.01 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 126.033 1.778 . . . . 0.0 115.75 179.005 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -88.42 7.28 33.46 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 117.972 2.582 . . . . 0.0 117.972 177.29 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 7.4 p -119.41 172.58 7.52 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 116.754 2.131 . . . . 0.0 116.754 169.58 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 15.2 m-85 -137.83 -89.0 0.25 Allowed 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 126.649 1.98 . . . . 0.0 113.382 -160.382 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.52 ' CD1' ' HB3' ' A' ' 7' ' ' GLU . 25.0 m-85 -140.58 169.72 17.12 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 129.225 3.01 . . . . 0.0 109.319 179.327 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . 0.271 5.7 tp10 -88.25 60.85 5.94 Favored 'General case' 0 N--CA 1.45 -0.456 0 O-C-N 120.436 -1.415 . . . . 0.0 110.594 -160.895 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -89.93 159.56 16.86 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 114.759 -1.11 . . . . 0.0 113.449 178.518 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 46.1 t -47.01 154.41 0.35 Allowed 'General case' 0 N--CA 1.45 -0.473 1 O-C-N 129.351 4.157 . . . . 0.0 113.286 173.555 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 57.2 ttt-85 -80.38 56.58 2.57 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 124.706 2.193 . . . . 0.0 113.189 167.43 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 3.1 mt -64.04 125.43 20.74 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 O-C-N 118.147 -2.846 . . . . 0.0 106.599 175.743 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 17.2 p30 -144.07 166.03 26.14 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 128.356 2.662 . . . . 0.0 111.448 -158.799 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -137.59 5.59 2.68 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 116.442 2.016 . . . . 0.0 116.442 172.551 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 21.2 t70 . . . . . 0 C--O 1.25 1.099 0 CA-C-O 124.921 2.296 . . . . 0.0 107.138 -179.687 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.514 0 N-CA-C 120.91 3.124 . . . . 0.0 120.91 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 12.9 mt -128.9 -26.76 2.61 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 115.379 1.622 . . . . 0.0 115.379 179.551 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.409 ' HB2' ' O ' ' A' ' 15' ' ' PHE . 61.3 m -147.03 -173.26 4.19 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 128.083 2.553 . . . . 0.0 109.478 -174.695 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 7.4 pm0 -55.02 171.54 0.14 Allowed 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 124.547 2.118 . . . . 0.0 114.334 176.319 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 166.3 -163.9 37.21 Favored Glycine 0 C--N 1.335 0.52 0 CA-C-O 126.425 3.236 . . . . 0.0 113.744 -176.642 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 16.1 m -130.13 -10.3 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 CA-C-N 111.412 -2.394 . . . . 0.0 113.064 179.474 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -114.59 84.43 9.95 Favored Pre-proline 0 N--CA 1.449 -0.482 0 C-N-CA 124.592 1.157 . . . . 0.0 110.842 174.55 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -63.88 148.04 91.92 Favored 'Trans proline' 0 N--CA 1.45 -1.086 0 CA-C-N 122.34 1.871 . . . . 0.0 108.955 -173.52 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -125.81 -58.36 1.4 Allowed 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 129.987 3.315 . . . . 0.0 109.221 -167.334 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 30.6 mm -83.01 175.54 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 C-N-CA 130.267 3.427 . . . . 0.0 109.042 165.501 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -54.09 -56.27 22.01 Favored Glycine 0 C--N 1.335 0.493 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 170.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -84.26 -33.76 23.96 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 127.726 2.41 . . . . 0.0 111.913 -175.642 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 27.9 p -132.94 173.65 11.18 Favored 'General case' 0 N--CA 1.45 -0.464 0 O-C-N 117.402 -3.311 . . . . 0.0 112.386 -155.536 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -128.22 -85.65 0.58 Allowed 'General case' 0 N--CA 1.45 -0.463 0 O-C-N 126.9 2.625 . . . . 0.0 116.455 -154.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.409 ' O ' ' HB2' ' A' ' 3' ' ' SER . 30.1 m-85 -137.43 169.35 17.94 Favored 'General case' 0 N--CA 1.448 -0.529 0 O-C-N 120.207 -1.558 . . . . 0.0 110.114 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -89.04 69.59 8.43 Favored 'General case' 0 N--CA 1.449 -0.5 0 O-C-N 118.393 -2.692 . . . . 0.0 108.505 175.196 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -58.16 -41.76 84.49 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-O 124.592 2.139 . . . . 0.0 112.02 -166.521 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 39.66 53.41 2.48 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 129.652 3.181 . . . . 0.0 111.477 -177.016 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 71.0 ttt-85 -123.29 67.09 0.99 Allowed 'General case' 0 N--CA 1.449 -0.494 0 O-C-N 118.852 -2.405 . . . . 0.0 108.007 -162.721 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 35.3 mm -113.68 122.59 68.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 C-N-CA 126.861 2.064 . . . . 0.0 107.302 -178.008 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -106.77 157.31 17.83 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 126.362 1.865 . . . . 0.0 111.576 -177.505 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 21.9 mm100 -71.82 116.33 12.07 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 126.64 1.976 . . . . 0.0 114.468 168.663 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 . . . . . 0 C--O 1.251 1.169 0 CA-C-N 121.331 1.878 . . . . 0.0 113.865 170.508 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.479 0 N-CA-C 117.353 1.701 . . . . 0.0 117.353 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . 0.351 0.5 OUTLIER -154.88 -17.11 0.12 Allowed 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 118.688 2.847 . . . . 0.0 118.688 165.557 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.0 m -130.92 165.88 22.15 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 126.719 2.008 . . . . 0.0 111.215 -177.119 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 22.7 mp0 -68.0 142.4 55.94 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 126.959 2.104 . . . . 0.0 110.607 -175.041 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -176.86 -150.23 8.18 Favored Glycine 0 CA--C 1.522 0.482 0 O-C-N 119.091 -2.256 . . . . 0.0 108.873 -175.548 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 43.5 t -117.91 -21.7 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 1 C-N-CA 133.224 4.61 . . . . 0.0 116.628 -173.873 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 13.4 tp10 -113.15 83.23 6.14 Favored Pre-proline 0 N--CA 1.449 -0.5 0 C-N-CA 127.222 2.209 . . . . 0.0 111.939 -177.414 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -68.93 146.98 67.16 Favored 'Trans proline' 0 N--CA 1.45 -1.088 0 C-N-CA 124.737 3.625 . . . . 0.0 109.28 -167.35 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -139.62 -74.77 0.36 Allowed 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 128.254 2.622 . . . . 0.0 111.716 -159.016 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 18.9 mm -112.1 141.51 27.37 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 N-CA-C 105.318 -2.104 . . . . 0.0 105.318 171.392 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 62.54 -91.41 0.07 OUTLIER Glycine 0 C--N 1.336 0.547 0 C-N-CA 127.503 2.478 . . . . 0.0 111.525 158.494 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 7.2 mm-40 -132.77 19.89 4.2 Favored 'General case' 0 N--CA 1.45 -0.464 1 C-N-CA 133.409 4.684 . . . . 0.0 113.532 178.772 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 80.3 p -141.86 164.16 30.94 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-O 125.369 2.509 . . . . 0.0 112.665 -170.632 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 14.6 m-85 -128.4 -87.73 0.55 Allowed 'General case' 0 N--CA 1.449 -0.496 0 O-C-N 118.814 -2.429 . . . . 0.0 115.108 -151.652 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -140.88 153.34 45.68 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-O 122.818 1.294 . . . . 0.0 110.995 176.022 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -62.92 98.13 0.12 Allowed 'General case' 0 N--CA 1.449 -0.506 0 O-C-N 118.348 -2.72 . . . . 0.0 116.313 -176.381 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 30.7 mm-40 -112.03 112.43 24.06 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 127.612 2.365 . . . . 0.0 108.942 177.477 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 67.5 m -138.82 45.6 2.01 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 128.481 2.713 . . . . 0.0 108.98 -174.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 36.5 ttm-85 -74.93 55.56 0.71 Allowed 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 129.063 2.945 . . . . 0.0 113.715 -178.586 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 19.0 mt -73.68 143.88 13.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 O-C-N 124.796 1.31 . . . . 0.0 112.676 -178.864 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 58.7 t30 -101.05 75.55 1.67 Allowed 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 127.379 2.272 . . . . 0.0 115.452 166.203 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 -74.36 -12.59 60.56 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 124.711 1.204 . . . . 0.0 112.9 -161.487 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 . . . . . 0 C--O 1.249 1.058 0 O-C-N 121.067 -1.021 . . . . 0.0 109.555 -177.297 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.434 ' HA3' ' O ' ' A' ' 14' ' ' TYR . . . . . . . . 0 CA--C 1.522 0.521 0 N-CA-C 120.499 2.96 . . . . 0.0 120.499 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 55.2 mt -120.33 -39.3 2.8 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 115.841 -2.028 . . . . 0.0 116.446 -169.768 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.7 m -139.7 178.58 7.13 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 127.705 2.402 . . . . 0.0 110.237 -168.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 21.9 pt20 -74.8 156.66 36.28 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 124.711 1.205 . . . . 0.0 113.612 -168.029 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 164.24 -153.01 23.1 Favored Glycine 0 CA--C 1.523 0.554 0 C-N-CA 119.893 -1.146 . . . . 0.0 114.731 -171.679 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 20.1 m -120.85 -8.79 10.28 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 1 C-N-CA 136.097 5.759 . . . . 0.0 115.824 -165.204 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 19.0 tt0 -128.33 88.93 51.27 Favored Pre-proline 0 N--CA 1.45 -0.461 0 C-N-CA 129.081 2.952 . . . . 0.0 113.785 171.791 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -73.31 99.14 1.08 Allowed 'Trans proline' 0 N--CA 1.449 -1.116 0 C-N-CA 122.526 2.151 . . . . 0.0 110.863 -177.566 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -61.02 -59.14 5.85 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 126.66 1.984 . . . . 0.0 112.951 167.21 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.509 HG22 ' H ' ' A' ' 12' ' ' GLN . 7.6 mt -90.78 141.99 13.59 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 C-N-CA 128.923 2.889 . . . . 0.0 103.958 162.571 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -48.13 -32.57 9.53 Favored Glycine 0 CA--C 1.522 0.515 0 O-C-N 119.613 -1.93 . . . . 0.0 114.025 167.145 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.509 ' H ' HG22 ' A' ' 10' ' ' ILE 0.269 25.5 tt0 -67.38 -43.08 82.26 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 117.25 2.315 . . . . 0.0 117.25 168.603 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 16.5 p -149.12 150.89 33.45 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 120.649 3.574 . . . . 0.0 120.649 -164.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.434 ' O ' ' HA3' ' A' ' 1' ' ' GLY 0.27 0.7 OUTLIER -110.66 -102.95 0.39 Allowed 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 130.118 3.367 . . . . 0.0 115.981 -151.687 . . . . . . . . 4 4 . 1 . 005 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 18.5 m-85 -136.16 167.55 21.06 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 169.637 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -73.6 60.53 0.68 Allowed 'General case' 0 N--CA 1.449 -0.488 0 O-C-N 126.738 2.524 . . . . 0.0 115.966 -158.303 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -75.86 96.71 3.76 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 126.431 1.893 . . . . 0.0 110.106 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 54.8 m -155.62 134.79 12.23 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 124.279 1.032 . . . . 0.0 110.262 177.57 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 22.3 mmt85 -138.8 27.6 2.43 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 126.398 1.879 . . . . 0.0 113.873 -171.033 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.411 HG13 ' H ' ' A' ' 20' ' ' ILE . 12.2 mt -42.08 110.05 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 C-N-CA 127.721 2.408 . . . . 0.0 110.451 179.115 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 58.1 t30 -150.3 150.15 31.1 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 113.283 -1.781 . . . . 0.0 111.444 174.299 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 28.5 tt0 -77.9 159.19 29.05 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 131.238 3.815 . . . . 0.0 111.695 167.266 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . 0.287 48.4 m-20 . . . . . 0 C--O 1.25 1.111 0 CA-C-O 126.971 3.272 . . . . 0.0 115.896 178.096 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.542 0 N-CA-C 122.434 3.733 . . . . 0.0 122.434 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 68.0 mt -126.53 -18.19 4.89 Favored 'General case' 0 N--CA 1.449 -0.514 0 O-C-N 129.241 3.553 . . . . 0.0 117.055 -172.133 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 70.2 m -144.91 176.65 9.31 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 131.3 3.84 . . . . 0.0 112.104 177.511 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 24.0 mp0 -70.67 156.77 39.04 Favored 'General case' 0 N--CA 1.448 -0.534 0 O-C-N 117.952 -2.968 . . . . 0.0 112.716 178.527 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 176.28 -139.55 4.61 Favored Glycine 0 CA--C 1.522 0.508 0 CA-C-O 121.763 0.646 . . . . 0.0 114.603 178.693 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 14.5 p -118.14 -17.0 7.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 O-C-N 119.652 -2.087 . . . . 0.0 113.141 -176.823 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -112.05 87.25 8.56 Favored Pre-proline 0 N--CA 1.45 -0.468 0 C-N-CA 128.683 2.793 . . . . 0.0 110.881 -172.11 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_endo -74.51 86.58 1.33 Allowed 'Trans proline' 0 N--CA 1.449 -1.14 0 CA-C-N 122.086 1.781 . . . . 0.0 112.829 -177.384 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -34.93 -82.73 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.519 1 C-N-CA 134.321 5.049 . . . . 0.0 111.958 154.055 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.444 HG22 ' N ' ' A' ' 11' ' ' GLY . 22.7 mm -76.27 174.7 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 O-C-N 118.77 -2.456 . . . . 0.0 106.747 163.04 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.444 ' N ' HG22 ' A' ' 10' ' ' ILE . . . -57.81 -51.45 58.03 Favored Glycine 0 C--N 1.336 0.536 0 O-C-N 118.129 -2.857 . . . . 0.0 114.602 154.612 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 21.3 tt0 -62.88 -47.33 83.78 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 120.122 3.379 . . . . 0.0 120.122 174.475 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 17.0 p -133.56 159.52 40.19 Favored 'General case' 0 N--CA 1.449 -0.483 0 O-C-N 117.163 -3.461 . . . . 0.0 116.872 -178.343 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 40.5 m-85 -111.11 -81.69 0.58 Allowed 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 124.911 1.284 . . . . 0.0 109.094 -158.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -149.86 156.29 41.52 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 178.524 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . 0.256 0.2 OUTLIER -79.34 77.04 5.89 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-O 116.975 -1.488 . . . . 0.0 109.092 -176.775 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -84.31 -33.72 23.88 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 128.049 2.539 . . . . 0.0 112.335 -165.807 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 3.3 t 45.09 47.36 9.74 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 123.27 2.759 . . . . 0.0 113.905 -177.321 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.57 2.39 5.55 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 114.732 1.382 . . . . 0.0 114.732 -159.783 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 3.8 mt -63.63 116.56 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 CA-C-O 117.696 -1.145 . . . . 0.0 111.187 154.071 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 34.1 m120 -75.24 71.54 2.25 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-O 123.785 1.755 . . . . 0.0 109.843 -176.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 47.0 tt0 -60.53 130.69 47.83 Favored 'General case' 0 N--CA 1.449 -0.494 1 C-N-CA 132.802 4.441 . . . . 0.0 110.816 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 24.7 t70 . . . . . 0 C--O 1.25 1.115 1 N-CA-C 122.03 4.085 . . . . 0.0 122.03 176.175 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.464 0 CA-C-O 122.059 0.811 . . . . 0.0 112.732 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.8 pp -153.36 -2.53 0.21 Allowed 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 118.179 2.659 . . . . 0.0 118.179 168.401 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 49.6 m -147.48 173.61 12.5 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-O 123.386 1.565 . . . . 0.0 110.81 176.688 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 -52.87 146.3 11.0 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 128.479 2.711 . . . . 0.0 112.079 172.507 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 171.67 -178.31 44.02 Favored Glycine 0 C--N 1.335 0.526 1 O-C-N 115.789 -4.32 . . . . 0.0 114.254 -173.171 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 33.1 m -92.68 -18.08 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 C-N-CA 124.855 1.262 . . . . 0.0 113.05 -178.448 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 12.5 tt0 -121.71 82.9 41.83 Favored Pre-proline 0 N--CA 1.45 -0.438 0 C-N-CA 124.245 1.018 . . . . 0.0 113.332 -165.535 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.471 ' HA ' ' HA ' ' A' ' 14' ' ' TYR . 5.0 Cg_exo -64.79 142.72 77.5 Favored 'Trans proline' 0 N--CA 1.449 -1.105 0 C-N-CA 120.693 0.928 . . . . 0.0 110.22 -165.723 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -119.03 -72.39 0.69 Allowed 'General case' 0 N--CA 1.449 -0.512 1 C-N-CA 133.196 4.599 . . . . 0.0 109.388 -178.145 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 96.8 mt -72.37 -20.28 19.73 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 CA-C-N 119.686 1.13 . . . . 0.0 108.586 171.005 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 94.17 -47.51 2.19 Favored Glycine 0 C--N 1.335 0.503 0 CA-C-O 123.879 1.822 . . . . 0.0 110.15 -177.596 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 58.5 mm-40 -63.06 -42.85 99.77 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 112.736 -1.732 . . . . 0.0 109.399 164.315 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 75.9 p -130.41 176.13 8.4 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 127.848 2.459 . . . . 0.0 111.63 171.151 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.471 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 4.3 m-85 -131.96 -85.88 0.48 Allowed 'General case' 0 N--CA 1.449 -0.498 1 C-N-CA 133.045 4.538 . . . . 0.0 112.718 -153.327 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -145.04 153.87 41.92 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 121.19 1.814 . . . . 0.0 109.324 -175.653 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -39.3 133.09 1.36 Allowed 'General case' 0 N--CA 1.45 -0.464 0 O-C-N 119.479 -2.013 . . . . 0.0 115.312 153.519 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -134.92 -67.06 0.56 Allowed 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 126.721 2.008 . . . . 0.0 109.365 -177.634 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . 0.265 16.2 m -61.1 76.49 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 120.568 3.544 . . . . 0.0 120.568 -166.195 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 27.5 ttm-85 -70.53 11.21 0.37 Allowed 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 126.604 1.961 . . . . 0.0 112.895 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.474 HD13 HG21 ' A' ' 20' ' ' ILE . 55.2 mt -50.16 131.91 9.77 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 C-N-CA 128.973 2.909 . . . . 0.0 113.32 -177.835 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -72.98 116.43 13.48 Favored 'General case' 0 N--CA 1.447 -0.583 0 O-C-N 126.499 2.374 . . . . 0.0 111.204 179.323 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 18.9 tt0 -74.47 125.33 28.34 Favored 'General case' 0 N--CA 1.449 -0.506 0 O-C-N 118.82 -2.425 . . . . 0.0 108.931 -172.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 . . . . . 0 C--O 1.25 1.126 0 C-N-CA 126.559 1.944 . . . . 0.0 110.232 174.36 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.523 0 N-CA-C 119.378 2.511 . . . . 0.0 119.378 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 50.5 mt -128.22 -28.11 2.63 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 117.518 2.414 . . . . 0.0 117.518 -179.732 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.2 m -132.23 171.59 13.49 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 128.192 2.597 . . . . 0.0 111.961 -177.071 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 31.3 mt-30 -63.43 137.87 58.31 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 127.728 2.411 . . . . 0.0 106.43 168.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -170.03 -150.28 6.79 Favored Glycine 0 CA--C 1.523 0.551 0 C-N-CA 119.28 -1.438 . . . . 0.0 111.262 -174.199 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 9.8 p -117.42 -19.22 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 N-CA-C 117.237 2.31 . . . . 0.0 117.237 -177.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 55.0 tt0 -113.06 82.62 5.52 Favored Pre-proline 0 N--CA 1.449 -0.482 0 C-N-CA 126.831 2.052 . . . . 0.0 111.442 -178.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_endo -60.67 144.32 99.53 Favored 'Trans proline' 0 N--CA 1.449 -1.09 0 C-N-CA 124.018 3.146 . . . . 0.0 113.994 -172.186 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -135.87 -81.2 0.41 Allowed 'General case' 0 N--CA 1.449 -0.483 1 C-N-CA 132.337 4.255 . . . . 0.0 107.947 -162.235 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 11.7 mm -87.75 169.67 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 O-C-N 119.81 -1.806 . . . . 0.0 108.926 174.001 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -25.03 -58.08 0.06 OUTLIER Glycine 0 C--N 1.336 0.533 0 C-N-CA 130.589 3.947 . . . . 0.0 114.404 168.311 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 17.4 tt0 -100.8 -22.37 14.88 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 118.712 2.856 . . . . 0.0 118.712 178.261 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 33.0 p -118.1 174.09 6.41 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 115.711 1.745 . . . . 0.0 115.711 -167.623 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 67.6 m-85 -132.75 -82.16 0.48 Allowed 'General case' 0 N--CA 1.449 -0.48 0 O-C-N 126.018 2.074 . . . . 0.0 110.135 -160.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -144.53 162.43 36.61 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 128.363 2.665 . . . . 0.0 110.432 177.31 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -73.1 59.21 0.52 Allowed 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 128.2 2.6 . . . . 0.0 113.655 177.688 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 62.8 mt-10 -68.59 -59.47 3.11 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-O 125.424 2.535 . . . . 0.0 112.96 -176.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 6.7 t -166.77 173.08 9.86 Favored 'General case' 0 N--CA 1.449 -0.479 1 C-N-CA 132.433 4.293 . . . . 0.0 110.753 179.352 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . 0.275 10.9 ttt180 -134.9 10.78 3.62 Favored 'General case' 0 N--CA 1.449 -0.5 1 C-N-CA 133.615 4.766 . . . . 0.0 113.598 167.785 . . . . . . . . 3 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 76.2 mt -54.81 138.51 14.82 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 C-N-CA 127.03 2.132 . . . . 0.0 114.116 177.581 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 27.2 m-80 -137.05 162.95 31.93 Favored 'General case' 0 N--CA 1.448 -0.53 0 O-C-N 117.471 -3.268 . . . . 0.0 109.504 171.674 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . 0.26 33.4 tt0 -132.14 57.71 1.77 Allowed 'General case' 0 N--CA 1.449 -0.501 0 O-C-N 117.832 -3.042 . . . . 0.0 110.534 -177.298 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 . . . . . 0 C--O 1.25 1.127 1 O-C-N 115.538 -4.476 . . . . 0.0 110.443 -176.112 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.546 0 CA-C-O 118.246 -1.308 . . . . 0.0 115.544 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -142.41 5.49 1.64 Allowed 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 117.735 2.494 . . . . 0.0 117.735 -179.14 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 38.2 m -118.48 -172.28 2.24 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 130.7 3.6 . . . . 0.0 117.565 -169.757 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 29.0 mt-30 -95.29 122.75 38.31 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 125.381 1.472 . . . . 0.0 111.649 171.61 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 176.87 -162.97 31.58 Favored Glycine 0 C--N 1.336 0.532 0 N-CA-C 109.104 -1.599 . . . . 0.0 109.104 -164.783 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 45.3 t -116.05 -16.27 8.95 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 1 C-N-CA 132.854 4.462 . . . . 0.0 115.233 -155.45 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 50.7 tt0 -114.39 88.98 16.57 Favored Pre-proline 0 N--CA 1.448 -0.541 0 O-C-N 119.267 -2.146 . . . . 0.0 109.271 177.15 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -67.42 110.39 2.04 Favored 'Trans proline' 0 N--CA 1.45 -1.061 0 C-N-CA 124.956 3.771 . . . . 0.0 111.988 -178.651 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -90.29 -86.42 0.2 Allowed 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 126.205 1.802 . . . . 0.0 109.909 -159.506 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 9.2 mt -88.63 65.5 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 CA-C-O 126.716 3.15 . . . . 0.0 106.844 177.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 53.17 -87.64 0.01 OUTLIER Glycine 0 C--N 1.335 0.503 0 C-N-CA 127.681 2.562 . . . . 0.0 118.173 -166.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 44.6 tt0 -58.87 -30.39 67.71 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 119.737 3.236 . . . . 0.0 119.737 -169.64 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 24.3 p -127.36 172.16 10.89 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 126.873 2.069 . . . . 0.0 110.901 174.406 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 41.9 m-85 -125.58 174.15 8.45 Favored 'General case' 0 N--CA 1.45 -0.457 1 C-N-CA 133.289 4.636 . . . . 0.0 111.706 -153.528 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -54.92 134.85 48.7 Favored 'General case' 0 N--CA 1.449 -0.505 0 O-C-N 124.217 0.948 . . . . 0.0 109.878 175.761 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . 0.306 30.6 tt0 -59.12 65.67 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 130.926 3.69 . . . . 0.0 111.875 159.216 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . 0.276 29.5 tt0 -78.44 -39.6 38.19 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 127.21 2.204 . . . . 0.0 111.391 178.062 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 17.3 t -169.86 125.48 0.82 Allowed 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.372 1.469 . . . . 0.0 112.862 167.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 35.2 ttt-85 -126.01 16.57 7.91 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 126.771 2.029 . . . . 0.0 112.693 176.527 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 73.7 mt -52.27 123.02 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 CA-C-O 124.829 2.252 . . . . 0.0 110.282 176.433 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 47.0 t30 -80.46 140.87 35.72 Favored 'General case' 0 N--CA 1.449 -0.504 0 O-C-N 120.194 -1.566 . . . . 0.0 114.073 178.657 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 11.5 tm0? -104.6 132.18 51.15 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 126.335 1.854 . . . . 0.0 109.678 173.471 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 15.5 t70 . . . . . 0 C--O 1.25 1.089 0 C-N-CA 125.376 1.471 . . . . 0.0 112.863 166.054 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.495 0 N-CA-C 116.146 1.218 . . . . 0.0 116.146 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -158.85 -1.66 0.09 Allowed 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 117.59 2.441 . . . . 0.0 117.59 177.418 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 25.9 m -149.45 167.31 26.58 Favored 'General case' 0 N--CA 1.45 -0.468 0 O-C-N 118.418 -2.676 . . . . 0.0 114.082 -175.418 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 40.6 mt-30 -61.46 138.18 58.26 Favored 'General case' 0 N--CA 1.449 -0.499 0 O-C-N 120.358 -1.464 . . . . 0.0 112.413 -177.243 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 178.1 -153.03 12.27 Favored Glycine 0 CA--C 1.523 0.556 0 O-C-N 121.099 -1.001 . . . . 0.0 114.093 -167.576 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 63.6 t -124.66 -20.52 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 C-N-CA 125.816 1.647 . . . . 0.0 113.118 -168.497 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 28.8 tp10 -105.62 89.27 3.29 Favored Pre-proline 0 N--CA 1.45 -0.465 0 CA-C-O 116.224 -1.846 . . . . 0.0 111.091 173.161 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -60.19 140.32 91.63 Favored 'Trans proline' 0 N--CA 1.449 -1.143 0 C-N-CA 123.31 2.673 . . . . 0.0 113.457 178.285 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 38.1 t0 -128.57 -93.94 0.44 Allowed 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 126.089 1.755 . . . . 0.0 111.857 -164.767 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 28.3 mm -107.27 143.88 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 C-N-CA 126.419 1.888 . . . . 0.0 108.748 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 56.52 -89.72 0.01 OUTLIER Glycine 0 C--N 1.336 0.53 0 C-N-CA 126.971 2.224 . . . . 0.0 115.226 174.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -134.04 4.04 3.48 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 116.083 1.883 . . . . 0.0 116.083 176.68 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.421 ' HB ' ' H ' ' A' ' 14' ' ' TYR . 42.8 p -114.31 -177.25 3.08 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 -179.783 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.421 ' H ' ' HB ' ' A' ' 13' ' ' THR . 0.5 OUTLIER -131.08 -170.71 2.41 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 131.159 3.784 . . . . 0.0 110.877 -160.717 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -68.53 150.89 47.52 Favored 'General case' 0 N--CA 1.449 -0.516 0 O-C-N 119.07 -2.269 . . . . 0.0 109.866 177.304 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -63.68 87.71 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 128.07 2.548 . . . . 0.0 113.566 174.648 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -76.19 -34.64 59.32 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-O 123.162 1.458 . . . . 0.0 112.53 159.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 2.2 t 59.06 50.59 7.99 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 128.701 2.8 . . . . 0.0 111.341 -168.49 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 33.9 ttt85 -82.36 39.29 0.59 Allowed 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 126.273 1.829 . . . . 0.0 113.376 -175.641 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 54.9 mt -75.04 133.72 30.89 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 O-C-N 120.823 -1.173 . . . . 0.0 108.551 -172.362 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 31.4 t30 -128.15 94.34 3.89 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 126.765 2.026 . . . . 0.0 110.924 -158.058 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 37.6 tt0 -138.91 169.18 18.26 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 126.34 1.856 . . . . 0.0 111.761 -175.013 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 31.6 t70 . . . . . 0 C--O 1.25 1.086 0 C-N-CA 127.519 2.328 . . . . 0.0 113.747 169.906 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.483 0 N-CA-C 111.131 -0.788 . . . . 0.0 111.131 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 78.9 mt -144.69 -12.86 0.57 Allowed 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.682 1.593 . . . . 0.0 113.177 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 6.1 t -138.68 -152.12 0.41 Allowed 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 127.87 2.468 . . . . 0.0 113.176 -166.349 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -116.7 156.92 26.3 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 125.128 1.371 . . . . 0.0 110.072 173.862 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 164.86 -144.37 9.28 Favored Glycine 0 N--CA 1.448 -0.547 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.46 -171.827 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 18.6 m -120.97 -15.56 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 -175.65 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 33.2 mm-40 -107.83 96.78 18.2 Favored Pre-proline 0 N--CA 1.449 -0.479 0 O-C-N 119.689 -1.882 . . . . 0.0 112.74 174.651 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -74.24 101.89 1.47 Allowed 'Trans proline' 0 N--CA 1.45 -1.033 0 C-N-CA 123.463 2.776 . . . . 0.0 109.853 -179.768 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -68.22 -63.12 1.12 Allowed 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 129.252 3.021 . . . . 0.0 112.492 176.578 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.404 HG22 ' H ' ' A' ' 12' ' ' GLN . 27.1 mt -75.89 157.21 5.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 N-CA-C 106.753 -1.573 . . . . 0.0 106.753 162.795 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -41.64 -48.27 4.92 Favored Glycine 0 CA--C 1.523 0.573 0 O-C-N 119.467 -2.021 . . . . 0.0 112.972 164.768 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.404 ' H ' HG22 ' A' ' 10' ' ' ILE . 39.1 tt0 -76.13 -47.66 23.53 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 116.597 2.073 . . . . 0.0 116.597 179.052 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 35.9 p -129.24 164.09 24.21 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 127.288 2.235 . . . . 0.0 116.034 -160.251 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 13.9 m-85 -121.79 178.22 4.95 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 126.353 1.861 . . . . 0.0 110.905 -161.717 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -62.91 144.71 56.47 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 -179.197 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -61.89 106.58 0.71 Allowed 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 125.97 1.708 . . . . 0.0 109.175 178.599 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -67.87 -45.63 73.99 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 114.239 -1.346 . . . . 0.0 112.627 173.67 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 42.5 t 176.62 137.31 0.06 Allowed 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 129.38 3.072 . . . . 0.0 107.782 177.702 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 42.3 mtt180 -151.46 89.57 1.5 Allowed 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 125.236 1.414 . . . . 0.0 108.166 167.789 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 46.9 mm -57.97 132.79 22.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 CA-C-N 115.135 -0.939 . . . . 0.0 111.058 159.718 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -51.43 146.65 6.93 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 126.449 1.899 . . . . 0.0 112.115 -178.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 30.6 tt0 49.08 90.98 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 128.256 2.623 . . . . 0.0 115.25 -177.311 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 . . . . . 0 C--O 1.25 1.108 0 C-N-CA 128.429 2.691 . . . . 0.0 115.466 -177.006 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.526 0 N-CA-C 117.45 1.74 . . . . 0.0 117.45 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 95.0 mt -137.7 -37.05 0.61 Allowed 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 116.566 2.062 . . . . 0.0 116.566 171.541 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.5 m -138.97 -162.14 1.28 Allowed 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 125.164 1.386 . . . . 0.0 112.325 -175.921 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 70.8 mt-30 -54.15 165.35 0.52 Allowed 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 114.351 1.241 . . . . 0.0 114.351 175.529 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 160.29 -173.79 36.94 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.95 -0.643 . . . . 0.0 114.196 160.135 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 13.7 p -91.3 -7.09 10.73 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 C-N-CA 125.812 1.645 . . . . 0.0 113.468 178.479 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -121.94 90.75 48.72 Favored Pre-proline 0 N--CA 1.449 -0.517 0 C-N-CA 125.644 1.578 . . . . 0.0 111.094 -171.412 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_exo -51.19 140.85 40.57 Favored 'Trans proline' 0 N--CA 1.45 -1.067 0 C-N-CA 121.912 1.742 . . . . 0.0 113.121 174.338 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -128.74 -53.38 1.24 Allowed 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 126.229 1.812 . . . . 0.0 109.242 -175.136 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.474 HG22 ' H ' ' A' ' 11' ' ' GLY . 3.0 mt -121.98 172.68 8.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 C-N-CA 125.823 1.649 . . . . 0.0 108.064 172.46 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.474 ' H ' HG22 ' A' ' 10' ' ' ILE . . . -46.58 -42.74 14.51 Favored Glycine 0 C--N 1.335 0.501 0 C-N-CA 126.202 1.858 . . . . 0.0 116.138 178.586 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 45.2 tt0 -92.85 -36.25 12.93 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 116.763 2.135 . . . . 0.0 116.763 176.058 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 82.2 p -124.38 167.7 14.03 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 119.587 -1.946 . . . . 0.0 115.972 -160.81 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 16.9 m-85 -131.64 -83.57 0.51 Allowed 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.982 1.313 . . . . 0.0 111.664 -161.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -141.02 171.15 14.47 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 125.556 1.543 . . . . 0.0 110.714 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -80.09 59.46 3.29 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 121.98 2.173 . . . . 0.0 111.87 177.786 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -67.94 146.45 53.58 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 126.372 1.869 . . . . 0.0 111.623 -175.392 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 22.6 t 117.62 123.51 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 131.438 3.895 . . . . 0.0 110.605 -173.513 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 34.1 ttp180 -146.58 28.57 1.06 Allowed 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 125.978 1.711 . . . . 0.0 112.545 -172.374 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 37.6 mt -52.96 115.35 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 O-C-N 118.927 -2.358 . . . . 0.0 111.749 174.386 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 31.4 t30 -129.78 82.41 2.07 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 127.029 2.132 . . . . 0.0 108.192 179.681 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 40.4 tt0 -143.48 -19.93 0.61 Allowed 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.815 1.646 . . . . 0.0 113.871 -169.166 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 . . . . . 0 C--O 1.251 1.139 0 N-CA-C 117.49 2.404 . . . . 0.0 117.49 177.266 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.534 0 CA-C-O 123.002 1.335 . . . . 0.0 114.979 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.542 ' H ' HD23 ' A' ' 2' ' ' LEU . 2.1 pt? -130.11 -5.79 4.41 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 129.317 3.047 . . . . 0.0 113.546 -174.949 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 26.6 m -120.56 -166.14 1.29 Allowed 'General case' 0 N--CA 1.448 -0.533 0 O-C-N 126.805 2.566 . . . . 0.0 114.772 -162.445 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 20.1 mp0 -102.68 155.76 18.09 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 119.42 1.009 . . . . 0.0 110.41 161.074 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 161.89 -165.16 35.68 Favored Glycine 0 CA--C 1.523 0.568 0 O-C-N 119.462 -2.024 . . . . 0.0 113.776 -177.614 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 14.0 p -69.68 -26.95 31.81 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 N-CA-C 119.203 3.038 . . . . 0.0 119.203 174.175 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 16.2 tp10 -118.12 90.12 36.75 Favored Pre-proline 0 N--CA 1.449 -0.515 0 O-C-N 118.324 -2.735 . . . . 0.0 114.691 -164.198 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . 0.326 17.8 Cg_endo -60.74 127.72 23.43 Favored 'Trans proline' 0 N--CA 1.449 -1.115 0 CA-C-O 125.371 2.154 . . . . 0.0 114.6 173.029 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 49.9 t0 -117.63 -88.76 0.6 Allowed 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 128.282 2.633 . . . . 0.0 115.17 -161.047 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.6 mm -99.86 144.34 12.41 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 C-N-CA 126.946 2.098 . . . . 0.0 106.471 163.562 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -45.56 143.5 3.63 Favored Glycine 0 CA--C 1.522 0.531 0 N-CA-C 121.338 3.295 . . . . 0.0 121.338 -163.747 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 15.7 tt0 62.39 -15.38 0.05 Allowed 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 109.966 -3.117 . . . . 0.0 114.323 -163.912 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . 0.277 24.9 p -122.28 168.54 11.91 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 126.01 2.814 . . . . 0.0 112.82 -166.006 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -134.5 162.69 31.56 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 128.041 2.536 . . . . 0.0 111.317 -166.166 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -57.73 145.58 34.09 Favored 'General case' 0 N--CA 1.449 -0.518 0 O-C-N 119.5 -2.0 . . . . 0.0 109.677 172.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -70.49 84.91 0.6 Allowed 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 127.931 2.492 . . . . 0.0 112.004 -169.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -75.3 -39.9 59.1 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 126.682 1.993 . . . . 0.0 111.828 174.544 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 47.0 m 52.51 53.72 11.82 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 126.87 2.068 . . . . 0.0 111.913 176.542 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 6.1 mmp_? -131.09 66.32 1.54 Allowed 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 126.456 1.902 . . . . 0.0 106.501 173.536 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.405 ' H ' HD12 ' A' ' 20' ' ' ILE . 2.2 mp -56.49 114.21 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 C-N-CA 127.876 2.47 . . . . 0.0 110.316 -172.756 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 5.4 t30 61.16 38.09 17.09 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 129.59 3.156 . . . . 0.0 114.068 164.415 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -37.3 155.5 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 117.927 2.566 . . . . 0.0 117.927 179.403 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.6 t70 . . . . . 0 C--O 1.249 1.053 0 N-CA-C 116.382 1.993 . . . . 0.0 116.382 169.097 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.546 0 N-CA-C 111.764 -0.535 . . . . 0.0 111.764 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -160.68 10.49 0.1 Allowed 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 126.36 1.864 . . . . 0.0 114.926 -169.377 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 53.8 m -131.58 169.85 15.55 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-O 115.017 -2.42 . . . . 0.0 117.137 164.294 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 16.9 mm100 -57.91 145.93 33.92 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 122.898 2.59 . . . . 0.0 111.317 164.263 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 169.17 -152.01 18.95 Favored Glycine 0 C--N 1.335 0.519 0 N-CA-C 116.911 1.524 . . . . 0.0 116.911 174.382 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.9 t -97.44 -18.63 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 O-C-N 127.08 2.282 . . . . 0.0 117.027 -177.518 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.503 ' O ' ' HA ' ' A' ' 14' ' ' TYR . 4.2 tp10 -125.88 92.42 46.22 Favored Pre-proline 0 N--CA 1.449 -0.518 0 N-CA-C 106.649 -1.611 . . . . 0.0 106.649 -168.048 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -71.99 94.98 0.73 Allowed 'Trans proline' 0 N--CA 1.448 -1.153 0 C-N-CA 124.409 3.406 . . . . 0.0 110.048 173.732 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -64.26 -52.28 59.44 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 130.734 3.613 . . . . 0.0 109.88 -177.83 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.441 HG22 ' H ' ' A' ' 12' ' ' GLN . 47.3 mm -85.12 160.03 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 161.282 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -51.3 -41.22 47.13 Favored Glycine 0 CA--C 1.523 0.534 0 CA-C-O 124.774 2.319 . . . . 0.0 114.806 173.472 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.441 ' H ' HG22 ' A' ' 10' ' ' ILE . 8.9 tt0 -61.99 -81.21 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 128.258 2.623 . . . . 0.0 111.506 172.314 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . 0.273 0.7 OUTLIER -121.79 178.28 4.93 Favored 'General case' 0 N--CA 1.449 -0.517 0 O-C-N 117.794 -3.066 . . . . 0.0 117.196 -167.563 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.503 ' HA ' ' O ' ' A' ' 7' ' ' GLU . 0.7 OUTLIER -117.13 170.67 8.48 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 130.82 3.648 . . . . 0.0 112.259 -154.79 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -51.64 137.23 25.4 Favored 'General case' 0 N--CA 1.449 -0.491 0 O-C-N 118.923 -2.361 . . . . 0.0 109.478 -174.552 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -46.52 125.02 6.47 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 129.69 3.196 . . . . 0.0 113.539 -175.675 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -120.77 -66.24 1.07 Allowed 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 122.307 2.322 . . . . 0.0 106.501 -168.167 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 35.6 t -145.45 156.1 43.53 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-O 116.236 -1.84 . . . . 0.0 113.589 -179.375 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 21.7 ttt-85 -134.89 9.48 3.57 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 125.265 1.426 . . . . 0.0 113.96 170.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 92.1 mt -61.11 122.69 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 O-C-N 118.727 -2.483 . . . . 0.0 111.876 -154.51 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 32.3 t30 -139.73 117.53 11.64 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 125.99 1.716 . . . . 0.0 111.614 -172.685 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 8.6 mp0 -79.63 -20.7 46.12 Favored 'General case' 0 N--CA 1.448 -0.538 0 O-C-N 121.022 -1.048 . . . . 0.0 113.681 174.745 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 51.1 t0 . . . . . 0 C--O 1.25 1.086 0 C-N-CA 128.163 2.585 . . . . 0.0 115.762 -167.654 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.493 0 CA-C-O 119.503 -0.609 . . . . 0.0 113.315 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -121.23 12.15 10.95 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 126.874 2.07 . . . . 0.0 114.33 -177.908 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -118.82 -148.65 0.42 Allowed 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 128.351 2.661 . . . . 0.0 110.94 178.772 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 15.4 mp0 -122.15 152.49 39.87 Favored 'General case' 0 N--CA 1.45 -0.45 0 O-C-N 116.959 -3.588 . . . . 0.0 115.042 167.002 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 170.57 -138.11 4.79 Favored Glycine 0 C--N 1.336 0.543 0 CA-C-N 113.055 -1.884 . . . . 0.0 112.291 -170.577 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 13.1 m -128.15 -8.64 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 CA-C-N 119.464 1.632 . . . . 0.0 110.647 -175.442 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -112.36 81.46 4.0 Favored Pre-proline 0 N--CA 1.449 -0.508 0 N-CA-C 116.442 2.015 . . . . 0.0 116.442 173.406 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -65.89 136.61 45.83 Favored 'Trans proline' 0 N--CA 1.449 -1.101 0 C-N-CA 123.439 2.759 . . . . 0.0 107.367 -179.418 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -130.8 -102.42 0.29 Allowed 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 109.61 -3.45 . . . . 0.0 110.074 -151.758 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 17.1 mt -70.8 88.83 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 CA-C-N 122.706 2.503 . . . . 0.0 110.447 168.224 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 46.82 -107.9 0.24 Allowed Glycine 0 CA--C 1.523 0.537 0 O-C-N 117.173 -3.455 . . . . 0.0 117.179 -175.102 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -64.58 -10.71 28.15 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 120.05 3.352 . . . . 0.0 120.05 179.227 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 46.2 p -124.06 159.92 28.86 Favored 'General case' 0 N--CA 1.449 -0.5 0 O-C-N 125.572 1.795 . . . . 0.0 113.541 -173.315 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -124.6 175.73 7.0 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 131.48 3.912 . . . . 0.0 112.729 -160.443 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -57.78 156.4 8.82 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 115.835 1.791 . . . . 0.0 115.835 -177.707 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -69.87 88.0 0.55 Allowed 'General case' 0 N--CA 1.449 -0.509 0 O-C-N 118.299 -2.751 . . . . 0.0 115.814 -166.918 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -81.52 151.49 27.74 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 131.228 3.811 . . . . 0.0 112.274 164.077 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . 0.268 28.0 p 59.87 -179.09 0.09 Allowed 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 118.953 2.946 . . . . 0.0 118.953 173.958 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 48.4 ttt180 43.16 56.0 4.36 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 129.866 3.266 . . . . 0.0 112.366 175.282 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 15.1 mm -65.35 140.38 19.77 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 CA-C-O 124.569 2.128 . . . . 0.0 107.459 175.366 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 67.0 m-20 -117.18 167.02 11.57 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 129.869 3.268 . . . . 0.0 112.447 170.436 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 20.8 tt0 34.28 61.56 0.52 Allowed 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 128.59 2.756 . . . . 0.0 116.013 -174.374 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . 0.346 41.3 m-20 . . . . . 0 C--O 1.25 1.089 0 C-N-CA 129.152 2.981 . . . . 0.0 118.167 -176.569 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.437 ' HA3' ' HB3' ' A' ' 9' ' ' ASP . . . . . . . . 0 CA--C 1.522 0.503 0 N-CA-C 116.59 1.396 . . . . 0.0 116.59 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -158.61 -3.93 0.08 Allowed 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 121.232 3.79 . . . . 0.0 121.232 171.133 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.421 ' HB2' ' HA ' ' A' ' 16' ' ' GLU . 17.7 m -150.17 -177.05 5.71 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 129.744 3.218 . . . . 0.0 111.311 175.195 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -63.3 162.44 12.18 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 130.618 3.567 . . . . 0.0 111.771 -170.535 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 163.21 -173.27 39.35 Favored Glycine 0 C--N 1.335 0.495 0 N-CA-C 118.303 2.081 . . . . 0.0 118.303 -170.273 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 20.2 m -111.51 -14.85 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 C-N-CA 128.102 2.561 . . . . 0.0 113.65 171.902 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -105.91 77.78 0.44 Allowed Pre-proline 0 N--CA 1.449 -0.514 0 C-N-CA 128.144 2.577 . . . . 0.0 115.625 177.158 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -63.87 96.8 0.22 Allowed 'Trans proline' 0 N--CA 1.449 -1.089 0 CA-C-O 124.301 1.709 . . . . 0.0 113.643 -176.391 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.437 ' HB3' ' HA3' ' A' ' 1' ' ' GLY . 0.2 OUTLIER -62.27 -66.62 0.51 Allowed 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 130.443 3.497 . . . . 0.0 112.37 -165.507 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . 0.254 42.8 pt -109.41 -166.39 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 CA-C-N 113.277 -1.783 . . . . 0.0 112.363 169.229 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -45.75 -47.21 13.54 Favored Glycine 0 C--N 1.335 0.514 0 N-CA-C 118.491 2.157 . . . . 0.0 118.491 -178.922 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 20.6 mp0 -121.84 150.39 41.99 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 129.605 3.162 . . . . 0.0 107.408 174.325 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.46 ' HA ' ' CD1' ' A' ' 14' ' ' TYR 0.28 4.7 p 56.38 179.45 0.04 OUTLIER 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 111.127 -2.76 . . . . 0.0 113.973 179.386 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.46 ' CD1' ' HA ' ' A' ' 13' ' ' THR . 2.2 m-85 -133.53 -99.06 0.27 Allowed 'General case' 0 N--CA 1.449 -0.518 0 O-C-N 117.823 -3.048 . . . . 0.0 111.203 -148.017 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -133.9 161.88 33.55 Favored 'General case' 0 N--CA 1.45 -0.475 0 CA-C-O 126.807 3.194 . . . . 0.0 107.363 -179.702 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.421 ' HA ' ' HB2' ' A' ' 3' ' ' SER . 21.0 tt0 -74.11 70.48 1.58 Allowed 'General case' 0 N--CA 1.449 -0.497 0 O-C-N 117.837 -3.039 . . . . 0.0 114.158 -175.334 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 -79.13 -8.23 58.82 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 131.229 3.812 . . . . 0.0 116.008 175.146 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 41.8 m -142.19 132.76 25.3 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 130.078 3.351 . . . . 0.0 116.844 -175.895 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 43.3 mtt180 -134.27 84.83 2.14 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 126.978 2.111 . . . . 0.0 108.251 168.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 30.2 mt -60.8 133.95 26.31 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 C-N-CA 126.938 2.095 . . . . 0.0 108.631 170.245 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 56.5 t30 -154.47 -177.71 6.65 Favored 'General case' 0 N--CA 1.45 -0.455 0 O-C-N 119.159 -2.213 . . . . 0.0 111.118 -165.874 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 19.3 tt0 -149.01 126.56 11.64 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-O 124.606 2.146 . . . . 0.0 109.789 -165.359 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 . . . . . 0 C--O 1.251 1.165 0 CA-C-N 113.625 -1.625 . . . . 0.0 114.489 179.395 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.501 0 N-CA-C 115.529 0.972 . . . . 0.0 115.529 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -159.41 -10.92 0.06 Allowed 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 115.98 1.844 . . . . 0.0 115.98 171.979 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 37.8 m -127.42 164.75 21.19 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 122.756 2.525 . . . . 0.0 116.003 -172.123 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -66.95 129.06 38.66 Favored 'General case' 0 N--CA 1.449 -0.519 0 O-C-N 120.532 -1.355 . . . . 0.0 110.581 -179.369 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -167.76 -151.88 7.24 Favored Glycine 0 C--N 1.334 0.449 0 N-CA-C 119.133 2.413 . . . . 0.0 119.133 -169.59 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 6.2 t -129.1 -19.15 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 C-N-CA 129.698 3.199 . . . . 0.0 113.911 -168.28 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -116.34 95.58 45.66 Favored Pre-proline 0 N--CA 1.45 -0.473 0 CA-C-O 117.49 -1.243 . . . . 0.0 111.637 171.58 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -74.76 90.5 1.05 Allowed 'Trans proline' 0 N--CA 1.449 -1.101 0 CA-C-N 124.092 2.497 . . . . 0.0 112.427 -175.286 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -52.34 -60.92 2.64 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 130.898 3.679 . . . . 0.0 111.458 170.652 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 20.9 pt -108.34 176.88 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 CA-C-O 124.424 2.059 . . . . 0.0 111.477 178.193 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -66.59 113.08 5.39 Favored Glycine 0 C--N 1.336 0.536 0 C-N-CA 128.438 2.923 . . . . 0.0 113.649 161.052 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 14.9 tt0 55.01 86.45 0.05 Allowed 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 128.526 2.73 . . . . 0.0 115.81 -159.792 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . 0.358 30.7 p 114.67 179.14 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.488 1 C-N-CA 133.63 4.772 . . . . 0.0 118.508 159.889 . . . . . . . . 3 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -129.59 -168.95 2.02 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 128.627 2.771 . . . . 0.0 108.373 -151.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -64.03 163.51 12.16 Favored 'General case' 0 N--CA 1.45 -0.466 0 O-C-N 119.401 -2.062 . . . . 0.0 113.102 -178.396 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -76.75 85.68 3.37 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-O 126.819 3.2 . . . . 0.0 113.459 178.577 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -66.63 173.99 3.11 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 110.558 -3.019 . . . . 0.0 116.609 173.349 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 36.6 t -46.35 132.9 10.06 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 130.905 3.682 . . . . 0.0 114.395 161.887 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 2.2 ttt180 -123.25 16.03 9.81 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 130.563 3.545 . . . . 0.0 114.593 164.402 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.8 mp -61.16 132.62 26.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 O-C-N 118.524 -2.61 . . . . 0.0 108.95 168.657 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 50.2 t30 -151.56 160.2 43.78 Favored 'General case' 0 N--CA 1.449 -0.523 0 O-C-N 118.745 -2.472 . . . . 0.0 113.42 -165.356 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 18.9 mp0 -126.16 167.33 15.56 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 127.73 2.412 . . . . 0.0 112.848 174.528 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 . . . . . 0 C--O 1.251 1.142 0 C-N-CA 127.361 2.264 . . . . 0.0 112.276 170.971 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.57 0 N-CA-C 114.052 0.381 . . . . 0.0 114.052 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 79.1 mt -139.61 -13.11 1.13 Allowed 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 126.312 1.845 . . . . 0.0 114.664 179.45 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 73.6 m -144.56 177.76 8.44 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-O 123.798 1.761 . . . . 0.0 109.395 -178.372 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 32.1 mt-30 -56.72 154.79 8.49 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 118.91 -2.369 . . . . 0.0 112.384 160.044 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 157.2 -156.39 27.19 Favored Glycine 0 C--N 1.335 0.516 0 O-C-N 118.773 -2.454 . . . . 0.0 114.453 178.556 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 16.8 m -110.26 -6.89 11.38 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 118.991 2.96 . . . . 0.0 118.991 -173.126 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 30.2 mm-40 -112.03 83.22 4.74 Favored Pre-proline 0 N--CA 1.45 -0.473 0 CA-C-O 116.012 -1.947 . . . . 0.0 114.476 176.102 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -64.59 142.53 77.97 Favored 'Trans proline' 0 N--CA 1.45 -1.074 0 C-N-CA 123.525 2.817 . . . . 0.0 111.44 -168.378 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -140.48 -79.88 0.28 Allowed 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 118.12 2.637 . . . . 0.0 118.12 -157.012 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.401 HG22 ' H ' ' A' ' 11' ' ' GLY . 8.0 mm -91.46 161.06 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 N-CA-C 102.965 -2.976 . . . . 0.0 102.965 165.371 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.401 ' H ' HG22 ' A' ' 10' ' ' ILE . . . -47.23 -18.64 0.52 Allowed Glycine 0 C--N 1.335 0.506 0 CA-C-N 113.633 -1.621 . . . . 0.0 117.135 -170.879 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 71.5 mt-30 -123.96 -8.56 7.76 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 129.822 3.249 . . . . 0.0 114.595 -171.568 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 64.0 p -137.98 178.79 6.86 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 117.39 2.367 . . . . 0.0 117.39 -166.896 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 -134.01 -97.99 0.27 Allowed 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 127.277 2.231 . . . . 0.0 112.421 -165.947 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 14.7 m-85 -142.81 150.28 39.74 Favored 'General case' 0 N--CA 1.449 -0.478 0 O-C-N 121.047 -1.033 . . . . 0.0 112.211 166.67 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -60.11 82.85 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.481 0 CA-C-O 127.231 3.396 . . . . 0.0 111.486 -174.373 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -65.87 -24.47 66.87 Favored 'General case' 0 N--CA 1.449 -0.478 1 O-C-N 116.181 -4.074 . . . . 0.0 112.08 164.454 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 58.7 m -64.98 47.73 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.482 1 C-N-CA 134.782 5.233 . . . . 0.0 117.541 -170.276 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 62.8 ttt-85 -71.23 56.67 0.22 Allowed 'General case' 0 N--CA 1.449 -0.506 1 O-C-N 129.309 4.131 . . . . 0.0 110.956 176.751 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 24.2 mt -135.14 111.61 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 C-N-CA 128.474 2.71 . . . . 0.0 107.703 -171.463 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 -130.68 157.65 42.21 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 112.98 -1.918 . . . . 0.0 113.601 168.192 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 56.6 mt-30 -128.79 4.13 5.44 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.817 -179.553 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 . . . . . 0 C--O 1.25 1.106 0 C-N-CA 129.378 3.071 . . . . 0.0 112.9 173.926 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.538 0 N-CA-C 116.509 1.364 . . . . 0.0 116.509 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -152.58 -8.47 0.19 Allowed 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 120.7 3.592 . . . . 0.0 120.7 157.412 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 21.4 m -134.01 -179.23 5.42 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 123.318 2.781 . . . . 0.0 115.816 174.289 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 22.6 mp0 -64.39 129.81 41.33 Favored 'General case' 0 N--CA 1.448 -0.527 0 O-C-N 118.197 -2.815 . . . . 0.0 113.956 -176.622 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -170.76 -149.16 6.3 Favored Glycine 0 C--N 1.336 0.539 0 CA-C-O 124.156 1.975 . . . . 0.0 113.048 171.541 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 26.7 m -117.01 -13.65 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 O-C-N 116.47 -3.959 . . . . 0.0 114.083 -171.349 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 23.6 tp10 -103.64 82.35 0.53 Allowed Pre-proline 0 N--CA 1.449 -0.479 0 O-C-N 126.943 2.652 . . . . 0.0 117.315 171.703 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.458 ' HB3' ' CE2' ' A' ' 14' ' ' TYR . 15.0 Cg_endo -64.47 149.75 89.44 Favored 'Trans proline' 0 N--CA 1.449 -1.136 0 C-N-CA 122.384 2.056 . . . . 0.0 108.683 -169.581 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -138.51 -92.25 0.2 Allowed 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 112.512 -2.131 . . . . 0.0 107.775 -159.34 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 6.4 mt -97.35 152.4 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 CA-C-O 117.138 -1.411 . . . . 0.0 107.217 169.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -36.35 141.81 0.19 Allowed Glycine 0 C--N 1.336 0.57 0 C-N-CA 129.534 3.445 . . . . 0.0 110.367 176.894 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 6.2 tm0? 58.13 -11.59 0.03 OUTLIER 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 116.962 2.208 . . . . 0.0 116.962 -168.186 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 22.6 p -133.73 168.07 19.37 Favored 'General case' 0 N--CA 1.45 -0.467 1 O-C-N 114.283 -5.261 . . . . 0.0 117.644 -170.221 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.458 ' CE2' ' HB3' ' A' ' 8' ' ' PRO . 9.1 m-85 -127.79 -82.92 0.6 Allowed 'General case' 0 N--CA 1.449 -0.48 0 CA-C-O 126.762 3.172 . . . . 0.0 112.316 -172.027 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.408 ' CD1' ' O ' ' A' ' 14' ' ' TYR . 19.7 m-85 -140.58 141.85 35.16 Favored 'General case' 0 N--CA 1.45 -0.469 1 O-C-N 116.11 -4.118 . . . . 0.0 113.463 175.887 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -59.03 84.83 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.484 0 CA-C-O 117.567 -1.206 . . . . 0.0 113.874 166.483 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -105.42 -59.14 1.8 Allowed 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 116.237 1.939 . . . . 0.0 116.237 -166.57 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 15.5 m -157.64 66.98 0.49 Allowed 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 129.354 3.062 . . . . 0.0 111.187 172.176 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 4.4 ppt_? -62.98 -11.17 17.03 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 127.97 2.508 . . . . 0.0 114.056 -172.189 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 19.3 mm -61.78 -17.18 16.76 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 CA-C-N 122.976 2.626 . . . . 0.0 110.015 178.135 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 11.4 p30 -54.72 166.95 0.41 Allowed 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 130.986 3.714 . . . . 0.0 120.004 -172.221 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -135.76 173.73 11.39 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 129.894 3.278 . . . . 0.0 108.527 176.185 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 37.2 m-20 . . . . . 0 C--O 1.25 1.107 0 CA-C-O 117.973 -1.013 . . . . 0.0 112.4 174.278 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.504 0 N-CA-C 118.233 2.053 . . . . 0.0 118.233 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -143.46 -11.64 0.71 Allowed 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 128.328 2.651 . . . . 0.0 117.916 -176.812 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 69.5 m -114.84 -174.01 2.41 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 127.85 2.46 . . . . 0.0 110.245 -164.59 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -102.76 135.27 44.72 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 128.83 2.852 . . . . 0.0 109.68 161.782 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 176.47 -158.5 24.81 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 108.126 -1.99 . . . . 0.0 108.126 -157.307 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.2 p -130.06 -0.27 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 O-C-N 121.29 -1.124 . . . . 0.0 111.743 -167.637 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 27.1 tp10 -116.56 107.58 46.56 Favored Pre-proline 0 N--CA 1.449 -0.522 1 O-C-N 115.477 -4.514 . . . . 0.0 102.673 163.687 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -66.02 142.91 70.24 Favored 'Trans proline' 0 N--CA 1.449 -1.146 0 CA-C-O 127.324 2.969 . . . . 0.0 110.867 169.194 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -119.58 -94.1 0.51 Allowed 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 110.545 -3.025 . . . . 0.0 109.477 -165.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 24.5 pt -118.36 154.73 20.48 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 C-N-CA 130.047 3.339 . . . . 0.0 109.7 177.026 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 45.15 -111.13 0.51 Allowed Glycine 0 C--N 1.335 0.498 0 C-N-CA 127.178 2.323 . . . . 0.0 112.388 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 71.8 mm-40 -97.36 -1.43 44.53 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-O 124.979 2.323 . . . . 0.0 115.624 -177.857 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 18.3 p -128.41 176.8 7.44 Favored 'General case' 0 N--CA 1.45 -0.429 0 O-C-N 117.075 -3.516 . . . . 0.0 110.636 -155.111 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 16.8 m-85 -127.92 173.09 10.3 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 125.415 1.486 . . . . 0.0 113.051 -165.544 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -53.31 141.34 24.38 Favored 'General case' 0 N--CA 1.448 -0.526 0 O-C-N 117.991 -2.943 . . . . 0.0 112.046 169.548 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . 0.445 30.4 tt0 -55.34 90.67 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 118.856 2.91 . . . . 0.0 118.856 174.672 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 29.7 tp10 -63.65 -22.37 66.86 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 114.448 1.277 . . . . 0.0 114.448 166.022 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 17.9 m -68.04 78.64 0.23 Allowed 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.973 1.709 . . . . 0.0 111.688 170.374 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 48.7 ttt180 -92.63 61.54 3.69 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-O 116.627 -1.654 . . . . 0.0 108.342 179.412 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 3.4 mt -58.09 105.72 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 C-N-CA 127.207 2.203 . . . . 0.0 108.009 179.776 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 14.7 t30 -128.07 105.68 8.55 Favored 'General case' 0 N--CA 1.449 -0.476 0 O-C-N 125.79 1.932 . . . . 0.0 108.889 -161.411 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -133.89 147.55 51.14 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 121.543 1.974 . . . . 0.0 114.976 154.144 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 13.7 t70 . . . . . 0 C--O 1.249 1.048 0 CA-C-O 115.59 -2.148 . . . . 0.0 113.51 -171.251 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . 0.449 ' HA3' ' O ' ' A' ' 14' ' ' TYR . . . . . . . . 0 CA--C 1.523 0.578 0 N-CA-C 117.138 1.615 . . . . 0.0 117.138 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 94.9 mt -125.06 -30.24 3.23 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 120.258 3.429 . . . . 0.0 120.258 177.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 70.5 m -143.57 -178.64 5.99 Favored 'General case' 0 N--CA 1.449 -0.522 0 O-C-N 125.556 1.785 . . . . 0.0 110.263 -176.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . 0.325 82.6 mm-40 -62.36 136.26 57.83 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 113.593 -1.639 . . . . 0.0 113.545 -174.109 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -174.3 -164.91 30.03 Favored Glycine 0 C--N 1.336 0.578 0 CA-C-N 119.764 1.166 . . . . 0.0 114.574 -176.162 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 12.1 t -87.21 -38.18 11.86 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 CA-C-N 111.819 -2.19 . . . . 0.0 110.986 -171.498 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -115.49 87.13 16.33 Favored Pre-proline 0 N--CA 1.449 -0.502 0 C-N-CA 131.031 3.733 . . . . 0.0 115.994 -164.142 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -64.26 140.73 72.21 Favored 'Trans proline' 0 N--CA 1.449 -1.109 0 C-N-CA 123.148 2.565 . . . . 0.0 109.42 -179.418 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -121.66 -88.0 0.63 Allowed 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 128.673 2.789 . . . . 0.0 111.138 -158.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 6.6 pt -130.3 160.77 41.11 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.475 0 CA-C-O 122.5 1.143 . . . . 0.0 110.989 165.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 66.98 -100.51 0.57 Allowed Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 125.454 1.502 . . . . 0.0 113.626 -177.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -137.04 1.15 2.44 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 116.538 2.051 . . . . 0.0 116.538 179.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 31.8 p -119.59 177.79 4.8 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.739 1.216 . . . . 0.0 110.306 -172.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.449 ' O ' ' HA3' ' A' ' 1' ' ' GLY . 6.2 m-85 -124.6 -83.61 0.64 Allowed 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.136 1.374 . . . . 0.0 113.98 -156.736 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -126.89 165.49 19.26 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.75 1.62 . . . . 0.0 111.921 172.338 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -85.99 50.75 2.04 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 124.744 2.212 . . . . 0.0 109.187 176.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 . . . . . 0 N--CA 1.45 -0.448 0 O-C-N 117.426 -3.296 . . . . 0.0 111.841 -166.826 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.434 0 N-CA-C 117.426 1.73 . . . . 0.0 117.426 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 62.4 mt -134.73 -29.18 1.18 Allowed 'General case' 0 N--CA 1.449 -0.502 0 CA-C-O 117.141 -1.409 . . . . 0.0 114.141 171.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 67.3 m -145.77 -161.76 1.37 Allowed 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 120.723 1.601 . . . . 0.0 107.44 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -62.46 164.26 7.62 Favored 'General case' 0 N--CA 1.448 -0.552 0 O-C-N 124.762 1.289 . . . . 0.0 114.287 -167.178 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 164.47 -152.28 21.91 Favored Glycine 0 C--N 1.334 0.466 0 C-N-CA 119.067 -1.539 . . . . 0.0 116.658 165.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 27.6 m -105.26 -20.04 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 C-N-CA 125.778 1.631 . . . . 0.0 114.605 169.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.52 ' HB3' ' CD1' ' A' ' 15' ' ' PHE . 6.5 tp10 -102.87 77.47 0.23 Allowed Pre-proline 0 N--CA 1.449 -0.497 0 C-N-CA 126.888 2.075 . . . . 0.0 115.72 -176.07 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_endo -66.11 143.34 71.3 Favored 'Trans proline' 0 N--CA 1.449 -1.128 0 O-C-N 117.205 -2.05 . . . . 0.0 107.465 -169.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -130.93 -84.86 0.52 Allowed 'General case' 0 N--CA 1.45 -0.463 1 C-N-CA 132.734 4.414 . . . . 0.0 110.056 -161.658 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 5.3 mt -97.0 97.48 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 O-C-N 124.732 1.27 . . . . 0.0 111.824 170.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 51.4 -100.01 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 126.033 1.778 . . . . 0.0 115.75 179.005 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -88.42 7.28 33.46 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 117.972 2.582 . . . . 0.0 117.972 177.29 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 7.4 p -119.41 172.58 7.52 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 116.754 2.131 . . . . 0.0 116.754 169.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 15.2 m-85 -137.83 -89.0 0.25 Allowed 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 126.649 1.98 . . . . 0.0 113.382 -160.382 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.52 ' CD1' ' HB3' ' A' ' 7' ' ' GLU . 25.0 m-85 -140.58 169.72 17.12 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 129.225 3.01 . . . . 0.0 109.319 179.327 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . 0.271 5.7 tp10 -88.25 60.85 5.94 Favored 'General case' 0 N--CA 1.45 -0.456 0 O-C-N 120.436 -1.415 . . . . 0.0 110.594 -160.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 . . . . . 0 N--CA 1.45 -0.469 0 CA-C-N 114.759 -1.11 . . . . 0.0 113.449 178.518 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.514 0 N-CA-C 120.91 3.124 . . . . 0.0 120.91 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 12.9 mt -128.9 -26.76 2.61 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 115.379 1.622 . . . . 0.0 115.379 179.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . 0.409 ' HB2' ' O ' ' A' ' 15' ' ' PHE . 61.3 m -147.03 -173.26 4.19 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 128.083 2.553 . . . . 0.0 109.478 -174.695 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 7.4 pm0 -55.02 171.54 0.14 Allowed 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 124.547 2.118 . . . . 0.0 114.334 176.319 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 166.3 -163.9 37.21 Favored Glycine 0 C--N 1.335 0.52 0 CA-C-O 126.425 3.236 . . . . 0.0 113.744 -176.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 16.1 m -130.13 -10.3 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 CA-C-N 111.412 -2.394 . . . . 0.0 113.064 179.474 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -114.59 84.43 9.95 Favored Pre-proline 0 N--CA 1.449 -0.482 0 C-N-CA 124.592 1.157 . . . . 0.0 110.842 174.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -63.88 148.04 91.92 Favored 'Trans proline' 0 N--CA 1.45 -1.086 0 CA-C-N 122.34 1.871 . . . . 0.0 108.955 -173.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -125.81 -58.36 1.4 Allowed 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 129.987 3.315 . . . . 0.0 109.221 -167.334 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 30.6 mm -83.01 175.54 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 C-N-CA 130.267 3.427 . . . . 0.0 109.042 165.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -54.09 -56.27 22.01 Favored Glycine 0 C--N 1.335 0.493 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 170.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -84.26 -33.76 23.96 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 127.726 2.41 . . . . 0.0 111.913 -175.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 27.9 p -132.94 173.65 11.18 Favored 'General case' 0 N--CA 1.45 -0.464 0 O-C-N 117.402 -3.311 . . . . 0.0 112.386 -155.536 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -128.22 -85.65 0.58 Allowed 'General case' 0 N--CA 1.45 -0.463 0 O-C-N 126.9 2.625 . . . . 0.0 116.455 -154.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.409 ' O ' ' HB2' ' A' ' 3' ' ' SER . 30.1 m-85 -137.43 169.35 17.94 Favored 'General case' 0 N--CA 1.448 -0.529 0 O-C-N 120.207 -1.558 . . . . 0.0 110.114 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -89.04 69.59 8.43 Favored 'General case' 0 N--CA 1.449 -0.5 0 O-C-N 118.393 -2.692 . . . . 0.0 108.505 175.196 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 . . . . . 0 N--CA 1.448 -0.537 0 CA-C-O 124.592 2.139 . . . . 0.0 112.02 -166.521 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.479 0 N-CA-C 117.353 1.701 . . . . 0.0 117.353 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . 0.351 0.5 OUTLIER -154.88 -17.11 0.12 Allowed 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 118.688 2.847 . . . . 0.0 118.688 165.557 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.0 m -130.92 165.88 22.15 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 126.719 2.008 . . . . 0.0 111.215 -177.119 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 22.7 mp0 -68.0 142.4 55.94 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 126.959 2.104 . . . . 0.0 110.607 -175.041 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -176.86 -150.23 8.18 Favored Glycine 0 CA--C 1.522 0.482 0 O-C-N 119.091 -2.256 . . . . 0.0 108.873 -175.548 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 43.5 t -117.91 -21.7 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 1 C-N-CA 133.224 4.61 . . . . 0.0 116.628 -173.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 13.4 tp10 -113.15 83.23 6.14 Favored Pre-proline 0 N--CA 1.449 -0.5 0 C-N-CA 127.222 2.209 . . . . 0.0 111.939 -177.414 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -68.93 146.98 67.16 Favored 'Trans proline' 0 N--CA 1.45 -1.088 0 C-N-CA 124.737 3.625 . . . . 0.0 109.28 -167.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -139.62 -74.77 0.36 Allowed 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 128.254 2.622 . . . . 0.0 111.716 -159.016 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 18.9 mm -112.1 141.51 27.37 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 N-CA-C 105.318 -2.104 . . . . 0.0 105.318 171.392 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 62.54 -91.41 0.07 OUTLIER Glycine 0 C--N 1.336 0.547 0 C-N-CA 127.503 2.478 . . . . 0.0 111.525 158.494 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 7.2 mm-40 -132.77 19.89 4.2 Favored 'General case' 0 N--CA 1.45 -0.464 1 C-N-CA 133.409 4.684 . . . . 0.0 113.532 178.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 80.3 p -141.86 164.16 30.94 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-O 125.369 2.509 . . . . 0.0 112.665 -170.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 14.6 m-85 -128.4 -87.73 0.55 Allowed 'General case' 0 N--CA 1.449 -0.496 0 O-C-N 118.814 -2.429 . . . . 0.0 115.108 -151.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -140.88 153.34 45.68 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-O 122.818 1.294 . . . . 0.0 110.995 176.022 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -62.92 98.13 0.12 Allowed 'General case' 0 N--CA 1.449 -0.506 0 O-C-N 118.348 -2.72 . . . . 0.0 116.313 -176.381 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 30.7 mm-40 . . . . . 0 N--CA 1.449 -0.494 0 C-N-CA 127.612 2.365 . . . . 0.0 108.942 177.477 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . 0.434 ' HA3' ' O ' ' A' ' 14' ' ' TYR . . . . . . . . 0 CA--C 1.522 0.521 0 N-CA-C 120.499 2.96 . . . . 0.0 120.499 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 55.2 mt -120.33 -39.3 2.8 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 115.841 -2.028 . . . . 0.0 116.446 -169.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.7 m -139.7 178.58 7.13 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 127.705 2.402 . . . . 0.0 110.237 -168.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 21.9 pt20 -74.8 156.66 36.28 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 124.711 1.205 . . . . 0.0 113.612 -168.029 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 164.24 -153.01 23.1 Favored Glycine 0 CA--C 1.523 0.554 0 C-N-CA 119.893 -1.146 . . . . 0.0 114.731 -171.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 20.1 m -120.85 -8.79 10.28 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 1 C-N-CA 136.097 5.759 . . . . 0.0 115.824 -165.204 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 19.0 tt0 -128.33 88.93 51.27 Favored Pre-proline 0 N--CA 1.45 -0.461 0 C-N-CA 129.081 2.952 . . . . 0.0 113.785 171.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -73.31 99.14 1.08 Allowed 'Trans proline' 0 N--CA 1.449 -1.116 0 C-N-CA 122.526 2.151 . . . . 0.0 110.863 -177.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -61.02 -59.14 5.85 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 126.66 1.984 . . . . 0.0 112.951 167.21 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.509 HG22 ' H ' ' A' ' 12' ' ' GLN . 7.6 mt -90.78 141.99 13.59 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 C-N-CA 128.923 2.889 . . . . 0.0 103.958 162.571 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -48.13 -32.57 9.53 Favored Glycine 0 CA--C 1.522 0.515 0 O-C-N 119.613 -1.93 . . . . 0.0 114.025 167.145 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.509 ' H ' HG22 ' A' ' 10' ' ' ILE 0.269 25.5 tt0 -67.38 -43.08 82.26 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 117.25 2.315 . . . . 0.0 117.25 168.603 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 16.5 p -149.12 150.89 33.45 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 120.649 3.574 . . . . 0.0 120.649 -164.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.434 ' O ' ' HA3' ' A' ' 1' ' ' GLY 0.27 0.7 OUTLIER -110.66 -102.95 0.39 Allowed 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 130.118 3.367 . . . . 0.0 115.981 -151.687 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 18.5 m-85 -136.16 167.55 21.06 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 169.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -73.6 60.53 0.68 Allowed 'General case' 0 N--CA 1.449 -0.488 0 O-C-N 126.738 2.524 . . . . 0.0 115.966 -158.303 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 . . . . . 0 N--CA 1.449 -0.508 0 C-N-CA 126.431 1.893 . . . . 0.0 110.106 -179.932 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.542 0 N-CA-C 122.434 3.733 . . . . 0.0 122.434 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 68.0 mt -126.53 -18.19 4.89 Favored 'General case' 0 N--CA 1.449 -0.514 0 O-C-N 129.241 3.553 . . . . 0.0 117.055 -172.133 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 70.2 m -144.91 176.65 9.31 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 131.3 3.84 . . . . 0.0 112.104 177.511 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 24.0 mp0 -70.67 156.77 39.04 Favored 'General case' 0 N--CA 1.448 -0.534 0 O-C-N 117.952 -2.968 . . . . 0.0 112.716 178.527 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 176.28 -139.55 4.61 Favored Glycine 0 CA--C 1.522 0.508 0 CA-C-O 121.763 0.646 . . . . 0.0 114.603 178.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 14.5 p -118.14 -17.0 7.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 O-C-N 119.652 -2.087 . . . . 0.0 113.141 -176.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -112.05 87.25 8.56 Favored Pre-proline 0 N--CA 1.45 -0.468 0 C-N-CA 128.683 2.793 . . . . 0.0 110.881 -172.11 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_endo -74.51 86.58 1.33 Allowed 'Trans proline' 0 N--CA 1.449 -1.14 0 CA-C-N 122.086 1.781 . . . . 0.0 112.829 -177.384 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -34.93 -82.73 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.519 1 C-N-CA 134.321 5.049 . . . . 0.0 111.958 154.055 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.444 HG22 ' N ' ' A' ' 11' ' ' GLY . 22.7 mm -76.27 174.7 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 O-C-N 118.77 -2.456 . . . . 0.0 106.747 163.04 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.444 ' N ' HG22 ' A' ' 10' ' ' ILE . . . -57.81 -51.45 58.03 Favored Glycine 0 C--N 1.336 0.536 0 O-C-N 118.129 -2.857 . . . . 0.0 114.602 154.612 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 21.3 tt0 -62.88 -47.33 83.78 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 120.122 3.379 . . . . 0.0 120.122 174.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 17.0 p -133.56 159.52 40.19 Favored 'General case' 0 N--CA 1.449 -0.483 0 O-C-N 117.163 -3.461 . . . . 0.0 116.872 -178.343 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 40.5 m-85 -111.11 -81.69 0.58 Allowed 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 124.911 1.284 . . . . 0.0 109.094 -158.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -149.86 156.29 41.52 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 178.524 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . 0.256 0.2 OUTLIER -79.34 77.04 5.89 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-O 116.975 -1.488 . . . . 0.0 109.092 -176.775 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 . . . . . 0 N--CA 1.45 -0.431 0 C-N-CA 128.049 2.539 . . . . 0.0 112.335 -165.807 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.464 0 CA-C-O 122.059 0.811 . . . . 0.0 112.732 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.8 pp -153.36 -2.53 0.21 Allowed 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 118.179 2.659 . . . . 0.0 118.179 168.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 49.6 m -147.48 173.61 12.5 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-O 123.386 1.565 . . . . 0.0 110.81 176.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 -52.87 146.3 11.0 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 128.479 2.711 . . . . 0.0 112.079 172.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 171.67 -178.31 44.02 Favored Glycine 0 C--N 1.335 0.526 1 O-C-N 115.789 -4.32 . . . . 0.0 114.254 -173.171 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 33.1 m -92.68 -18.08 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 C-N-CA 124.855 1.262 . . . . 0.0 113.05 -178.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 12.5 tt0 -121.71 82.9 41.83 Favored Pre-proline 0 N--CA 1.45 -0.438 0 C-N-CA 124.245 1.018 . . . . 0.0 113.332 -165.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.471 ' HA ' ' HA ' ' A' ' 14' ' ' TYR . 5.0 Cg_exo -64.79 142.72 77.5 Favored 'Trans proline' 0 N--CA 1.449 -1.105 0 C-N-CA 120.693 0.928 . . . . 0.0 110.22 -165.723 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -119.03 -72.39 0.69 Allowed 'General case' 0 N--CA 1.449 -0.512 1 C-N-CA 133.196 4.599 . . . . 0.0 109.388 -178.145 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 96.8 mt -72.37 -20.28 19.73 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 CA-C-N 119.686 1.13 . . . . 0.0 108.586 171.005 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 94.17 -47.51 2.19 Favored Glycine 0 C--N 1.335 0.503 0 CA-C-O 123.879 1.822 . . . . 0.0 110.15 -177.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 58.5 mm-40 -63.06 -42.85 99.77 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 112.736 -1.732 . . . . 0.0 109.399 164.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 75.9 p -130.41 176.13 8.4 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 127.848 2.459 . . . . 0.0 111.63 171.151 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.471 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 4.3 m-85 -131.96 -85.88 0.48 Allowed 'General case' 0 N--CA 1.449 -0.498 1 C-N-CA 133.045 4.538 . . . . 0.0 112.718 -153.327 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -145.04 153.87 41.92 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 121.19 1.814 . . . . 0.0 109.324 -175.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -39.3 133.09 1.36 Allowed 'General case' 0 N--CA 1.45 -0.464 0 O-C-N 119.479 -2.013 . . . . 0.0 115.312 153.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 . . . . . 0 N--CA 1.449 -0.502 0 C-N-CA 126.721 2.008 . . . . 0.0 109.365 -177.634 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.523 0 N-CA-C 119.378 2.511 . . . . 0.0 119.378 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 50.5 mt -128.22 -28.11 2.63 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 117.518 2.414 . . . . 0.0 117.518 -179.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.2 m -132.23 171.59 13.49 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 128.192 2.597 . . . . 0.0 111.961 -177.071 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 31.3 mt-30 -63.43 137.87 58.31 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 127.728 2.411 . . . . 0.0 106.43 168.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -170.03 -150.28 6.79 Favored Glycine 0 CA--C 1.523 0.551 0 C-N-CA 119.28 -1.438 . . . . 0.0 111.262 -174.199 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 9.8 p -117.42 -19.22 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 N-CA-C 117.237 2.31 . . . . 0.0 117.237 -177.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 55.0 tt0 -113.06 82.62 5.52 Favored Pre-proline 0 N--CA 1.449 -0.482 0 C-N-CA 126.831 2.052 . . . . 0.0 111.442 -178.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_endo -60.67 144.32 99.53 Favored 'Trans proline' 0 N--CA 1.449 -1.09 0 C-N-CA 124.018 3.146 . . . . 0.0 113.994 -172.186 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -135.87 -81.2 0.41 Allowed 'General case' 0 N--CA 1.449 -0.483 1 C-N-CA 132.337 4.255 . . . . 0.0 107.947 -162.235 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 11.7 mm -87.75 169.67 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 O-C-N 119.81 -1.806 . . . . 0.0 108.926 174.001 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -25.03 -58.08 0.06 OUTLIER Glycine 0 C--N 1.336 0.533 0 C-N-CA 130.589 3.947 . . . . 0.0 114.404 168.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 17.4 tt0 -100.8 -22.37 14.88 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 118.712 2.856 . . . . 0.0 118.712 178.261 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 33.0 p -118.1 174.09 6.41 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 115.711 1.745 . . . . 0.0 115.711 -167.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 67.6 m-85 -132.75 -82.16 0.48 Allowed 'General case' 0 N--CA 1.449 -0.48 0 O-C-N 126.018 2.074 . . . . 0.0 110.135 -160.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -144.53 162.43 36.61 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 128.363 2.665 . . . . 0.0 110.432 177.31 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -73.1 59.21 0.52 Allowed 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 128.2 2.6 . . . . 0.0 113.655 177.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 62.8 mt-10 . . . . . 0 N--CA 1.449 -0.503 0 CA-C-O 125.424 2.535 . . . . 0.0 112.96 -176.986 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.546 0 CA-C-O 118.246 -1.308 . . . . 0.0 115.544 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -142.41 5.49 1.64 Allowed 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 117.735 2.494 . . . . 0.0 117.735 -179.14 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 38.2 m -118.48 -172.28 2.24 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 130.7 3.6 . . . . 0.0 117.565 -169.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 29.0 mt-30 -95.29 122.75 38.31 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 125.381 1.472 . . . . 0.0 111.649 171.61 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 176.87 -162.97 31.58 Favored Glycine 0 C--N 1.336 0.532 0 N-CA-C 109.104 -1.599 . . . . 0.0 109.104 -164.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 45.3 t -116.05 -16.27 8.95 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 1 C-N-CA 132.854 4.462 . . . . 0.0 115.233 -155.45 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 50.7 tt0 -114.39 88.98 16.57 Favored Pre-proline 0 N--CA 1.448 -0.541 0 O-C-N 119.267 -2.146 . . . . 0.0 109.271 177.15 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -67.42 110.39 2.04 Favored 'Trans proline' 0 N--CA 1.45 -1.061 0 C-N-CA 124.956 3.771 . . . . 0.0 111.988 -178.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -90.29 -86.42 0.2 Allowed 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 126.205 1.802 . . . . 0.0 109.909 -159.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 9.2 mt -88.63 65.5 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 CA-C-O 126.716 3.15 . . . . 0.0 106.844 177.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 53.17 -87.64 0.01 OUTLIER Glycine 0 C--N 1.335 0.503 0 C-N-CA 127.681 2.562 . . . . 0.0 118.173 -166.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 44.6 tt0 -58.87 -30.39 67.71 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 119.737 3.236 . . . . 0.0 119.737 -169.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 24.3 p -127.36 172.16 10.89 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 126.873 2.069 . . . . 0.0 110.901 174.406 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 41.9 m-85 -125.58 174.15 8.45 Favored 'General case' 0 N--CA 1.45 -0.457 1 C-N-CA 133.289 4.636 . . . . 0.0 111.706 -153.528 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -54.92 134.85 48.7 Favored 'General case' 0 N--CA 1.449 -0.505 0 O-C-N 124.217 0.948 . . . . 0.0 109.878 175.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . 0.306 30.6 tt0 -59.12 65.67 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 130.926 3.69 . . . . 0.0 111.875 159.216 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . 0.276 29.5 tt0 . . . . . 0 N--CA 1.449 -0.511 0 C-N-CA 127.21 2.204 . . . . 0.0 111.391 178.062 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.495 0 N-CA-C 116.146 1.218 . . . . 0.0 116.146 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -158.85 -1.66 0.09 Allowed 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 117.59 2.441 . . . . 0.0 117.59 177.418 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 25.9 m -149.45 167.31 26.58 Favored 'General case' 0 N--CA 1.45 -0.468 0 O-C-N 118.418 -2.676 . . . . 0.0 114.082 -175.418 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 40.6 mt-30 -61.46 138.18 58.26 Favored 'General case' 0 N--CA 1.449 -0.499 0 O-C-N 120.358 -1.464 . . . . 0.0 112.413 -177.243 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 178.1 -153.03 12.27 Favored Glycine 0 CA--C 1.523 0.556 0 O-C-N 121.099 -1.001 . . . . 0.0 114.093 -167.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 63.6 t -124.66 -20.52 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 C-N-CA 125.816 1.647 . . . . 0.0 113.118 -168.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 28.8 tp10 -105.62 89.27 3.29 Favored Pre-proline 0 N--CA 1.45 -0.465 0 CA-C-O 116.224 -1.846 . . . . 0.0 111.091 173.161 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -60.19 140.32 91.63 Favored 'Trans proline' 0 N--CA 1.449 -1.143 0 C-N-CA 123.31 2.673 . . . . 0.0 113.457 178.285 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 38.1 t0 -128.57 -93.94 0.44 Allowed 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 126.089 1.755 . . . . 0.0 111.857 -164.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 28.3 mm -107.27 143.88 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 C-N-CA 126.419 1.888 . . . . 0.0 108.748 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 56.52 -89.72 0.01 OUTLIER Glycine 0 C--N 1.336 0.53 0 C-N-CA 126.971 2.224 . . . . 0.0 115.226 174.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -134.04 4.04 3.48 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 116.083 1.883 . . . . 0.0 116.083 176.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.421 ' HB ' ' H ' ' A' ' 14' ' ' TYR . 42.8 p -114.31 -177.25 3.08 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 -179.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.421 ' H ' ' HB ' ' A' ' 13' ' ' THR . 0.5 OUTLIER -131.08 -170.71 2.41 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 131.159 3.784 . . . . 0.0 110.877 -160.717 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -68.53 150.89 47.52 Favored 'General case' 0 N--CA 1.449 -0.516 0 O-C-N 119.07 -2.269 . . . . 0.0 109.866 177.304 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -63.68 87.71 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 128.07 2.548 . . . . 0.0 113.566 174.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 . . . . . 0 N--CA 1.449 -0.502 0 CA-C-O 123.162 1.458 . . . . 0.0 112.53 159.928 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.483 0 N-CA-C 111.131 -0.788 . . . . 0.0 111.131 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 78.9 mt -144.69 -12.86 0.57 Allowed 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.682 1.593 . . . . 0.0 113.177 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 6.1 t -138.68 -152.12 0.41 Allowed 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 127.87 2.468 . . . . 0.0 113.176 -166.349 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -116.7 156.92 26.3 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 125.128 1.371 . . . . 0.0 110.072 173.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 164.86 -144.37 9.28 Favored Glycine 0 N--CA 1.448 -0.547 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.46 -171.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 18.6 m -120.97 -15.56 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 -175.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 33.2 mm-40 -107.83 96.78 18.2 Favored Pre-proline 0 N--CA 1.449 -0.479 0 O-C-N 119.689 -1.882 . . . . 0.0 112.74 174.651 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -74.24 101.89 1.47 Allowed 'Trans proline' 0 N--CA 1.45 -1.033 0 C-N-CA 123.463 2.776 . . . . 0.0 109.853 -179.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -68.22 -63.12 1.12 Allowed 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 129.252 3.021 . . . . 0.0 112.492 176.578 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.404 HG22 ' H ' ' A' ' 12' ' ' GLN . 27.1 mt -75.89 157.21 5.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 N-CA-C 106.753 -1.573 . . . . 0.0 106.753 162.795 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -41.64 -48.27 4.92 Favored Glycine 0 CA--C 1.523 0.573 0 O-C-N 119.467 -2.021 . . . . 0.0 112.972 164.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.404 ' H ' HG22 ' A' ' 10' ' ' ILE . 39.1 tt0 -76.13 -47.66 23.53 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 116.597 2.073 . . . . 0.0 116.597 179.052 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 35.9 p -129.24 164.09 24.21 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 127.288 2.235 . . . . 0.0 116.034 -160.251 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 13.9 m-85 -121.79 178.22 4.95 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 126.353 1.861 . . . . 0.0 110.905 -161.717 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -62.91 144.71 56.47 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 -179.197 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -61.89 106.58 0.71 Allowed 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 125.97 1.708 . . . . 0.0 109.175 178.599 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 . . . . . 0 N--CA 1.449 -0.5 0 CA-C-N 114.239 -1.346 . . . . 0.0 112.627 173.67 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.526 0 N-CA-C 117.45 1.74 . . . . 0.0 117.45 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 95.0 mt -137.7 -37.05 0.61 Allowed 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 116.566 2.062 . . . . 0.0 116.566 171.541 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.5 m -138.97 -162.14 1.28 Allowed 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 125.164 1.386 . . . . 0.0 112.325 -175.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 70.8 mt-30 -54.15 165.35 0.52 Allowed 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 114.351 1.241 . . . . 0.0 114.351 175.529 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 160.29 -173.79 36.94 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.95 -0.643 . . . . 0.0 114.196 160.135 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 13.7 p -91.3 -7.09 10.73 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 C-N-CA 125.812 1.645 . . . . 0.0 113.468 178.479 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -121.94 90.75 48.72 Favored Pre-proline 0 N--CA 1.449 -0.517 0 C-N-CA 125.644 1.578 . . . . 0.0 111.094 -171.412 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_exo -51.19 140.85 40.57 Favored 'Trans proline' 0 N--CA 1.45 -1.067 0 C-N-CA 121.912 1.742 . . . . 0.0 113.121 174.338 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -128.74 -53.38 1.24 Allowed 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 126.229 1.812 . . . . 0.0 109.242 -175.136 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.474 HG22 ' H ' ' A' ' 11' ' ' GLY . 3.0 mt -121.98 172.68 8.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 C-N-CA 125.823 1.649 . . . . 0.0 108.064 172.46 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.474 ' H ' HG22 ' A' ' 10' ' ' ILE . . . -46.58 -42.74 14.51 Favored Glycine 0 C--N 1.335 0.501 0 C-N-CA 126.202 1.858 . . . . 0.0 116.138 178.586 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 45.2 tt0 -92.85 -36.25 12.93 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 116.763 2.135 . . . . 0.0 116.763 176.058 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 82.2 p -124.38 167.7 14.03 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 119.587 -1.946 . . . . 0.0 115.972 -160.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 16.9 m-85 -131.64 -83.57 0.51 Allowed 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.982 1.313 . . . . 0.0 111.664 -161.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -141.02 171.15 14.47 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 125.556 1.543 . . . . 0.0 110.714 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -80.09 59.46 3.29 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 121.98 2.173 . . . . 0.0 111.87 177.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 . . . . . 0 N--CA 1.45 -0.463 0 C-N-CA 126.372 1.869 . . . . 0.0 111.623 -175.392 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.534 0 CA-C-O 123.002 1.335 . . . . 0.0 114.979 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . 0.542 ' H ' HD23 ' A' ' 2' ' ' LEU . 2.1 pt? -130.11 -5.79 4.41 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 129.317 3.047 . . . . 0.0 113.546 -174.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 26.6 m -120.56 -166.14 1.29 Allowed 'General case' 0 N--CA 1.448 -0.533 0 O-C-N 126.805 2.566 . . . . 0.0 114.772 -162.445 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 20.1 mp0 -102.68 155.76 18.09 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 119.42 1.009 . . . . 0.0 110.41 161.074 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 161.89 -165.16 35.68 Favored Glycine 0 CA--C 1.523 0.568 0 O-C-N 119.462 -2.024 . . . . 0.0 113.776 -177.614 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 14.0 p -69.68 -26.95 31.81 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 N-CA-C 119.203 3.038 . . . . 0.0 119.203 174.175 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 16.2 tp10 -118.12 90.12 36.75 Favored Pre-proline 0 N--CA 1.449 -0.515 0 O-C-N 118.324 -2.735 . . . . 0.0 114.691 -164.198 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . 0.326 17.8 Cg_endo -60.74 127.72 23.43 Favored 'Trans proline' 0 N--CA 1.449 -1.115 0 CA-C-O 125.371 2.154 . . . . 0.0 114.6 173.029 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 49.9 t0 -117.63 -88.76 0.6 Allowed 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 128.282 2.633 . . . . 0.0 115.17 -161.047 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.6 mm -99.86 144.34 12.41 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 C-N-CA 126.946 2.098 . . . . 0.0 106.471 163.562 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -45.56 143.5 3.63 Favored Glycine 0 CA--C 1.522 0.531 0 N-CA-C 121.338 3.295 . . . . 0.0 121.338 -163.747 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 15.7 tt0 62.39 -15.38 0.05 Allowed 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 109.966 -3.117 . . . . 0.0 114.323 -163.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . 0.277 24.9 p -122.28 168.54 11.91 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 126.01 2.814 . . . . 0.0 112.82 -166.006 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -134.5 162.69 31.56 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 128.041 2.536 . . . . 0.0 111.317 -166.166 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -57.73 145.58 34.09 Favored 'General case' 0 N--CA 1.449 -0.518 0 O-C-N 119.5 -2.0 . . . . 0.0 109.677 172.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -70.49 84.91 0.6 Allowed 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 127.931 2.492 . . . . 0.0 112.004 -169.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 . . . . . 0 N--CA 1.449 -0.511 0 C-N-CA 126.682 1.993 . . . . 0.0 111.828 174.544 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.546 0 N-CA-C 111.764 -0.535 . . . . 0.0 111.764 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -160.68 10.49 0.1 Allowed 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 126.36 1.864 . . . . 0.0 114.926 -169.377 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 53.8 m -131.58 169.85 15.55 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-O 115.017 -2.42 . . . . 0.0 117.137 164.294 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 16.9 mm100 -57.91 145.93 33.92 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 122.898 2.59 . . . . 0.0 111.317 164.263 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 169.17 -152.01 18.95 Favored Glycine 0 C--N 1.335 0.519 0 N-CA-C 116.911 1.524 . . . . 0.0 116.911 174.382 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.9 t -97.44 -18.63 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 O-C-N 127.08 2.282 . . . . 0.0 117.027 -177.518 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.503 ' O ' ' HA ' ' A' ' 14' ' ' TYR . 4.2 tp10 -125.88 92.42 46.22 Favored Pre-proline 0 N--CA 1.449 -0.518 0 N-CA-C 106.649 -1.611 . . . . 0.0 106.649 -168.048 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -71.99 94.98 0.73 Allowed 'Trans proline' 0 N--CA 1.448 -1.153 0 C-N-CA 124.409 3.406 . . . . 0.0 110.048 173.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -64.26 -52.28 59.44 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 130.734 3.613 . . . . 0.0 109.88 -177.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.441 HG22 ' H ' ' A' ' 12' ' ' GLN . 47.3 mm -85.12 160.03 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 161.282 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -51.3 -41.22 47.13 Favored Glycine 0 CA--C 1.523 0.534 0 CA-C-O 124.774 2.319 . . . . 0.0 114.806 173.472 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.441 ' H ' HG22 ' A' ' 10' ' ' ILE . 8.9 tt0 -61.99 -81.21 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 128.258 2.623 . . . . 0.0 111.506 172.314 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . 0.273 0.7 OUTLIER -121.79 178.28 4.93 Favored 'General case' 0 N--CA 1.449 -0.517 0 O-C-N 117.794 -3.066 . . . . 0.0 117.196 -167.563 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.503 ' HA ' ' O ' ' A' ' 7' ' ' GLU . 0.7 OUTLIER -117.13 170.67 8.48 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 130.82 3.648 . . . . 0.0 112.259 -154.79 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -51.64 137.23 25.4 Favored 'General case' 0 N--CA 1.449 -0.491 0 O-C-N 118.923 -2.361 . . . . 0.0 109.478 -174.552 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -46.52 125.02 6.47 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 129.69 3.196 . . . . 0.0 113.539 -175.675 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 . . . . . 0 N--CA 1.449 -0.505 0 CA-C-N 122.307 2.322 . . . . 0.0 106.501 -168.167 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.493 0 CA-C-O 119.503 -0.609 . . . . 0.0 113.315 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -121.23 12.15 10.95 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 126.874 2.07 . . . . 0.0 114.33 -177.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -118.82 -148.65 0.42 Allowed 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 128.351 2.661 . . . . 0.0 110.94 178.772 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 15.4 mp0 -122.15 152.49 39.87 Favored 'General case' 0 N--CA 1.45 -0.45 0 O-C-N 116.959 -3.588 . . . . 0.0 115.042 167.002 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 170.57 -138.11 4.79 Favored Glycine 0 C--N 1.336 0.543 0 CA-C-N 113.055 -1.884 . . . . 0.0 112.291 -170.577 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 13.1 m -128.15 -8.64 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 CA-C-N 119.464 1.632 . . . . 0.0 110.647 -175.442 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -112.36 81.46 4.0 Favored Pre-proline 0 N--CA 1.449 -0.508 0 N-CA-C 116.442 2.015 . . . . 0.0 116.442 173.406 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -65.89 136.61 45.83 Favored 'Trans proline' 0 N--CA 1.449 -1.101 0 C-N-CA 123.439 2.759 . . . . 0.0 107.367 -179.418 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -130.8 -102.42 0.29 Allowed 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 109.61 -3.45 . . . . 0.0 110.074 -151.758 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 17.1 mt -70.8 88.83 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 CA-C-N 122.706 2.503 . . . . 0.0 110.447 168.224 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 46.82 -107.9 0.24 Allowed Glycine 0 CA--C 1.523 0.537 0 O-C-N 117.173 -3.455 . . . . 0.0 117.179 -175.102 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -64.58 -10.71 28.15 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 120.05 3.352 . . . . 0.0 120.05 179.227 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 46.2 p -124.06 159.92 28.86 Favored 'General case' 0 N--CA 1.449 -0.5 0 O-C-N 125.572 1.795 . . . . 0.0 113.541 -173.315 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -124.6 175.73 7.0 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 131.48 3.912 . . . . 0.0 112.729 -160.443 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -57.78 156.4 8.82 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 115.835 1.791 . . . . 0.0 115.835 -177.707 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -69.87 88.0 0.55 Allowed 'General case' 0 N--CA 1.449 -0.509 0 O-C-N 118.299 -2.751 . . . . 0.0 115.814 -166.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 . . . . . 0 N--CA 1.449 -0.488 0 C-N-CA 131.228 3.811 . . . . 0.0 112.274 164.077 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . 0.437 ' HA3' ' HB3' ' A' ' 9' ' ' ASP . . . . . . . . 0 CA--C 1.522 0.503 0 N-CA-C 116.59 1.396 . . . . 0.0 116.59 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -158.61 -3.93 0.08 Allowed 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 121.232 3.79 . . . . 0.0 121.232 171.133 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . 0.421 ' HB2' ' HA ' ' A' ' 16' ' ' GLU . 17.7 m -150.17 -177.05 5.71 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 129.744 3.218 . . . . 0.0 111.311 175.195 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -63.3 162.44 12.18 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 130.618 3.567 . . . . 0.0 111.771 -170.535 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 163.21 -173.27 39.35 Favored Glycine 0 C--N 1.335 0.495 0 N-CA-C 118.303 2.081 . . . . 0.0 118.303 -170.273 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 20.2 m -111.51 -14.85 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 C-N-CA 128.102 2.561 . . . . 0.0 113.65 171.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -105.91 77.78 0.44 Allowed Pre-proline 0 N--CA 1.449 -0.514 0 C-N-CA 128.144 2.577 . . . . 0.0 115.625 177.158 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -63.87 96.8 0.22 Allowed 'Trans proline' 0 N--CA 1.449 -1.089 0 CA-C-O 124.301 1.709 . . . . 0.0 113.643 -176.391 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.437 ' HB3' ' HA3' ' A' ' 1' ' ' GLY . 0.2 OUTLIER -62.27 -66.62 0.51 Allowed 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 130.443 3.497 . . . . 0.0 112.37 -165.507 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . 0.254 42.8 pt -109.41 -166.39 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 CA-C-N 113.277 -1.783 . . . . 0.0 112.363 169.229 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -45.75 -47.21 13.54 Favored Glycine 0 C--N 1.335 0.514 0 N-CA-C 118.491 2.157 . . . . 0.0 118.491 -178.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 20.6 mp0 -121.84 150.39 41.99 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 129.605 3.162 . . . . 0.0 107.408 174.325 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.46 ' HA ' ' CD1' ' A' ' 14' ' ' TYR 0.28 4.7 p 56.38 179.45 0.04 OUTLIER 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 111.127 -2.76 . . . . 0.0 113.973 179.386 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.46 ' CD1' ' HA ' ' A' ' 13' ' ' THR . 2.2 m-85 -133.53 -99.06 0.27 Allowed 'General case' 0 N--CA 1.449 -0.518 0 O-C-N 117.823 -3.048 . . . . 0.0 111.203 -148.017 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -133.9 161.88 33.55 Favored 'General case' 0 N--CA 1.45 -0.475 0 CA-C-O 126.807 3.194 . . . . 0.0 107.363 -179.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.421 ' HA ' ' HB2' ' A' ' 3' ' ' SER . 21.0 tt0 -74.11 70.48 1.58 Allowed 'General case' 0 N--CA 1.449 -0.497 0 O-C-N 117.837 -3.039 . . . . 0.0 114.158 -175.334 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 . . . . . 0 N--CA 1.449 -0.518 0 C-N-CA 131.229 3.812 . . . . 0.0 116.008 175.146 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.501 0 N-CA-C 115.529 0.972 . . . . 0.0 115.529 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -159.41 -10.92 0.06 Allowed 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 115.98 1.844 . . . . 0.0 115.98 171.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 37.8 m -127.42 164.75 21.19 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 122.756 2.525 . . . . 0.0 116.003 -172.123 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -66.95 129.06 38.66 Favored 'General case' 0 N--CA 1.449 -0.519 0 O-C-N 120.532 -1.355 . . . . 0.0 110.581 -179.369 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -167.76 -151.88 7.24 Favored Glycine 0 C--N 1.334 0.449 0 N-CA-C 119.133 2.413 . . . . 0.0 119.133 -169.59 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 6.2 t -129.1 -19.15 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 C-N-CA 129.698 3.199 . . . . 0.0 113.911 -168.28 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -116.34 95.58 45.66 Favored Pre-proline 0 N--CA 1.45 -0.473 0 CA-C-O 117.49 -1.243 . . . . 0.0 111.637 171.58 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -74.76 90.5 1.05 Allowed 'Trans proline' 0 N--CA 1.449 -1.101 0 CA-C-N 124.092 2.497 . . . . 0.0 112.427 -175.286 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -52.34 -60.92 2.64 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 130.898 3.679 . . . . 0.0 111.458 170.652 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 20.9 pt -108.34 176.88 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 CA-C-O 124.424 2.059 . . . . 0.0 111.477 178.193 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -66.59 113.08 5.39 Favored Glycine 0 C--N 1.336 0.536 0 C-N-CA 128.438 2.923 . . . . 0.0 113.649 161.052 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 14.9 tt0 55.01 86.45 0.05 Allowed 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 128.526 2.73 . . . . 0.0 115.81 -159.792 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . 0.358 30.7 p 114.67 179.14 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.488 1 C-N-CA 133.63 4.772 . . . . 0.0 118.508 159.889 . . . . . . . . 3 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -129.59 -168.95 2.02 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 128.627 2.771 . . . . 0.0 108.373 -151.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -64.03 163.51 12.16 Favored 'General case' 0 N--CA 1.45 -0.466 0 O-C-N 119.401 -2.062 . . . . 0.0 113.102 -178.396 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -76.75 85.68 3.37 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-O 126.819 3.2 . . . . 0.0 113.459 178.577 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.448 -0.542 0 CA-C-N 110.558 -3.019 . . . . 0.0 116.609 173.349 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.57 0 N-CA-C 114.052 0.381 . . . . 0.0 114.052 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 79.1 mt -139.61 -13.11 1.13 Allowed 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 126.312 1.845 . . . . 0.0 114.664 179.45 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 73.6 m -144.56 177.76 8.44 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-O 123.798 1.761 . . . . 0.0 109.395 -178.372 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 32.1 mt-30 -56.72 154.79 8.49 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 118.91 -2.369 . . . . 0.0 112.384 160.044 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 157.2 -156.39 27.19 Favored Glycine 0 C--N 1.335 0.516 0 O-C-N 118.773 -2.454 . . . . 0.0 114.453 178.556 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 16.8 m -110.26 -6.89 11.38 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 118.991 2.96 . . . . 0.0 118.991 -173.126 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 30.2 mm-40 -112.03 83.22 4.74 Favored Pre-proline 0 N--CA 1.45 -0.473 0 CA-C-O 116.012 -1.947 . . . . 0.0 114.476 176.102 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -64.59 142.53 77.97 Favored 'Trans proline' 0 N--CA 1.45 -1.074 0 C-N-CA 123.525 2.817 . . . . 0.0 111.44 -168.378 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -140.48 -79.88 0.28 Allowed 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 118.12 2.637 . . . . 0.0 118.12 -157.012 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.401 HG22 ' H ' ' A' ' 11' ' ' GLY . 8.0 mm -91.46 161.06 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 N-CA-C 102.965 -2.976 . . . . 0.0 102.965 165.371 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.401 ' H ' HG22 ' A' ' 10' ' ' ILE . . . -47.23 -18.64 0.52 Allowed Glycine 0 C--N 1.335 0.506 0 CA-C-N 113.633 -1.621 . . . . 0.0 117.135 -170.879 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 71.5 mt-30 -123.96 -8.56 7.76 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 129.822 3.249 . . . . 0.0 114.595 -171.568 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 64.0 p -137.98 178.79 6.86 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 117.39 2.367 . . . . 0.0 117.39 -166.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 -134.01 -97.99 0.27 Allowed 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 127.277 2.231 . . . . 0.0 112.421 -165.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 14.7 m-85 -142.81 150.28 39.74 Favored 'General case' 0 N--CA 1.449 -0.478 0 O-C-N 121.047 -1.033 . . . . 0.0 112.211 166.67 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -60.11 82.85 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.481 0 CA-C-O 127.231 3.396 . . . . 0.0 111.486 -174.373 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 . . . . . 0 N--CA 1.449 -0.478 1 O-C-N 116.181 -4.074 . . . . 0.0 112.08 164.454 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.538 0 N-CA-C 116.509 1.364 . . . . 0.0 116.509 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -152.58 -8.47 0.19 Allowed 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 120.7 3.592 . . . . 0.0 120.7 157.412 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 21.4 m -134.01 -179.23 5.42 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 123.318 2.781 . . . . 0.0 115.816 174.289 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 22.6 mp0 -64.39 129.81 41.33 Favored 'General case' 0 N--CA 1.448 -0.527 0 O-C-N 118.197 -2.815 . . . . 0.0 113.956 -176.622 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -170.76 -149.16 6.3 Favored Glycine 0 C--N 1.336 0.539 0 CA-C-O 124.156 1.975 . . . . 0.0 113.048 171.541 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 26.7 m -117.01 -13.65 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 O-C-N 116.47 -3.959 . . . . 0.0 114.083 -171.349 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 23.6 tp10 -103.64 82.35 0.53 Allowed Pre-proline 0 N--CA 1.449 -0.479 0 O-C-N 126.943 2.652 . . . . 0.0 117.315 171.703 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.458 ' HB3' ' CE2' ' A' ' 14' ' ' TYR . 15.0 Cg_endo -64.47 149.75 89.44 Favored 'Trans proline' 0 N--CA 1.449 -1.136 0 C-N-CA 122.384 2.056 . . . . 0.0 108.683 -169.581 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -138.51 -92.25 0.2 Allowed 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 112.512 -2.131 . . . . 0.0 107.775 -159.34 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 6.4 mt -97.35 152.4 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 CA-C-O 117.138 -1.411 . . . . 0.0 107.217 169.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -36.35 141.81 0.19 Allowed Glycine 0 C--N 1.336 0.57 0 C-N-CA 129.534 3.445 . . . . 0.0 110.367 176.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 6.2 tm0? 58.13 -11.59 0.03 OUTLIER 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 116.962 2.208 . . . . 0.0 116.962 -168.186 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 22.6 p -133.73 168.07 19.37 Favored 'General case' 0 N--CA 1.45 -0.467 1 O-C-N 114.283 -5.261 . . . . 0.0 117.644 -170.221 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.458 ' CE2' ' HB3' ' A' ' 8' ' ' PRO . 9.1 m-85 -127.79 -82.92 0.6 Allowed 'General case' 0 N--CA 1.449 -0.48 0 CA-C-O 126.762 3.172 . . . . 0.0 112.316 -172.027 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.408 ' CD1' ' O ' ' A' ' 14' ' ' TYR . 19.7 m-85 -140.58 141.85 35.16 Favored 'General case' 0 N--CA 1.45 -0.469 1 O-C-N 116.11 -4.118 . . . . 0.0 113.463 175.887 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -59.03 84.83 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.484 0 CA-C-O 117.567 -1.206 . . . . 0.0 113.874 166.483 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 . . . . . 0 N--CA 1.45 -0.46 0 N-CA-C 116.237 1.939 . . . . 0.0 116.237 -166.57 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.504 0 N-CA-C 118.233 2.053 . . . . 0.0 118.233 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -143.46 -11.64 0.71 Allowed 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 128.328 2.651 . . . . 0.0 117.916 -176.812 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 69.5 m -114.84 -174.01 2.41 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 127.85 2.46 . . . . 0.0 110.245 -164.59 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -102.76 135.27 44.72 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 128.83 2.852 . . . . 0.0 109.68 161.782 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 176.47 -158.5 24.81 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 108.126 -1.99 . . . . 0.0 108.126 -157.307 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.2 p -130.06 -0.27 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 O-C-N 121.29 -1.124 . . . . 0.0 111.743 -167.637 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 27.1 tp10 -116.56 107.58 46.56 Favored Pre-proline 0 N--CA 1.449 -0.522 1 O-C-N 115.477 -4.514 . . . . 0.0 102.673 163.687 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -66.02 142.91 70.24 Favored 'Trans proline' 0 N--CA 1.449 -1.146 0 CA-C-O 127.324 2.969 . . . . 0.0 110.867 169.194 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -119.58 -94.1 0.51 Allowed 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 110.545 -3.025 . . . . 0.0 109.477 -165.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 24.5 pt -118.36 154.73 20.48 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 C-N-CA 130.047 3.339 . . . . 0.0 109.7 177.026 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 45.15 -111.13 0.51 Allowed Glycine 0 C--N 1.335 0.498 0 C-N-CA 127.178 2.323 . . . . 0.0 112.388 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 71.8 mm-40 -97.36 -1.43 44.53 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-O 124.979 2.323 . . . . 0.0 115.624 -177.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 18.3 p -128.41 176.8 7.44 Favored 'General case' 0 N--CA 1.45 -0.429 0 O-C-N 117.075 -3.516 . . . . 0.0 110.636 -155.111 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 16.8 m-85 -127.92 173.09 10.3 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 125.415 1.486 . . . . 0.0 113.051 -165.544 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -53.31 141.34 24.38 Favored 'General case' 0 N--CA 1.448 -0.526 0 O-C-N 117.991 -2.943 . . . . 0.0 112.046 169.548 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . 0.445 30.4 tt0 -55.34 90.67 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 118.856 2.91 . . . . 0.0 118.856 174.672 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 29.7 tp10 . . . . . 0 N--CA 1.449 -0.516 0 N-CA-C 114.448 1.277 . . . . 0.0 114.448 166.022 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.449 ' HA3' ' O ' ' A' ' 14' ' ' TYR . . . . . . . . 0 CA--C 1.523 0.578 0 N-CA-C 117.138 1.615 . . . . 0.0 117.138 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 94.9 mt -125.06 -30.24 3.23 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 120.258 3.429 . . . . 0.0 120.258 177.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 70.5 m -143.57 -178.64 5.99 Favored 'General case' 0 N--CA 1.449 -0.522 0 O-C-N 125.556 1.785 . . . . 0.0 110.263 -176.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . 0.325 82.6 mm-40 -62.36 136.26 57.83 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 113.593 -1.639 . . . . 0.0 113.545 -174.109 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -174.3 -164.91 30.03 Favored Glycine 0 C--N 1.336 0.578 0 CA-C-N 119.764 1.166 . . . . 0.0 114.574 -176.162 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 12.1 t -87.21 -38.18 11.86 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 CA-C-N 111.819 -2.19 . . . . 0.0 110.986 -171.498 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -115.49 87.13 16.33 Favored Pre-proline 0 N--CA 1.449 -0.502 0 C-N-CA 131.031 3.733 . . . . 0.0 115.994 -164.142 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -64.26 140.73 72.21 Favored 'Trans proline' 0 N--CA 1.449 -1.109 0 C-N-CA 123.148 2.565 . . . . 0.0 109.42 -179.418 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -121.66 -88.0 0.63 Allowed 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 128.673 2.789 . . . . 0.0 111.138 -158.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 6.6 pt -130.3 160.77 41.11 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.475 0 CA-C-O 122.5 1.143 . . . . 0.0 110.989 165.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 66.98 -100.51 0.57 Allowed Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 125.454 1.502 . . . . 0.0 113.626 -177.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -137.04 1.15 2.44 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 116.538 2.051 . . . . 0.0 116.538 179.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 31.8 p -119.59 177.79 4.8 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.739 1.216 . . . . 0.0 110.306 -172.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.449 ' O ' ' HA3' ' A' ' 1' ' ' GLY . 6.2 m-85 -124.6 -83.61 0.64 Allowed 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.136 1.374 . . . . 0.0 113.98 -156.736 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -126.89 165.49 19.26 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.75 1.62 . . . . 0.0 111.921 172.338 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -85.99 50.75 2.04 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 124.744 2.212 . . . . 0.0 109.187 176.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -60.93 140.71 57.67 Favored 'General case' 0 N--CA 1.45 -0.448 0 O-C-N 117.426 -3.296 . . . . 0.0 111.841 -166.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 43.4 m -70.35 46.19 0.08 Allowed 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 117.098 2.258 . . . . 0.0 117.098 -162.188 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 38.1 ptt85 -56.46 37.72 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.508 1 C-N-CA 133.186 4.595 . . . . 0.0 120.139 -167.323 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 59.8 mt -57.09 129.88 19.32 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 CA-C-O 115.225 -2.321 . . . . 0.0 112.09 -176.099 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 57.8 t30 -147.41 160.14 42.9 Favored 'General case' 0 N--CA 1.449 -0.493 0 O-C-N 125.849 1.968 . . . . 0.0 114.12 -178.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 21.3 tt0 -133.07 -76.81 0.49 Allowed 'General case' 0 N--CA 1.449 -0.494 0 O-C-N 127.268 2.855 . . . . 0.0 106.637 177.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.7 t70 . . . . . 0 C--O 1.25 1.083 0 CA-C-O 114.858 -2.496 . . . . 0.0 116.392 163.495 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.434 0 N-CA-C 117.426 1.73 . . . . 0.0 117.426 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 62.4 mt -134.73 -29.18 1.18 Allowed 'General case' 0 N--CA 1.449 -0.502 0 CA-C-O 117.141 -1.409 . . . . 0.0 114.141 171.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 67.3 m -145.77 -161.76 1.37 Allowed 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 120.723 1.601 . . . . 0.0 107.44 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -62.46 164.26 7.62 Favored 'General case' 0 N--CA 1.448 -0.552 0 O-C-N 124.762 1.289 . . . . 0.0 114.287 -167.178 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 164.47 -152.28 21.91 Favored Glycine 0 C--N 1.334 0.466 0 C-N-CA 119.067 -1.539 . . . . 0.0 116.658 165.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 27.6 m -105.26 -20.04 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 C-N-CA 125.778 1.631 . . . . 0.0 114.605 169.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.52 ' HB3' ' CD1' ' A' ' 15' ' ' PHE . 6.5 tp10 -102.87 77.47 0.23 Allowed Pre-proline 0 N--CA 1.449 -0.497 0 C-N-CA 126.888 2.075 . . . . 0.0 115.72 -176.07 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_endo -66.11 143.34 71.3 Favored 'Trans proline' 0 N--CA 1.449 -1.128 0 O-C-N 117.205 -2.05 . . . . 0.0 107.465 -169.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -130.93 -84.86 0.52 Allowed 'General case' 0 N--CA 1.45 -0.463 1 C-N-CA 132.734 4.414 . . . . 0.0 110.056 -161.658 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 5.3 mt -97.0 97.48 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 O-C-N 124.732 1.27 . . . . 0.0 111.824 170.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 51.4 -100.01 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 126.033 1.778 . . . . 0.0 115.75 179.005 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -88.42 7.28 33.46 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 117.972 2.582 . . . . 0.0 117.972 177.29 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 7.4 p -119.41 172.58 7.52 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 116.754 2.131 . . . . 0.0 116.754 169.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 15.2 m-85 -137.83 -89.0 0.25 Allowed 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 126.649 1.98 . . . . 0.0 113.382 -160.382 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.52 ' CD1' ' HB3' ' A' ' 7' ' ' GLU . 25.0 m-85 -140.58 169.72 17.12 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 129.225 3.01 . . . . 0.0 109.319 179.327 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . 0.271 5.7 tp10 -88.25 60.85 5.94 Favored 'General case' 0 N--CA 1.45 -0.456 0 O-C-N 120.436 -1.415 . . . . 0.0 110.594 -160.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -89.93 159.56 16.86 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 114.759 -1.11 . . . . 0.0 113.449 178.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 46.1 t -47.01 154.41 0.35 Allowed 'General case' 0 N--CA 1.45 -0.473 1 O-C-N 129.351 4.157 . . . . 0.0 113.286 173.555 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 57.2 ttt-85 -80.38 56.58 2.57 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 124.706 2.193 . . . . 0.0 113.189 167.43 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 3.1 mt -64.04 125.43 20.74 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 O-C-N 118.147 -2.846 . . . . 0.0 106.599 175.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 17.2 p30 -144.07 166.03 26.14 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 128.356 2.662 . . . . 0.0 111.448 -158.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -137.59 5.59 2.68 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 116.442 2.016 . . . . 0.0 116.442 172.551 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 21.2 t70 . . . . . 0 C--O 1.25 1.099 0 CA-C-O 124.921 2.296 . . . . 0.0 107.138 -179.687 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.514 0 N-CA-C 120.91 3.124 . . . . 0.0 120.91 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 12.9 mt -128.9 -26.76 2.61 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 115.379 1.622 . . . . 0.0 115.379 179.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.409 ' HB2' ' O ' ' A' ' 15' ' ' PHE . 61.3 m -147.03 -173.26 4.19 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 128.083 2.553 . . . . 0.0 109.478 -174.695 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 7.4 pm0 -55.02 171.54 0.14 Allowed 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 124.547 2.118 . . . . 0.0 114.334 176.319 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 166.3 -163.9 37.21 Favored Glycine 0 C--N 1.335 0.52 0 CA-C-O 126.425 3.236 . . . . 0.0 113.744 -176.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 16.1 m -130.13 -10.3 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 CA-C-N 111.412 -2.394 . . . . 0.0 113.064 179.474 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -114.59 84.43 9.95 Favored Pre-proline 0 N--CA 1.449 -0.482 0 C-N-CA 124.592 1.157 . . . . 0.0 110.842 174.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -63.88 148.04 91.92 Favored 'Trans proline' 0 N--CA 1.45 -1.086 0 CA-C-N 122.34 1.871 . . . . 0.0 108.955 -173.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -125.81 -58.36 1.4 Allowed 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 129.987 3.315 . . . . 0.0 109.221 -167.334 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 30.6 mm -83.01 175.54 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 C-N-CA 130.267 3.427 . . . . 0.0 109.042 165.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -54.09 -56.27 22.01 Favored Glycine 0 C--N 1.335 0.493 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 170.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -84.26 -33.76 23.96 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 127.726 2.41 . . . . 0.0 111.913 -175.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 27.9 p -132.94 173.65 11.18 Favored 'General case' 0 N--CA 1.45 -0.464 0 O-C-N 117.402 -3.311 . . . . 0.0 112.386 -155.536 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -128.22 -85.65 0.58 Allowed 'General case' 0 N--CA 1.45 -0.463 0 O-C-N 126.9 2.625 . . . . 0.0 116.455 -154.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.409 ' O ' ' HB2' ' A' ' 3' ' ' SER . 30.1 m-85 -137.43 169.35 17.94 Favored 'General case' 0 N--CA 1.448 -0.529 0 O-C-N 120.207 -1.558 . . . . 0.0 110.114 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -89.04 69.59 8.43 Favored 'General case' 0 N--CA 1.449 -0.5 0 O-C-N 118.393 -2.692 . . . . 0.0 108.505 175.196 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -58.16 -41.76 84.49 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-O 124.592 2.139 . . . . 0.0 112.02 -166.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 39.66 53.41 2.48 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 129.652 3.181 . . . . 0.0 111.477 -177.016 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 71.0 ttt-85 -123.29 67.09 0.99 Allowed 'General case' 0 N--CA 1.449 -0.494 0 O-C-N 118.852 -2.405 . . . . 0.0 108.007 -162.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 35.3 mm -113.68 122.59 68.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 C-N-CA 126.861 2.064 . . . . 0.0 107.302 -178.008 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -106.77 157.31 17.83 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 126.362 1.865 . . . . 0.0 111.576 -177.505 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 21.9 mm100 -71.82 116.33 12.07 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 126.64 1.976 . . . . 0.0 114.468 168.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 . . . . . 0 C--O 1.251 1.169 0 CA-C-N 121.331 1.878 . . . . 0.0 113.865 170.508 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.479 0 N-CA-C 117.353 1.701 . . . . 0.0 117.353 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . 0.351 0.5 OUTLIER -154.88 -17.11 0.12 Allowed 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 118.688 2.847 . . . . 0.0 118.688 165.557 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.0 m -130.92 165.88 22.15 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 126.719 2.008 . . . . 0.0 111.215 -177.119 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 22.7 mp0 -68.0 142.4 55.94 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 126.959 2.104 . . . . 0.0 110.607 -175.041 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -176.86 -150.23 8.18 Favored Glycine 0 CA--C 1.522 0.482 0 O-C-N 119.091 -2.256 . . . . 0.0 108.873 -175.548 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 43.5 t -117.91 -21.7 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 1 C-N-CA 133.224 4.61 . . . . 0.0 116.628 -173.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 13.4 tp10 -113.15 83.23 6.14 Favored Pre-proline 0 N--CA 1.449 -0.5 0 C-N-CA 127.222 2.209 . . . . 0.0 111.939 -177.414 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -68.93 146.98 67.16 Favored 'Trans proline' 0 N--CA 1.45 -1.088 0 C-N-CA 124.737 3.625 . . . . 0.0 109.28 -167.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -139.62 -74.77 0.36 Allowed 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 128.254 2.622 . . . . 0.0 111.716 -159.016 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 18.9 mm -112.1 141.51 27.37 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 N-CA-C 105.318 -2.104 . . . . 0.0 105.318 171.392 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 62.54 -91.41 0.07 OUTLIER Glycine 0 C--N 1.336 0.547 0 C-N-CA 127.503 2.478 . . . . 0.0 111.525 158.494 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 7.2 mm-40 -132.77 19.89 4.2 Favored 'General case' 0 N--CA 1.45 -0.464 1 C-N-CA 133.409 4.684 . . . . 0.0 113.532 178.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 80.3 p -141.86 164.16 30.94 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-O 125.369 2.509 . . . . 0.0 112.665 -170.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 14.6 m-85 -128.4 -87.73 0.55 Allowed 'General case' 0 N--CA 1.449 -0.496 0 O-C-N 118.814 -2.429 . . . . 0.0 115.108 -151.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -140.88 153.34 45.68 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-O 122.818 1.294 . . . . 0.0 110.995 176.022 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -62.92 98.13 0.12 Allowed 'General case' 0 N--CA 1.449 -0.506 0 O-C-N 118.348 -2.72 . . . . 0.0 116.313 -176.381 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 30.7 mm-40 -112.03 112.43 24.06 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 127.612 2.365 . . . . 0.0 108.942 177.477 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 67.5 m -138.82 45.6 2.01 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 128.481 2.713 . . . . 0.0 108.98 -174.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 36.5 ttm-85 -74.93 55.56 0.71 Allowed 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 129.063 2.945 . . . . 0.0 113.715 -178.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 19.0 mt -73.68 143.88 13.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 O-C-N 124.796 1.31 . . . . 0.0 112.676 -178.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 58.7 t30 -101.05 75.55 1.67 Allowed 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 127.379 2.272 . . . . 0.0 115.452 166.203 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 -74.36 -12.59 60.56 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 124.711 1.204 . . . . 0.0 112.9 -161.487 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 . . . . . 0 C--O 1.249 1.058 0 O-C-N 121.067 -1.021 . . . . 0.0 109.555 -177.297 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.434 ' HA3' ' O ' ' A' ' 14' ' ' TYR . . . . . . . . 0 CA--C 1.522 0.521 0 N-CA-C 120.499 2.96 . . . . 0.0 120.499 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 55.2 mt -120.33 -39.3 2.8 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 115.841 -2.028 . . . . 0.0 116.446 -169.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.7 m -139.7 178.58 7.13 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 127.705 2.402 . . . . 0.0 110.237 -168.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 21.9 pt20 -74.8 156.66 36.28 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 124.711 1.205 . . . . 0.0 113.612 -168.029 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 164.24 -153.01 23.1 Favored Glycine 0 CA--C 1.523 0.554 0 C-N-CA 119.893 -1.146 . . . . 0.0 114.731 -171.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 20.1 m -120.85 -8.79 10.28 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 1 C-N-CA 136.097 5.759 . . . . 0.0 115.824 -165.204 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 19.0 tt0 -128.33 88.93 51.27 Favored Pre-proline 0 N--CA 1.45 -0.461 0 C-N-CA 129.081 2.952 . . . . 0.0 113.785 171.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -73.31 99.14 1.08 Allowed 'Trans proline' 0 N--CA 1.449 -1.116 0 C-N-CA 122.526 2.151 . . . . 0.0 110.863 -177.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -61.02 -59.14 5.85 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 126.66 1.984 . . . . 0.0 112.951 167.21 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.509 HG22 ' H ' ' A' ' 12' ' ' GLN . 7.6 mt -90.78 141.99 13.59 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 C-N-CA 128.923 2.889 . . . . 0.0 103.958 162.571 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -48.13 -32.57 9.53 Favored Glycine 0 CA--C 1.522 0.515 0 O-C-N 119.613 -1.93 . . . . 0.0 114.025 167.145 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.509 ' H ' HG22 ' A' ' 10' ' ' ILE 0.269 25.5 tt0 -67.38 -43.08 82.26 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 117.25 2.315 . . . . 0.0 117.25 168.603 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 16.5 p -149.12 150.89 33.45 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 120.649 3.574 . . . . 0.0 120.649 -164.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.434 ' O ' ' HA3' ' A' ' 1' ' ' GLY 0.27 0.7 OUTLIER -110.66 -102.95 0.39 Allowed 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 130.118 3.367 . . . . 0.0 115.981 -151.687 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 18.5 m-85 -136.16 167.55 21.06 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 169.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -73.6 60.53 0.68 Allowed 'General case' 0 N--CA 1.449 -0.488 0 O-C-N 126.738 2.524 . . . . 0.0 115.966 -158.303 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -75.86 96.71 3.76 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 126.431 1.893 . . . . 0.0 110.106 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 54.8 m -155.62 134.79 12.23 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 124.279 1.032 . . . . 0.0 110.262 177.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 22.3 mmt85 -138.8 27.6 2.43 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 126.398 1.879 . . . . 0.0 113.873 -171.033 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.411 HG13 ' H ' ' A' ' 20' ' ' ILE . 12.2 mt -42.08 110.05 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 C-N-CA 127.721 2.408 . . . . 0.0 110.451 179.115 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 58.1 t30 -150.3 150.15 31.1 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 113.283 -1.781 . . . . 0.0 111.444 174.299 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 28.5 tt0 -77.9 159.19 29.05 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 131.238 3.815 . . . . 0.0 111.695 167.266 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . 0.287 48.4 m-20 . . . . . 0 C--O 1.25 1.111 0 CA-C-O 126.971 3.272 . . . . 0.0 115.896 178.096 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.542 0 N-CA-C 122.434 3.733 . . . . 0.0 122.434 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 68.0 mt -126.53 -18.19 4.89 Favored 'General case' 0 N--CA 1.449 -0.514 0 O-C-N 129.241 3.553 . . . . 0.0 117.055 -172.133 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 70.2 m -144.91 176.65 9.31 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 131.3 3.84 . . . . 0.0 112.104 177.511 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 24.0 mp0 -70.67 156.77 39.04 Favored 'General case' 0 N--CA 1.448 -0.534 0 O-C-N 117.952 -2.968 . . . . 0.0 112.716 178.527 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 176.28 -139.55 4.61 Favored Glycine 0 CA--C 1.522 0.508 0 CA-C-O 121.763 0.646 . . . . 0.0 114.603 178.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 14.5 p -118.14 -17.0 7.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 O-C-N 119.652 -2.087 . . . . 0.0 113.141 -176.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -112.05 87.25 8.56 Favored Pre-proline 0 N--CA 1.45 -0.468 0 C-N-CA 128.683 2.793 . . . . 0.0 110.881 -172.11 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_endo -74.51 86.58 1.33 Allowed 'Trans proline' 0 N--CA 1.449 -1.14 0 CA-C-N 122.086 1.781 . . . . 0.0 112.829 -177.384 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -34.93 -82.73 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.519 1 C-N-CA 134.321 5.049 . . . . 0.0 111.958 154.055 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.444 HG22 ' N ' ' A' ' 11' ' ' GLY . 22.7 mm -76.27 174.7 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 O-C-N 118.77 -2.456 . . . . 0.0 106.747 163.04 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.444 ' N ' HG22 ' A' ' 10' ' ' ILE . . . -57.81 -51.45 58.03 Favored Glycine 0 C--N 1.336 0.536 0 O-C-N 118.129 -2.857 . . . . 0.0 114.602 154.612 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 21.3 tt0 -62.88 -47.33 83.78 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 120.122 3.379 . . . . 0.0 120.122 174.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 17.0 p -133.56 159.52 40.19 Favored 'General case' 0 N--CA 1.449 -0.483 0 O-C-N 117.163 -3.461 . . . . 0.0 116.872 -178.343 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 40.5 m-85 -111.11 -81.69 0.58 Allowed 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 124.911 1.284 . . . . 0.0 109.094 -158.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -149.86 156.29 41.52 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 178.524 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . 0.256 0.2 OUTLIER -79.34 77.04 5.89 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-O 116.975 -1.488 . . . . 0.0 109.092 -176.775 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -84.31 -33.72 23.88 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 128.049 2.539 . . . . 0.0 112.335 -165.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 3.3 t 45.09 47.36 9.74 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 123.27 2.759 . . . . 0.0 113.905 -177.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.57 2.39 5.55 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 114.732 1.382 . . . . 0.0 114.732 -159.783 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 3.8 mt -63.63 116.56 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 CA-C-O 117.696 -1.145 . . . . 0.0 111.187 154.071 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 34.1 m120 -75.24 71.54 2.25 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-O 123.785 1.755 . . . . 0.0 109.843 -176.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 47.0 tt0 -60.53 130.69 47.83 Favored 'General case' 0 N--CA 1.449 -0.494 1 C-N-CA 132.802 4.441 . . . . 0.0 110.816 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 24.7 t70 . . . . . 0 C--O 1.25 1.115 1 N-CA-C 122.03 4.085 . . . . 0.0 122.03 176.175 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.464 0 CA-C-O 122.059 0.811 . . . . 0.0 112.732 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.8 pp -153.36 -2.53 0.21 Allowed 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 118.179 2.659 . . . . 0.0 118.179 168.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 49.6 m -147.48 173.61 12.5 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-O 123.386 1.565 . . . . 0.0 110.81 176.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 -52.87 146.3 11.0 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 128.479 2.711 . . . . 0.0 112.079 172.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 171.67 -178.31 44.02 Favored Glycine 0 C--N 1.335 0.526 1 O-C-N 115.789 -4.32 . . . . 0.0 114.254 -173.171 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 33.1 m -92.68 -18.08 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 C-N-CA 124.855 1.262 . . . . 0.0 113.05 -178.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 12.5 tt0 -121.71 82.9 41.83 Favored Pre-proline 0 N--CA 1.45 -0.438 0 C-N-CA 124.245 1.018 . . . . 0.0 113.332 -165.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.471 ' HA ' ' HA ' ' A' ' 14' ' ' TYR . 5.0 Cg_exo -64.79 142.72 77.5 Favored 'Trans proline' 0 N--CA 1.449 -1.105 0 C-N-CA 120.693 0.928 . . . . 0.0 110.22 -165.723 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -119.03 -72.39 0.69 Allowed 'General case' 0 N--CA 1.449 -0.512 1 C-N-CA 133.196 4.599 . . . . 0.0 109.388 -178.145 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 96.8 mt -72.37 -20.28 19.73 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 CA-C-N 119.686 1.13 . . . . 0.0 108.586 171.005 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 94.17 -47.51 2.19 Favored Glycine 0 C--N 1.335 0.503 0 CA-C-O 123.879 1.822 . . . . 0.0 110.15 -177.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 58.5 mm-40 -63.06 -42.85 99.77 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 112.736 -1.732 . . . . 0.0 109.399 164.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 75.9 p -130.41 176.13 8.4 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 127.848 2.459 . . . . 0.0 111.63 171.151 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.471 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 4.3 m-85 -131.96 -85.88 0.48 Allowed 'General case' 0 N--CA 1.449 -0.498 1 C-N-CA 133.045 4.538 . . . . 0.0 112.718 -153.327 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -145.04 153.87 41.92 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 121.19 1.814 . . . . 0.0 109.324 -175.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -39.3 133.09 1.36 Allowed 'General case' 0 N--CA 1.45 -0.464 0 O-C-N 119.479 -2.013 . . . . 0.0 115.312 153.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -134.92 -67.06 0.56 Allowed 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 126.721 2.008 . . . . 0.0 109.365 -177.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . 0.265 16.2 m -61.1 76.49 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 120.568 3.544 . . . . 0.0 120.568 -166.195 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 27.5 ttm-85 -70.53 11.21 0.37 Allowed 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 126.604 1.961 . . . . 0.0 112.895 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.474 HD13 HG21 ' A' ' 20' ' ' ILE . 55.2 mt -50.16 131.91 9.77 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 C-N-CA 128.973 2.909 . . . . 0.0 113.32 -177.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -72.98 116.43 13.48 Favored 'General case' 0 N--CA 1.447 -0.583 0 O-C-N 126.499 2.374 . . . . 0.0 111.204 179.323 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 18.9 tt0 -74.47 125.33 28.34 Favored 'General case' 0 N--CA 1.449 -0.506 0 O-C-N 118.82 -2.425 . . . . 0.0 108.931 -172.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 . . . . . 0 C--O 1.25 1.126 0 C-N-CA 126.559 1.944 . . . . 0.0 110.232 174.36 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.523 0 N-CA-C 119.378 2.511 . . . . 0.0 119.378 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 50.5 mt -128.22 -28.11 2.63 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 117.518 2.414 . . . . 0.0 117.518 -179.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.2 m -132.23 171.59 13.49 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 128.192 2.597 . . . . 0.0 111.961 -177.071 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 31.3 mt-30 -63.43 137.87 58.31 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 127.728 2.411 . . . . 0.0 106.43 168.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -170.03 -150.28 6.79 Favored Glycine 0 CA--C 1.523 0.551 0 C-N-CA 119.28 -1.438 . . . . 0.0 111.262 -174.199 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 9.8 p -117.42 -19.22 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 N-CA-C 117.237 2.31 . . . . 0.0 117.237 -177.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 55.0 tt0 -113.06 82.62 5.52 Favored Pre-proline 0 N--CA 1.449 -0.482 0 C-N-CA 126.831 2.052 . . . . 0.0 111.442 -178.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_endo -60.67 144.32 99.53 Favored 'Trans proline' 0 N--CA 1.449 -1.09 0 C-N-CA 124.018 3.146 . . . . 0.0 113.994 -172.186 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -135.87 -81.2 0.41 Allowed 'General case' 0 N--CA 1.449 -0.483 1 C-N-CA 132.337 4.255 . . . . 0.0 107.947 -162.235 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 11.7 mm -87.75 169.67 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 O-C-N 119.81 -1.806 . . . . 0.0 108.926 174.001 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -25.03 -58.08 0.06 OUTLIER Glycine 0 C--N 1.336 0.533 0 C-N-CA 130.589 3.947 . . . . 0.0 114.404 168.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 17.4 tt0 -100.8 -22.37 14.88 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 118.712 2.856 . . . . 0.0 118.712 178.261 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 33.0 p -118.1 174.09 6.41 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 115.711 1.745 . . . . 0.0 115.711 -167.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 67.6 m-85 -132.75 -82.16 0.48 Allowed 'General case' 0 N--CA 1.449 -0.48 0 O-C-N 126.018 2.074 . . . . 0.0 110.135 -160.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -144.53 162.43 36.61 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 128.363 2.665 . . . . 0.0 110.432 177.31 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -73.1 59.21 0.52 Allowed 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 128.2 2.6 . . . . 0.0 113.655 177.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 62.8 mt-10 -68.59 -59.47 3.11 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-O 125.424 2.535 . . . . 0.0 112.96 -176.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 6.7 t -166.77 173.08 9.86 Favored 'General case' 0 N--CA 1.449 -0.479 1 C-N-CA 132.433 4.293 . . . . 0.0 110.753 179.352 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . 0.275 10.9 ttt180 -134.9 10.78 3.62 Favored 'General case' 0 N--CA 1.449 -0.5 1 C-N-CA 133.615 4.766 . . . . 0.0 113.598 167.785 . . . . . . . . 3 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 76.2 mt -54.81 138.51 14.82 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 C-N-CA 127.03 2.132 . . . . 0.0 114.116 177.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 27.2 m-80 -137.05 162.95 31.93 Favored 'General case' 0 N--CA 1.448 -0.53 0 O-C-N 117.471 -3.268 . . . . 0.0 109.504 171.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . 0.26 33.4 tt0 -132.14 57.71 1.77 Allowed 'General case' 0 N--CA 1.449 -0.501 0 O-C-N 117.832 -3.042 . . . . 0.0 110.534 -177.298 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 . . . . . 0 C--O 1.25 1.127 1 O-C-N 115.538 -4.476 . . . . 0.0 110.443 -176.112 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.546 0 CA-C-O 118.246 -1.308 . . . . 0.0 115.544 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -142.41 5.49 1.64 Allowed 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 117.735 2.494 . . . . 0.0 117.735 -179.14 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 38.2 m -118.48 -172.28 2.24 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 130.7 3.6 . . . . 0.0 117.565 -169.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 29.0 mt-30 -95.29 122.75 38.31 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 125.381 1.472 . . . . 0.0 111.649 171.61 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 176.87 -162.97 31.58 Favored Glycine 0 C--N 1.336 0.532 0 N-CA-C 109.104 -1.599 . . . . 0.0 109.104 -164.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 45.3 t -116.05 -16.27 8.95 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 1 C-N-CA 132.854 4.462 . . . . 0.0 115.233 -155.45 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 50.7 tt0 -114.39 88.98 16.57 Favored Pre-proline 0 N--CA 1.448 -0.541 0 O-C-N 119.267 -2.146 . . . . 0.0 109.271 177.15 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -67.42 110.39 2.04 Favored 'Trans proline' 0 N--CA 1.45 -1.061 0 C-N-CA 124.956 3.771 . . . . 0.0 111.988 -178.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -90.29 -86.42 0.2 Allowed 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 126.205 1.802 . . . . 0.0 109.909 -159.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 9.2 mt -88.63 65.5 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 CA-C-O 126.716 3.15 . . . . 0.0 106.844 177.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 53.17 -87.64 0.01 OUTLIER Glycine 0 C--N 1.335 0.503 0 C-N-CA 127.681 2.562 . . . . 0.0 118.173 -166.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 44.6 tt0 -58.87 -30.39 67.71 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 119.737 3.236 . . . . 0.0 119.737 -169.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 24.3 p -127.36 172.16 10.89 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 126.873 2.069 . . . . 0.0 110.901 174.406 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 41.9 m-85 -125.58 174.15 8.45 Favored 'General case' 0 N--CA 1.45 -0.457 1 C-N-CA 133.289 4.636 . . . . 0.0 111.706 -153.528 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -54.92 134.85 48.7 Favored 'General case' 0 N--CA 1.449 -0.505 0 O-C-N 124.217 0.948 . . . . 0.0 109.878 175.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . 0.306 30.6 tt0 -59.12 65.67 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 130.926 3.69 . . . . 0.0 111.875 159.216 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . 0.276 29.5 tt0 -78.44 -39.6 38.19 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 127.21 2.204 . . . . 0.0 111.391 178.062 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 17.3 t -169.86 125.48 0.82 Allowed 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.372 1.469 . . . . 0.0 112.862 167.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 35.2 ttt-85 -126.01 16.57 7.91 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 126.771 2.029 . . . . 0.0 112.693 176.527 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 73.7 mt -52.27 123.02 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 CA-C-O 124.829 2.252 . . . . 0.0 110.282 176.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 47.0 t30 -80.46 140.87 35.72 Favored 'General case' 0 N--CA 1.449 -0.504 0 O-C-N 120.194 -1.566 . . . . 0.0 114.073 178.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 11.5 tm0? -104.6 132.18 51.15 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 126.335 1.854 . . . . 0.0 109.678 173.471 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 15.5 t70 . . . . . 0 C--O 1.25 1.089 0 C-N-CA 125.376 1.471 . . . . 0.0 112.863 166.054 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.495 0 N-CA-C 116.146 1.218 . . . . 0.0 116.146 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -158.85 -1.66 0.09 Allowed 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 117.59 2.441 . . . . 0.0 117.59 177.418 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 25.9 m -149.45 167.31 26.58 Favored 'General case' 0 N--CA 1.45 -0.468 0 O-C-N 118.418 -2.676 . . . . 0.0 114.082 -175.418 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 40.6 mt-30 -61.46 138.18 58.26 Favored 'General case' 0 N--CA 1.449 -0.499 0 O-C-N 120.358 -1.464 . . . . 0.0 112.413 -177.243 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 178.1 -153.03 12.27 Favored Glycine 0 CA--C 1.523 0.556 0 O-C-N 121.099 -1.001 . . . . 0.0 114.093 -167.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 63.6 t -124.66 -20.52 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 C-N-CA 125.816 1.647 . . . . 0.0 113.118 -168.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 28.8 tp10 -105.62 89.27 3.29 Favored Pre-proline 0 N--CA 1.45 -0.465 0 CA-C-O 116.224 -1.846 . . . . 0.0 111.091 173.161 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -60.19 140.32 91.63 Favored 'Trans proline' 0 N--CA 1.449 -1.143 0 C-N-CA 123.31 2.673 . . . . 0.0 113.457 178.285 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 38.1 t0 -128.57 -93.94 0.44 Allowed 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 126.089 1.755 . . . . 0.0 111.857 -164.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 28.3 mm -107.27 143.88 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 C-N-CA 126.419 1.888 . . . . 0.0 108.748 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 56.52 -89.72 0.01 OUTLIER Glycine 0 C--N 1.336 0.53 0 C-N-CA 126.971 2.224 . . . . 0.0 115.226 174.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -134.04 4.04 3.48 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 116.083 1.883 . . . . 0.0 116.083 176.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.421 ' HB ' ' H ' ' A' ' 14' ' ' TYR . 42.8 p -114.31 -177.25 3.08 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 -179.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.421 ' H ' ' HB ' ' A' ' 13' ' ' THR . 0.5 OUTLIER -131.08 -170.71 2.41 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 131.159 3.784 . . . . 0.0 110.877 -160.717 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -68.53 150.89 47.52 Favored 'General case' 0 N--CA 1.449 -0.516 0 O-C-N 119.07 -2.269 . . . . 0.0 109.866 177.304 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -63.68 87.71 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 128.07 2.548 . . . . 0.0 113.566 174.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -76.19 -34.64 59.32 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-O 123.162 1.458 . . . . 0.0 112.53 159.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 2.2 t 59.06 50.59 7.99 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 128.701 2.8 . . . . 0.0 111.341 -168.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 33.9 ttt85 -82.36 39.29 0.59 Allowed 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 126.273 1.829 . . . . 0.0 113.376 -175.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 54.9 mt -75.04 133.72 30.89 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 O-C-N 120.823 -1.173 . . . . 0.0 108.551 -172.362 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 31.4 t30 -128.15 94.34 3.89 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 126.765 2.026 . . . . 0.0 110.924 -158.058 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 37.6 tt0 -138.91 169.18 18.26 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 126.34 1.856 . . . . 0.0 111.761 -175.013 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 31.6 t70 . . . . . 0 C--O 1.25 1.086 0 C-N-CA 127.519 2.328 . . . . 0.0 113.747 169.906 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.483 0 N-CA-C 111.131 -0.788 . . . . 0.0 111.131 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 78.9 mt -144.69 -12.86 0.57 Allowed 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.682 1.593 . . . . 0.0 113.177 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 6.1 t -138.68 -152.12 0.41 Allowed 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 127.87 2.468 . . . . 0.0 113.176 -166.349 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -116.7 156.92 26.3 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 125.128 1.371 . . . . 0.0 110.072 173.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 164.86 -144.37 9.28 Favored Glycine 0 N--CA 1.448 -0.547 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.46 -171.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 18.6 m -120.97 -15.56 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 -175.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 33.2 mm-40 -107.83 96.78 18.2 Favored Pre-proline 0 N--CA 1.449 -0.479 0 O-C-N 119.689 -1.882 . . . . 0.0 112.74 174.651 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -74.24 101.89 1.47 Allowed 'Trans proline' 0 N--CA 1.45 -1.033 0 C-N-CA 123.463 2.776 . . . . 0.0 109.853 -179.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -68.22 -63.12 1.12 Allowed 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 129.252 3.021 . . . . 0.0 112.492 176.578 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.404 HG22 ' H ' ' A' ' 12' ' ' GLN . 27.1 mt -75.89 157.21 5.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 N-CA-C 106.753 -1.573 . . . . 0.0 106.753 162.795 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -41.64 -48.27 4.92 Favored Glycine 0 CA--C 1.523 0.573 0 O-C-N 119.467 -2.021 . . . . 0.0 112.972 164.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.404 ' H ' HG22 ' A' ' 10' ' ' ILE . 39.1 tt0 -76.13 -47.66 23.53 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 116.597 2.073 . . . . 0.0 116.597 179.052 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 35.9 p -129.24 164.09 24.21 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 127.288 2.235 . . . . 0.0 116.034 -160.251 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 13.9 m-85 -121.79 178.22 4.95 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 126.353 1.861 . . . . 0.0 110.905 -161.717 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -62.91 144.71 56.47 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 -179.197 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -61.89 106.58 0.71 Allowed 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 125.97 1.708 . . . . 0.0 109.175 178.599 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -67.87 -45.63 73.99 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 114.239 -1.346 . . . . 0.0 112.627 173.67 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 42.5 t 176.62 137.31 0.06 Allowed 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 129.38 3.072 . . . . 0.0 107.782 177.702 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 42.3 mtt180 -151.46 89.57 1.5 Allowed 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 125.236 1.414 . . . . 0.0 108.166 167.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 46.9 mm -57.97 132.79 22.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 CA-C-N 115.135 -0.939 . . . . 0.0 111.058 159.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -51.43 146.65 6.93 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 126.449 1.899 . . . . 0.0 112.115 -178.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 30.6 tt0 49.08 90.98 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 128.256 2.623 . . . . 0.0 115.25 -177.311 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 . . . . . 0 C--O 1.25 1.108 0 C-N-CA 128.429 2.691 . . . . 0.0 115.466 -177.006 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.526 0 N-CA-C 117.45 1.74 . . . . 0.0 117.45 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 95.0 mt -137.7 -37.05 0.61 Allowed 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 116.566 2.062 . . . . 0.0 116.566 171.541 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.5 m -138.97 -162.14 1.28 Allowed 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 125.164 1.386 . . . . 0.0 112.325 -175.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 70.8 mt-30 -54.15 165.35 0.52 Allowed 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 114.351 1.241 . . . . 0.0 114.351 175.529 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 160.29 -173.79 36.94 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.95 -0.643 . . . . 0.0 114.196 160.135 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 13.7 p -91.3 -7.09 10.73 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 C-N-CA 125.812 1.645 . . . . 0.0 113.468 178.479 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -121.94 90.75 48.72 Favored Pre-proline 0 N--CA 1.449 -0.517 0 C-N-CA 125.644 1.578 . . . . 0.0 111.094 -171.412 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_exo -51.19 140.85 40.57 Favored 'Trans proline' 0 N--CA 1.45 -1.067 0 C-N-CA 121.912 1.742 . . . . 0.0 113.121 174.338 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -128.74 -53.38 1.24 Allowed 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 126.229 1.812 . . . . 0.0 109.242 -175.136 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.474 HG22 ' H ' ' A' ' 11' ' ' GLY . 3.0 mt -121.98 172.68 8.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 C-N-CA 125.823 1.649 . . . . 0.0 108.064 172.46 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.474 ' H ' HG22 ' A' ' 10' ' ' ILE . . . -46.58 -42.74 14.51 Favored Glycine 0 C--N 1.335 0.501 0 C-N-CA 126.202 1.858 . . . . 0.0 116.138 178.586 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 45.2 tt0 -92.85 -36.25 12.93 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 116.763 2.135 . . . . 0.0 116.763 176.058 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 82.2 p -124.38 167.7 14.03 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 119.587 -1.946 . . . . 0.0 115.972 -160.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 16.9 m-85 -131.64 -83.57 0.51 Allowed 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.982 1.313 . . . . 0.0 111.664 -161.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -141.02 171.15 14.47 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 125.556 1.543 . . . . 0.0 110.714 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -80.09 59.46 3.29 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 121.98 2.173 . . . . 0.0 111.87 177.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -67.94 146.45 53.58 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 126.372 1.869 . . . . 0.0 111.623 -175.392 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 22.6 t 117.62 123.51 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 131.438 3.895 . . . . 0.0 110.605 -173.513 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 34.1 ttp180 -146.58 28.57 1.06 Allowed 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 125.978 1.711 . . . . 0.0 112.545 -172.374 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 37.6 mt -52.96 115.35 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 O-C-N 118.927 -2.358 . . . . 0.0 111.749 174.386 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 31.4 t30 -129.78 82.41 2.07 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 127.029 2.132 . . . . 0.0 108.192 179.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 40.4 tt0 -143.48 -19.93 0.61 Allowed 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.815 1.646 . . . . 0.0 113.871 -169.166 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 . . . . . 0 C--O 1.251 1.139 0 N-CA-C 117.49 2.404 . . . . 0.0 117.49 177.266 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.534 0 CA-C-O 123.002 1.335 . . . . 0.0 114.979 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.542 ' H ' HD23 ' A' ' 2' ' ' LEU . 2.1 pt? -130.11 -5.79 4.41 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 129.317 3.047 . . . . 0.0 113.546 -174.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 26.6 m -120.56 -166.14 1.29 Allowed 'General case' 0 N--CA 1.448 -0.533 0 O-C-N 126.805 2.566 . . . . 0.0 114.772 -162.445 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 20.1 mp0 -102.68 155.76 18.09 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 119.42 1.009 . . . . 0.0 110.41 161.074 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 161.89 -165.16 35.68 Favored Glycine 0 CA--C 1.523 0.568 0 O-C-N 119.462 -2.024 . . . . 0.0 113.776 -177.614 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 14.0 p -69.68 -26.95 31.81 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 N-CA-C 119.203 3.038 . . . . 0.0 119.203 174.175 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 16.2 tp10 -118.12 90.12 36.75 Favored Pre-proline 0 N--CA 1.449 -0.515 0 O-C-N 118.324 -2.735 . . . . 0.0 114.691 -164.198 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . 0.326 17.8 Cg_endo -60.74 127.72 23.43 Favored 'Trans proline' 0 N--CA 1.449 -1.115 0 CA-C-O 125.371 2.154 . . . . 0.0 114.6 173.029 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 49.9 t0 -117.63 -88.76 0.6 Allowed 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 128.282 2.633 . . . . 0.0 115.17 -161.047 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.6 mm -99.86 144.34 12.41 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 C-N-CA 126.946 2.098 . . . . 0.0 106.471 163.562 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -45.56 143.5 3.63 Favored Glycine 0 CA--C 1.522 0.531 0 N-CA-C 121.338 3.295 . . . . 0.0 121.338 -163.747 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 15.7 tt0 62.39 -15.38 0.05 Allowed 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 109.966 -3.117 . . . . 0.0 114.323 -163.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . 0.277 24.9 p -122.28 168.54 11.91 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 126.01 2.814 . . . . 0.0 112.82 -166.006 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -134.5 162.69 31.56 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 128.041 2.536 . . . . 0.0 111.317 -166.166 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -57.73 145.58 34.09 Favored 'General case' 0 N--CA 1.449 -0.518 0 O-C-N 119.5 -2.0 . . . . 0.0 109.677 172.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -70.49 84.91 0.6 Allowed 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 127.931 2.492 . . . . 0.0 112.004 -169.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -75.3 -39.9 59.1 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 126.682 1.993 . . . . 0.0 111.828 174.544 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 47.0 m 52.51 53.72 11.82 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 126.87 2.068 . . . . 0.0 111.913 176.542 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 6.1 mmp_? -131.09 66.32 1.54 Allowed 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 126.456 1.902 . . . . 0.0 106.501 173.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.405 ' H ' HD12 ' A' ' 20' ' ' ILE . 2.2 mp -56.49 114.21 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 C-N-CA 127.876 2.47 . . . . 0.0 110.316 -172.756 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 5.4 t30 61.16 38.09 17.09 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 129.59 3.156 . . . . 0.0 114.068 164.415 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -37.3 155.5 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 117.927 2.566 . . . . 0.0 117.927 179.403 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.6 t70 . . . . . 0 C--O 1.249 1.053 0 N-CA-C 116.382 1.993 . . . . 0.0 116.382 169.097 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.546 0 N-CA-C 111.764 -0.535 . . . . 0.0 111.764 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -160.68 10.49 0.1 Allowed 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 126.36 1.864 . . . . 0.0 114.926 -169.377 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 53.8 m -131.58 169.85 15.55 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-O 115.017 -2.42 . . . . 0.0 117.137 164.294 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 16.9 mm100 -57.91 145.93 33.92 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 122.898 2.59 . . . . 0.0 111.317 164.263 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 169.17 -152.01 18.95 Favored Glycine 0 C--N 1.335 0.519 0 N-CA-C 116.911 1.524 . . . . 0.0 116.911 174.382 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.9 t -97.44 -18.63 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 O-C-N 127.08 2.282 . . . . 0.0 117.027 -177.518 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.503 ' O ' ' HA ' ' A' ' 14' ' ' TYR . 4.2 tp10 -125.88 92.42 46.22 Favored Pre-proline 0 N--CA 1.449 -0.518 0 N-CA-C 106.649 -1.611 . . . . 0.0 106.649 -168.048 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -71.99 94.98 0.73 Allowed 'Trans proline' 0 N--CA 1.448 -1.153 0 C-N-CA 124.409 3.406 . . . . 0.0 110.048 173.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -64.26 -52.28 59.44 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 130.734 3.613 . . . . 0.0 109.88 -177.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.441 HG22 ' H ' ' A' ' 12' ' ' GLN . 47.3 mm -85.12 160.03 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 161.282 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -51.3 -41.22 47.13 Favored Glycine 0 CA--C 1.523 0.534 0 CA-C-O 124.774 2.319 . . . . 0.0 114.806 173.472 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.441 ' H ' HG22 ' A' ' 10' ' ' ILE . 8.9 tt0 -61.99 -81.21 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 128.258 2.623 . . . . 0.0 111.506 172.314 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . 0.273 0.7 OUTLIER -121.79 178.28 4.93 Favored 'General case' 0 N--CA 1.449 -0.517 0 O-C-N 117.794 -3.066 . . . . 0.0 117.196 -167.563 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.503 ' HA ' ' O ' ' A' ' 7' ' ' GLU . 0.7 OUTLIER -117.13 170.67 8.48 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 130.82 3.648 . . . . 0.0 112.259 -154.79 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -51.64 137.23 25.4 Favored 'General case' 0 N--CA 1.449 -0.491 0 O-C-N 118.923 -2.361 . . . . 0.0 109.478 -174.552 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -46.52 125.02 6.47 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 129.69 3.196 . . . . 0.0 113.539 -175.675 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -120.77 -66.24 1.07 Allowed 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 122.307 2.322 . . . . 0.0 106.501 -168.167 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 35.6 t -145.45 156.1 43.53 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-O 116.236 -1.84 . . . . 0.0 113.589 -179.375 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 21.7 ttt-85 -134.89 9.48 3.57 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 125.265 1.426 . . . . 0.0 113.96 170.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 92.1 mt -61.11 122.69 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 O-C-N 118.727 -2.483 . . . . 0.0 111.876 -154.51 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 32.3 t30 -139.73 117.53 11.64 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 125.99 1.716 . . . . 0.0 111.614 -172.685 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 8.6 mp0 -79.63 -20.7 46.12 Favored 'General case' 0 N--CA 1.448 -0.538 0 O-C-N 121.022 -1.048 . . . . 0.0 113.681 174.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 51.1 t0 . . . . . 0 C--O 1.25 1.086 0 C-N-CA 128.163 2.585 . . . . 0.0 115.762 -167.654 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.493 0 CA-C-O 119.503 -0.609 . . . . 0.0 113.315 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -121.23 12.15 10.95 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 126.874 2.07 . . . . 0.0 114.33 -177.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -118.82 -148.65 0.42 Allowed 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 128.351 2.661 . . . . 0.0 110.94 178.772 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 15.4 mp0 -122.15 152.49 39.87 Favored 'General case' 0 N--CA 1.45 -0.45 0 O-C-N 116.959 -3.588 . . . . 0.0 115.042 167.002 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 170.57 -138.11 4.79 Favored Glycine 0 C--N 1.336 0.543 0 CA-C-N 113.055 -1.884 . . . . 0.0 112.291 -170.577 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 13.1 m -128.15 -8.64 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 CA-C-N 119.464 1.632 . . . . 0.0 110.647 -175.442 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -112.36 81.46 4.0 Favored Pre-proline 0 N--CA 1.449 -0.508 0 N-CA-C 116.442 2.015 . . . . 0.0 116.442 173.406 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -65.89 136.61 45.83 Favored 'Trans proline' 0 N--CA 1.449 -1.101 0 C-N-CA 123.439 2.759 . . . . 0.0 107.367 -179.418 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -130.8 -102.42 0.29 Allowed 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 109.61 -3.45 . . . . 0.0 110.074 -151.758 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 17.1 mt -70.8 88.83 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 CA-C-N 122.706 2.503 . . . . 0.0 110.447 168.224 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 46.82 -107.9 0.24 Allowed Glycine 0 CA--C 1.523 0.537 0 O-C-N 117.173 -3.455 . . . . 0.0 117.179 -175.102 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -64.58 -10.71 28.15 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 120.05 3.352 . . . . 0.0 120.05 179.227 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 46.2 p -124.06 159.92 28.86 Favored 'General case' 0 N--CA 1.449 -0.5 0 O-C-N 125.572 1.795 . . . . 0.0 113.541 -173.315 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -124.6 175.73 7.0 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 131.48 3.912 . . . . 0.0 112.729 -160.443 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -57.78 156.4 8.82 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 115.835 1.791 . . . . 0.0 115.835 -177.707 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -69.87 88.0 0.55 Allowed 'General case' 0 N--CA 1.449 -0.509 0 O-C-N 118.299 -2.751 . . . . 0.0 115.814 -166.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -81.52 151.49 27.74 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 131.228 3.811 . . . . 0.0 112.274 164.077 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . 0.268 28.0 p 59.87 -179.09 0.09 Allowed 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 118.953 2.946 . . . . 0.0 118.953 173.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 48.4 ttt180 43.16 56.0 4.36 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 129.866 3.266 . . . . 0.0 112.366 175.282 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 15.1 mm -65.35 140.38 19.77 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 CA-C-O 124.569 2.128 . . . . 0.0 107.459 175.366 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 67.0 m-20 -117.18 167.02 11.57 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 129.869 3.268 . . . . 0.0 112.447 170.436 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 20.8 tt0 34.28 61.56 0.52 Allowed 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 128.59 2.756 . . . . 0.0 116.013 -174.374 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . 0.346 41.3 m-20 . . . . . 0 C--O 1.25 1.089 0 C-N-CA 129.152 2.981 . . . . 0.0 118.167 -176.569 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.437 ' HA3' ' HB3' ' A' ' 9' ' ' ASP . . . . . . . . 0 CA--C 1.522 0.503 0 N-CA-C 116.59 1.396 . . . . 0.0 116.59 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -158.61 -3.93 0.08 Allowed 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 121.232 3.79 . . . . 0.0 121.232 171.133 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.421 ' HB2' ' HA ' ' A' ' 16' ' ' GLU . 17.7 m -150.17 -177.05 5.71 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 129.744 3.218 . . . . 0.0 111.311 175.195 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -63.3 162.44 12.18 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 130.618 3.567 . . . . 0.0 111.771 -170.535 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 163.21 -173.27 39.35 Favored Glycine 0 C--N 1.335 0.495 0 N-CA-C 118.303 2.081 . . . . 0.0 118.303 -170.273 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 20.2 m -111.51 -14.85 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 C-N-CA 128.102 2.561 . . . . 0.0 113.65 171.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -105.91 77.78 0.44 Allowed Pre-proline 0 N--CA 1.449 -0.514 0 C-N-CA 128.144 2.577 . . . . 0.0 115.625 177.158 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -63.87 96.8 0.22 Allowed 'Trans proline' 0 N--CA 1.449 -1.089 0 CA-C-O 124.301 1.709 . . . . 0.0 113.643 -176.391 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.437 ' HB3' ' HA3' ' A' ' 1' ' ' GLY . 0.2 OUTLIER -62.27 -66.62 0.51 Allowed 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 130.443 3.497 . . . . 0.0 112.37 -165.507 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . 0.254 42.8 pt -109.41 -166.39 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 CA-C-N 113.277 -1.783 . . . . 0.0 112.363 169.229 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -45.75 -47.21 13.54 Favored Glycine 0 C--N 1.335 0.514 0 N-CA-C 118.491 2.157 . . . . 0.0 118.491 -178.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 20.6 mp0 -121.84 150.39 41.99 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 129.605 3.162 . . . . 0.0 107.408 174.325 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.46 ' HA ' ' CD1' ' A' ' 14' ' ' TYR 0.28 4.7 p 56.38 179.45 0.04 OUTLIER 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 111.127 -2.76 . . . . 0.0 113.973 179.386 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.46 ' CD1' ' HA ' ' A' ' 13' ' ' THR . 2.2 m-85 -133.53 -99.06 0.27 Allowed 'General case' 0 N--CA 1.449 -0.518 0 O-C-N 117.823 -3.048 . . . . 0.0 111.203 -148.017 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -133.9 161.88 33.55 Favored 'General case' 0 N--CA 1.45 -0.475 0 CA-C-O 126.807 3.194 . . . . 0.0 107.363 -179.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.421 ' HA ' ' HB2' ' A' ' 3' ' ' SER . 21.0 tt0 -74.11 70.48 1.58 Allowed 'General case' 0 N--CA 1.449 -0.497 0 O-C-N 117.837 -3.039 . . . . 0.0 114.158 -175.334 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 -79.13 -8.23 58.82 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 131.229 3.812 . . . . 0.0 116.008 175.146 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 41.8 m -142.19 132.76 25.3 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 130.078 3.351 . . . . 0.0 116.844 -175.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 43.3 mtt180 -134.27 84.83 2.14 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 126.978 2.111 . . . . 0.0 108.251 168.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 30.2 mt -60.8 133.95 26.31 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 C-N-CA 126.938 2.095 . . . . 0.0 108.631 170.245 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 56.5 t30 -154.47 -177.71 6.65 Favored 'General case' 0 N--CA 1.45 -0.455 0 O-C-N 119.159 -2.213 . . . . 0.0 111.118 -165.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 19.3 tt0 -149.01 126.56 11.64 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-O 124.606 2.146 . . . . 0.0 109.789 -165.359 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 . . . . . 0 C--O 1.251 1.165 0 CA-C-N 113.625 -1.625 . . . . 0.0 114.489 179.395 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.501 0 N-CA-C 115.529 0.972 . . . . 0.0 115.529 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -159.41 -10.92 0.06 Allowed 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 115.98 1.844 . . . . 0.0 115.98 171.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 37.8 m -127.42 164.75 21.19 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 122.756 2.525 . . . . 0.0 116.003 -172.123 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -66.95 129.06 38.66 Favored 'General case' 0 N--CA 1.449 -0.519 0 O-C-N 120.532 -1.355 . . . . 0.0 110.581 -179.369 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -167.76 -151.88 7.24 Favored Glycine 0 C--N 1.334 0.449 0 N-CA-C 119.133 2.413 . . . . 0.0 119.133 -169.59 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 6.2 t -129.1 -19.15 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 C-N-CA 129.698 3.199 . . . . 0.0 113.911 -168.28 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -116.34 95.58 45.66 Favored Pre-proline 0 N--CA 1.45 -0.473 0 CA-C-O 117.49 -1.243 . . . . 0.0 111.637 171.58 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -74.76 90.5 1.05 Allowed 'Trans proline' 0 N--CA 1.449 -1.101 0 CA-C-N 124.092 2.497 . . . . 0.0 112.427 -175.286 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -52.34 -60.92 2.64 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 130.898 3.679 . . . . 0.0 111.458 170.652 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 20.9 pt -108.34 176.88 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 CA-C-O 124.424 2.059 . . . . 0.0 111.477 178.193 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -66.59 113.08 5.39 Favored Glycine 0 C--N 1.336 0.536 0 C-N-CA 128.438 2.923 . . . . 0.0 113.649 161.052 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 14.9 tt0 55.01 86.45 0.05 Allowed 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 128.526 2.73 . . . . 0.0 115.81 -159.792 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . 0.358 30.7 p 114.67 179.14 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.488 1 C-N-CA 133.63 4.772 . . . . 0.0 118.508 159.889 . . . . . . . . 3 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -129.59 -168.95 2.02 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 128.627 2.771 . . . . 0.0 108.373 -151.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -64.03 163.51 12.16 Favored 'General case' 0 N--CA 1.45 -0.466 0 O-C-N 119.401 -2.062 . . . . 0.0 113.102 -178.396 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -76.75 85.68 3.37 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-O 126.819 3.2 . . . . 0.0 113.459 178.577 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -66.63 173.99 3.11 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 110.558 -3.019 . . . . 0.0 116.609 173.349 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 36.6 t -46.35 132.9 10.06 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 130.905 3.682 . . . . 0.0 114.395 161.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 2.2 ttt180 -123.25 16.03 9.81 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 130.563 3.545 . . . . 0.0 114.593 164.402 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.8 mp -61.16 132.62 26.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 O-C-N 118.524 -2.61 . . . . 0.0 108.95 168.657 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 50.2 t30 -151.56 160.2 43.78 Favored 'General case' 0 N--CA 1.449 -0.523 0 O-C-N 118.745 -2.472 . . . . 0.0 113.42 -165.356 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 18.9 mp0 -126.16 167.33 15.56 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 127.73 2.412 . . . . 0.0 112.848 174.528 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 . . . . . 0 C--O 1.251 1.142 0 C-N-CA 127.361 2.264 . . . . 0.0 112.276 170.971 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.57 0 N-CA-C 114.052 0.381 . . . . 0.0 114.052 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 79.1 mt -139.61 -13.11 1.13 Allowed 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 126.312 1.845 . . . . 0.0 114.664 179.45 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 73.6 m -144.56 177.76 8.44 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-O 123.798 1.761 . . . . 0.0 109.395 -178.372 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 32.1 mt-30 -56.72 154.79 8.49 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 118.91 -2.369 . . . . 0.0 112.384 160.044 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 157.2 -156.39 27.19 Favored Glycine 0 C--N 1.335 0.516 0 O-C-N 118.773 -2.454 . . . . 0.0 114.453 178.556 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 16.8 m -110.26 -6.89 11.38 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 118.991 2.96 . . . . 0.0 118.991 -173.126 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 30.2 mm-40 -112.03 83.22 4.74 Favored Pre-proline 0 N--CA 1.45 -0.473 0 CA-C-O 116.012 -1.947 . . . . 0.0 114.476 176.102 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -64.59 142.53 77.97 Favored 'Trans proline' 0 N--CA 1.45 -1.074 0 C-N-CA 123.525 2.817 . . . . 0.0 111.44 -168.378 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -140.48 -79.88 0.28 Allowed 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 118.12 2.637 . . . . 0.0 118.12 -157.012 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.401 HG22 ' H ' ' A' ' 11' ' ' GLY . 8.0 mm -91.46 161.06 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 N-CA-C 102.965 -2.976 . . . . 0.0 102.965 165.371 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.401 ' H ' HG22 ' A' ' 10' ' ' ILE . . . -47.23 -18.64 0.52 Allowed Glycine 0 C--N 1.335 0.506 0 CA-C-N 113.633 -1.621 . . . . 0.0 117.135 -170.879 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 71.5 mt-30 -123.96 -8.56 7.76 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 129.822 3.249 . . . . 0.0 114.595 -171.568 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 64.0 p -137.98 178.79 6.86 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 117.39 2.367 . . . . 0.0 117.39 -166.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 -134.01 -97.99 0.27 Allowed 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 127.277 2.231 . . . . 0.0 112.421 -165.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 14.7 m-85 -142.81 150.28 39.74 Favored 'General case' 0 N--CA 1.449 -0.478 0 O-C-N 121.047 -1.033 . . . . 0.0 112.211 166.67 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -60.11 82.85 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.481 0 CA-C-O 127.231 3.396 . . . . 0.0 111.486 -174.373 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -65.87 -24.47 66.87 Favored 'General case' 0 N--CA 1.449 -0.478 1 O-C-N 116.181 -4.074 . . . . 0.0 112.08 164.454 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 58.7 m -64.98 47.73 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.482 1 C-N-CA 134.782 5.233 . . . . 0.0 117.541 -170.276 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 62.8 ttt-85 -71.23 56.67 0.22 Allowed 'General case' 0 N--CA 1.449 -0.506 1 O-C-N 129.309 4.131 . . . . 0.0 110.956 176.751 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 24.2 mt -135.14 111.61 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 C-N-CA 128.474 2.71 . . . . 0.0 107.703 -171.463 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 -130.68 157.65 42.21 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 112.98 -1.918 . . . . 0.0 113.601 168.192 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 56.6 mt-30 -128.79 4.13 5.44 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.817 -179.553 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 . . . . . 0 C--O 1.25 1.106 0 C-N-CA 129.378 3.071 . . . . 0.0 112.9 173.926 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.538 0 N-CA-C 116.509 1.364 . . . . 0.0 116.509 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -152.58 -8.47 0.19 Allowed 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 120.7 3.592 . . . . 0.0 120.7 157.412 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 21.4 m -134.01 -179.23 5.42 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 123.318 2.781 . . . . 0.0 115.816 174.289 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 22.6 mp0 -64.39 129.81 41.33 Favored 'General case' 0 N--CA 1.448 -0.527 0 O-C-N 118.197 -2.815 . . . . 0.0 113.956 -176.622 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -170.76 -149.16 6.3 Favored Glycine 0 C--N 1.336 0.539 0 CA-C-O 124.156 1.975 . . . . 0.0 113.048 171.541 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 26.7 m -117.01 -13.65 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 O-C-N 116.47 -3.959 . . . . 0.0 114.083 -171.349 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 23.6 tp10 -103.64 82.35 0.53 Allowed Pre-proline 0 N--CA 1.449 -0.479 0 O-C-N 126.943 2.652 . . . . 0.0 117.315 171.703 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.458 ' HB3' ' CE2' ' A' ' 14' ' ' TYR . 15.0 Cg_endo -64.47 149.75 89.44 Favored 'Trans proline' 0 N--CA 1.449 -1.136 0 C-N-CA 122.384 2.056 . . . . 0.0 108.683 -169.581 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -138.51 -92.25 0.2 Allowed 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 112.512 -2.131 . . . . 0.0 107.775 -159.34 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 6.4 mt -97.35 152.4 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 CA-C-O 117.138 -1.411 . . . . 0.0 107.217 169.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -36.35 141.81 0.19 Allowed Glycine 0 C--N 1.336 0.57 0 C-N-CA 129.534 3.445 . . . . 0.0 110.367 176.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 6.2 tm0? 58.13 -11.59 0.03 OUTLIER 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 116.962 2.208 . . . . 0.0 116.962 -168.186 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 22.6 p -133.73 168.07 19.37 Favored 'General case' 0 N--CA 1.45 -0.467 1 O-C-N 114.283 -5.261 . . . . 0.0 117.644 -170.221 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.458 ' CE2' ' HB3' ' A' ' 8' ' ' PRO . 9.1 m-85 -127.79 -82.92 0.6 Allowed 'General case' 0 N--CA 1.449 -0.48 0 CA-C-O 126.762 3.172 . . . . 0.0 112.316 -172.027 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.408 ' CD1' ' O ' ' A' ' 14' ' ' TYR . 19.7 m-85 -140.58 141.85 35.16 Favored 'General case' 0 N--CA 1.45 -0.469 1 O-C-N 116.11 -4.118 . . . . 0.0 113.463 175.887 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -59.03 84.83 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.484 0 CA-C-O 117.567 -1.206 . . . . 0.0 113.874 166.483 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -105.42 -59.14 1.8 Allowed 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 116.237 1.939 . . . . 0.0 116.237 -166.57 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 15.5 m -157.64 66.98 0.49 Allowed 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 129.354 3.062 . . . . 0.0 111.187 172.176 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 4.4 ppt_? -62.98 -11.17 17.03 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 127.97 2.508 . . . . 0.0 114.056 -172.189 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 19.3 mm -61.78 -17.18 16.76 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 CA-C-N 122.976 2.626 . . . . 0.0 110.015 178.135 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 11.4 p30 -54.72 166.95 0.41 Allowed 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 130.986 3.714 . . . . 0.0 120.004 -172.221 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -135.76 173.73 11.39 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 129.894 3.278 . . . . 0.0 108.527 176.185 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 37.2 m-20 . . . . . 0 C--O 1.25 1.107 0 CA-C-O 117.973 -1.013 . . . . 0.0 112.4 174.278 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.504 0 N-CA-C 118.233 2.053 . . . . 0.0 118.233 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -143.46 -11.64 0.71 Allowed 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 128.328 2.651 . . . . 0.0 117.916 -176.812 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 69.5 m -114.84 -174.01 2.41 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 127.85 2.46 . . . . 0.0 110.245 -164.59 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -102.76 135.27 44.72 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 128.83 2.852 . . . . 0.0 109.68 161.782 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 176.47 -158.5 24.81 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 108.126 -1.99 . . . . 0.0 108.126 -157.307 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.2 p -130.06 -0.27 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 O-C-N 121.29 -1.124 . . . . 0.0 111.743 -167.637 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 27.1 tp10 -116.56 107.58 46.56 Favored Pre-proline 0 N--CA 1.449 -0.522 1 O-C-N 115.477 -4.514 . . . . 0.0 102.673 163.687 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -66.02 142.91 70.24 Favored 'Trans proline' 0 N--CA 1.449 -1.146 0 CA-C-O 127.324 2.969 . . . . 0.0 110.867 169.194 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -119.58 -94.1 0.51 Allowed 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 110.545 -3.025 . . . . 0.0 109.477 -165.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 24.5 pt -118.36 154.73 20.48 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 C-N-CA 130.047 3.339 . . . . 0.0 109.7 177.026 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 45.15 -111.13 0.51 Allowed Glycine 0 C--N 1.335 0.498 0 C-N-CA 127.178 2.323 . . . . 0.0 112.388 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 71.8 mm-40 -97.36 -1.43 44.53 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-O 124.979 2.323 . . . . 0.0 115.624 -177.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 18.3 p -128.41 176.8 7.44 Favored 'General case' 0 N--CA 1.45 -0.429 0 O-C-N 117.075 -3.516 . . . . 0.0 110.636 -155.111 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 16.8 m-85 -127.92 173.09 10.3 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 125.415 1.486 . . . . 0.0 113.051 -165.544 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -53.31 141.34 24.38 Favored 'General case' 0 N--CA 1.448 -0.526 0 O-C-N 117.991 -2.943 . . . . 0.0 112.046 169.548 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . 0.445 30.4 tt0 -55.34 90.67 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 118.856 2.91 . . . . 0.0 118.856 174.672 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 29.7 tp10 -63.65 -22.37 66.86 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 114.448 1.277 . . . . 0.0 114.448 166.022 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 17.9 m -68.04 78.64 0.23 Allowed 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.973 1.709 . . . . 0.0 111.688 170.374 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 48.7 ttt180 -92.63 61.54 3.69 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-O 116.627 -1.654 . . . . 0.0 108.342 179.412 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 3.4 mt -58.09 105.72 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 C-N-CA 127.207 2.203 . . . . 0.0 108.009 179.776 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 14.7 t30 -128.07 105.68 8.55 Favored 'General case' 0 N--CA 1.449 -0.476 0 O-C-N 125.79 1.932 . . . . 0.0 108.889 -161.411 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -133.89 147.55 51.14 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 121.543 1.974 . . . . 0.0 114.976 154.144 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 13.7 t70 . . . . . 0 C--O 1.249 1.048 0 CA-C-O 115.59 -2.148 . . . . 0.0 113.51 -171.251 . . . . . . . . 0 0 . 1 stop_ save_